Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended JuneSeptember 30, 2023
OR
oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _____  to _____
Commission file number 001-39403

Abacus Life, Inc.
(Exact name of registrant as specified in its charter)
Delaware85-1210472
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
2101 Park Center Drive, Suite 170
Orlando Florida
32835
(Address of Principal Executive Offices)(Zip Code)
(800) 561-4148
Registrant's telephone number, including area code
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, par value $0.0001 per shareABLThe NASDAQ Stock Market LLC
Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 per shareABLLWThe NASDAQ Stock Market LLC
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  o 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).     Yes  x   No  o 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated fileroAccelerated filero
Non-accelerated filer  xSmaller reporting companyx
Emerging growth companyx
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).     Yes   o     No  x
APPLICABLE ONLY TO REGISTRANTS INVOLVED IN BANKRUPTCY
PROCEEDINGS DURING THE PRECEDING FIVE YEARS:
Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.
o  Yes o No
APPLICABLE ONLY TO CORPORATE ISSUERS:
The registrant had 62,961,68863,349,823 shares of common stock, $0.0001 par value per share, outstanding as of August 14,November 13, 2023.


Table of Contents
ABACUS LIFE, INC.
TABLE OF CONTENTS
Page


Table of Contents
Part I - Financial Information
Item 1. Financial Statements

1

Table of Contents
ABACUS LIFE, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
AS OF JUNESEPTEMBER 30, 2023 AND DECEMBER 31, 2022
June 30,
2023
(unaudited)
December 31,
2022 (unaudited)
September 30,
2023
(unaudited)
December 31,
2022
ASSETSASSETSASSETS
CURRENT ASSETS:CURRENT ASSETS:CURRENT ASSETS:
Cash and cash equivalentsCash and cash equivalents$20,611,122 $30,052,823 Cash and cash equivalents$36,649,190 $30,052,823 
Accounts receivableAccounts receivable192,595 10,448 Accounts receivable960,720 10,448 
Related party receivable78,310 198,364 
Accounts receivable, related partyAccounts receivable, related party174,875 198,364 
Due from affiliatesDue from affiliates10,473,748 2,904,646 Due from affiliates772,545 2,904,646 
Other receivables21,252 
Prepaid expenses and other current assetsPrepaid expenses and other current assets829,595 116,646 Prepaid expenses and other current assets961,427 116,646 
Total current assetsTotal current assets32,206,622 33,282,927 Total current assets39,518,757 33,282,927 
Property and equipment, netProperty and equipment, net177,931 18,617 Property and equipment, net261,882 18,617 
Intangible assets, netIntangible assets, net32,900,000 Intangible assets, net31,217,917 — 
GoodwillGoodwill140,287,000 Goodwill140,287,000 — 
Operating right-of-use assetsOperating right-of-use assets240,816 77,011 Operating right-of-use assets171,295 77,011 
Life settlement policies, at costLife settlement policies, at cost9,889,610 8,716,111 Life settlement policies, at cost4,116,499 8,716,111 
Life settlement policies, at fair valueLife settlement policies, at fair value56,685,617 13,809,352 Life settlement policies, at fair value83,585,374 13,809,352 
Available for sale securities, at fair value1,000,000 1,000,000 
Other investments1,600,000 1,300,000 
Due from members and affiliates75,582 
State security deposit206,873 
Certificate of deposit262,500 
Other assets, at fair value1,801,886 890,829 
Available-for-sale securities, at fair valueAvailable-for-sale securities, at fair value1,000,000 1,000,000 
Other investments, at costOther investments, at cost1,650,000 1,300,000 
Other assetsOther assets998,469 — 
Equity securities, at fair valueEquity securities, at fair value1,494,744 890,829 
TOTAL ASSETSTOTAL ASSETS$277,334,437 $59,094,847 TOTAL ASSETS$304,301,937 $59,094,847 
LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT)
LIABILITIES AND SHAREHOLDERS' EQUITYLIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES:CURRENT LIABILITIES:CURRENT LIABILITIES:
Accrued expensesAccrued expenses$524,400 $Accrued expenses$636,788 $— 
Accounts payableAccounts payable401,500 40,014 Accounts payable2,000 40,014 
Operating lease liabilities - current portion227,561 48,127 
Due to members and affiliates10,415,154 263,785 
Operating lease liability, currentOperating lease liability, current173,799 48,127 
Due to affiliatesDue to affiliates5,236 263,785 
Due to ownersDue to owners717,429 Due to owners1,159,712 — 
Contract liabilities - deposits on pending settlementsContract liabilities - deposits on pending settlements981,217 Contract liabilities - deposits on pending settlements348,836 — 
Accrued transaction costsAccrued transaction costs182,571 908,256 Accrued transaction costs— 908,256 
Other current liabilitiesOther current liabilities258,759 42,227 Other current liabilities3,050,731 42,227 
Income taxes payableIncome taxes payable185,831 Income taxes payable80,573 — 
Total current liabilitiesTotal current liabilities13,894,422 1,302,409 Total current liabilities5,457,675 1,302,409 
2

Table of Contents
ABACUS LIFE, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
AS OF JUNESEPTEMBER 30, 2023 AND DECEMBER 31, 2022 (CONT.)
SPV purchase and sale note25,000,000 
Long-term debt, at fair value66,165,396 28,249,653 
Operating lease liabilities - noncurrent portion16,864 29,268 
Deferred tax liability9,320,240 1,363,820 
Warrant liability2,438,600 
TOTAL LIABILITIES116,835,522 30,945,150 
COMMITMENTS AND CONTINGENCIES (11)
SHAREHOLDERS' EQUITY (DEFICIT)
Class A common stock, $0.0001 par value; 200,000,000 authorized shares; 62,961,688 and 50,369,350 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively6,296 5,037 
Additional paid-in capital188,641,886 704,963 
Retained earnings/(accumulated deficit)(29,382,362)25,487,323 
Accumulated other comprehensive income877,306 1,052,836 
Non-controlling interest355,789 899,538 
Total shareholders' equity (deficit)160,498,915 28,149,697 
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT)$277,334,437 $59,094,847 
September 30,
2023
(unaudited)
December 31,
2022

 Long-term debt- Related party36,535,778 — 
Long-term debt82,278,050 28,249,653 
Operating lease liability, noncurrent— 29,268 
Deferred tax liability10,558,687 1,363,820 
Warrant liability3,382,000 — 
TOTAL LIABILITIES138,212,190 30,945,150 
COMMITMENTS AND CONTINGENCIES (Note 11)
SHAREHOLDERS' EQUITY
Class A common stock, 0.0001 par value; 200,000,000 authorized shares; 63,349,823 and 50,369,350 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively6,335 5,037 
Additional paid-in capital194,197,741 704,963 
(Accumulated deficit) retained earnings(28,503,752)25,487,323 
Accumulated other comprehensive income100,175 1,052,836 
Non-controlling interest289,248 899,538 
Total shareholders' equity166,089,747 28,149,697 
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY$304,301,937 $59,094,847 
The accompanying notes are an integral part of these interim condensed consolidated financial statements.
3

Table of Contents
ABACUS LIFE, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
FOR THE THREE MONTHS AND SIXNINE MONTHS ENDED JUNESEPTEMBER 30, 2023 AND 2022
Three Months Ended
June 30,
Six Months Ended
June 30,
Three Months Ended
September 30,
Nine Months Ended
September 30,
20232022202320222023202220232022
REVENUES:REVENUES:REVENUES:
Portfolio servicing revenuePortfolio servicing revenuePortfolio servicing revenue
Related party servicing revenue$329,629 $419,253 $543,076 $620,159 
Portfolio Servicing revenue24,737 169 46,981 370,169 
Related party service revenueRelated party service revenue$168,899 $132,220 $711,975 $752,379 
Portfolio servicingPortfolio servicing55,670 250,025 102,651 620,194 
Total portfolio servicing revenueTotal portfolio servicing revenue354,366 419,422 590,057 990,328 Total portfolio servicing revenue224,569 382,245 814,626 1,372,573 
Active management revenueActive management revenueActive management revenue
Investment Income from life insurance policies held using investment methodInvestment Income from life insurance policies held using investment method8,263,499 5,965,466 16,655,833 13,980,466 Investment Income from life insurance policies held using investment method1,817,764 10,629,978 18,473,597 24,610,444 
Change in fair value of life insurance policies (policies held using fair value method)Change in fair value of life insurance policies (policies held using fair value method)2,760,900 2,014,013 4,339,084 3,305,505 Change in fair value of life insurance policies (policies held using fair value method)17,108,380 495,525 21,447,464 3,801,031 
Total active management revenueTotal active management revenue11,024,399 7,979,479 20,994,917 17,285,971 Total active management revenue18,926,144 11,125,503 39,921,061 28,411,475 
Originations revenueOriginations revenue
Related Party origination revenueRelated Party origination revenue254,517 — 254,517 — 
Origination revenueOrigination revenue1,715,700 — 1,715,700 — 
Total origination revenueTotal origination revenue1,970,217 — 1,970,217 — 
Total revenuesTotal revenues11,378,765 8,398,901 21,584,974 18,276,299 Total revenues21,120,930 11,507,748 42,705,904 29,784,048 
COST OF REVENUES (excluding depreciation stated below)
Cost of revenue973,400 666,119 1,462,950 2,086,075 
COST OF REVENUES (excluding depreciation and amortization stated below)COST OF REVENUES (excluding depreciation and amortization stated below)
Total cost of revenueTotal cost of revenue973,400 666,119 1,462,950 2,086,075 Total cost of revenue3,364,957 1,754,894 4,827,907 3,840,969 
Gross ProfitGross Profit10,405,365 7,732,782 20,122,024 16,190,224 Gross Profit17,755,973 9,752,854 37,877,997 25,943,079 
OPERATING EXPENSES:OPERATING EXPENSES:OPERATING EXPENSES:
Sales and marketingSales and marketing683,841 1,019,498 1,412,845 1,649,498 Sales and marketing1,704,154 14,905 3,116,999 1,664,403 
General and administrative expenses577,539 5,499 1,274,431 646,705 
General and administrative (including stock based compensation of $4,583,632)General and administrative (including stock based compensation of $4,583,632)9,838,951 59,816 11,113,382 706,523 
Loss on change in fair value of debt1,445,229 333,879 2,398,662 375,513 
(Gain) loss on change in fair value of debt(Gain) loss on change in fair value of debt(2,088,797)(1,235,032)309,865 (859,519)
Unrealized loss (gain) on investmentsUnrealized loss (gain) on investments(672,936)1,039,022 (798,156)1,054,975 Unrealized loss (gain) on investments306,800 246,846 (491,356)1,301,821 
Depreciation1,098 1,098 2,141 2,141 
Depreciation and amortization expenseDepreciation and amortization expense1,694,853 1,071 1,696,994 3,211 
Total operating expensesTotal operating expenses2,034,771 2,398,996 4,289,923 3,728,832 Total operating expenses11,455,961 (912,394)15,745,884 2,816,439 
Operating IncomeOperating Income$8,370,594 $5,333,786 $15,832,101 $12,461,392 Operating Income$6,300,012 $10,665,248 $22,132,113 $23,126,640 
4

Table of Contents
ABACUS LIFE, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
FOR THE THREE MONTHS AND SIXNINE MONTHS ENDED JUNESEPTEMBER 30, 2023 AND 2022 (CONT.)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023202220232022
OTHER INCOME (EXPENSE)OTHER INCOME (EXPENSE)OTHER INCOME (EXPENSE)
Loss on change in fair value of warrant liabilityLoss on change in fair value of warrant liability(943,400)— (943,400)— 
Interest (expense)Interest (expense)(584,075)(941,458)Interest (expense)(2,679,237)— (3,620,695)— 
Interest incomeInterest income7,457 Interest income63,826 — 71,283 — 
Other income (expense)Other income (expense)121,601 (127,455)(21,651)(242,247)Other income (expense)20,086 42,289 (1,565)(199,958)
Total other income (expense)Total other income (expense)(462,474)(127,455)(955,652)(242,247)Total other income (expense)(3,538,725)42,289 (4,494,377)(199,958)
Net income before provision for income taxesNet income before provision for income taxes2,761,287 10,707,537 17,637,736 22,926,682 
Income tax expenseIncome tax expense1,710,315 352,081 2,238,419 648,887 
NET INCOMENET INCOME1,050,972 10,355,456 15,399,317 22,277,795 
LESS: NET INCOME (LOSS) ATTRIBUTABLE TO NONCONTROLLING INTERESTLESS: NET INCOME (LOSS) ATTRIBUTABLE TO NONCONTROLLING INTEREST147,611 363,452 (339,692)770,093 
NET INCOME ATTRIBUTABLE TO SHAREHOLDERSNET INCOME ATTRIBUTABLE TO SHAREHOLDERS$903,361 $9,992,004 $15,739,009 $21,507,702 
EARNINGS PER SHARE:EARNINGS PER SHARE:
Earnings per share - basic and dilutedEarnings per share - basic and diluted0.01 0.20 0.29 0.43 
Net income before provision for income taxes7,908,120 5,206,331 14,876,449 12,219,145 
Provision for income taxes(1,184,571)(120,132)(528,104)(296,806)
NET INCOME6,723,549 5,086,199 14,348,345 11,922,339 
LESS: NET INCOME (LOSS) ATTRIBUTABLE TO NONCONTROLLING INTEREST(26,596)406,641 (487,303)406,641 
NET INCOME ATTRIBUTABLE TO SHAREHOLDERS6,750,145 4,679,558 14,835,648 11,515,698 
EARNINGS PER SHARE:
Basic and diluted weighted average shares outstanding(1)
50,507,728 50,369,350 50,438,921 50,369,350 
Basic and diluted net income per share0.13 0.09 0.29 0.23 
Weighted-average units outstanding—basic and dilutedWeighted-average units outstanding—basic and diluted63,349,823 50,369,350 54,632,826 50,369,350 
NET INCOMENET INCOME6,723,549 5,086,199 14,348,345 11,922,339 NET INCOME1,050,972 10,355,456 15,399,317 22,277,795 
Other comprehensive income, net of tax:Other comprehensive income, net of tax:Other comprehensive income, net of tax:
Change in fair value of debt(119,663)2,017,559 (231,976)2,017,559 
Comprehensive income6,603,886 7,103,758 14,116,369 13,939,898 
Comprehensive income (loss) attributable to non-controlling interests(56,111)1,011,909 (543,749)1,011,909 
Comprehensive income attributable to Abacus Life Inc.6,659,997 6,091,849 14,660,118 12,927,989 
Change in fair value of debt (risk adjusted)Change in fair value of debt (risk adjusted)(1,016,034)(523,083)(1,248,010)1,494,476 
Comprehensive income before non-controlling interestsComprehensive income before non-controlling interests34,938 9,832,373 14,151,307 23,772,271 
Net and comprehensive income (loss) attributable to non-controlling interestsNet and comprehensive income (loss) attributable to non-controlling interests(91,292)124,677 (635,041)1,136,586 
Comprehensive income attributable to Abacus Life, Inc.Comprehensive income attributable to Abacus Life, Inc.$126,230 $9,707,696 $14,786,348 $22,635,685 
(1) Both the number of shares outstanding and their par value have been retrospectively recast for all prior periods presented to reflect the par value of the outstanding stock of the Abacus Life, Inc. as a result of the Business Combination.
The accompanying notes are an integral part of these interim condensed consolidated financial statements.
5

Table of Contents
ABACUS LIFE, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
FOR THE THREE MONTHS ENDED JUNESEPTEMBER 30, 2023 AND 2022
Class A Common StockAdditional
Paid-In
Capital
Retained EarningsAccumulated
Other
Comprehensive
Income
Non-
Controlling
Interests
Total
Shareholders’
Equity
SharesAmount
BALANCE AS OF MARCH 31, 2022 (1)
50,369,350 $5,037 $704,963 $4,951,188 $— $(148,155)$5,513,033 
Distributions— — — (310,000)— — (310,000)
Other Comprehensive Income— — — — 1,412,291 605,268 2,017,559 
Net Income— — — 4,679,558 — 406,641 5,086,199 
BALANCE AS OF JUNE 30, 2022 (1)
50,369,350 $5,037 $704,963 $9,320,746 $1,412,291 $863,754 $12,306,791 
Class A Common StockAdditional
Paid-In
Capital
Retained EarningsAccumulated
Other
Comprehensive
Income
Non-
Controlling
Interests
Total
Shareholders’
Equity
SharesAmount
BALANCE AS OF JUNE 30, 2022 (1)
50,369,350 $5,037 $704,963 $9,320,746 $1,412,291 $863,754 $12,306,791 
Other comprehensive income— — — — (284,308)(238,775)(523,083)
Net Income— — — 9,992,004 — 363,452 10,355,456 
BALANCE AS OF SEPTEMBER 30, 2022 (1)
50,369,350 $5,037 $704,963 $19,312,750 $1,127,983 $988,431 $22,139,164 
Class A Common StockAdditional
Paid-In
Capital
Accumulated DeficitAccumulated Other Comprehensive LossNon-
Controlling
Interests
Total
Shareholders’
Equity
SharesAmount
BALANCE AS OF MARCH 31, 2023 (1)
50,369,350 $5,037 $704,963 $33,572,826 $967,454 $411,900 $35,662,180 
Distributions— — — (34,451,607)— — (34,451,607)
Deferred transaction costs— — — (10,841,551)— — (10,841,551)
Public warrants— — 4,726,500 (3,765,600)— — 960,900 
Merger with East Resources Acquisition Company12,592,338 1,259 17,849,091 (20,646,575)— — (2,796,225)
Acquisition of Abacus Settlements, LLC— — 165,361,332 — — — 165,361,332 
Other Comprehensive Income— — — — (90,148)(29,515)(119,663)
Net Income— — — 6,750,145 — (26,596)6,723,549 
BALANCE AS OF JUNE 30, 202362,961,688$6,296 $188,641,886 $(29,382,362)$877,306 $355,789 $160,498,915 

Class A Common StockAdditional
Paid-In
Capital
Accumulated DeficitAccumulated Other Comprehensive LossNon-
Controlling
Interests
Total
Shareholders’
Equity
SharesAmount
BALANCE AS OF JUNE 30, 2023 (1)
62,961,688 $6,296 $188,641,886 $(29,382,362)$877,306 $355,789 $160,498,915 
Merger with East Resources Acquisition Company388,135 39 (39)— — 
Proceeds received from SPAC trust— — 972,262 — — — 972,262 
Stock based compensation— — 4,583,632 — — — 4,583,632 
Transfer of non-controlling interest— — — (24,751)— 24,751 — 
Other Comprehensive Income— — — — (777,131)(238,903)(1,016,034)
Net Income— — — 903,361 — 147,611 1,050,972 
BALANCE AS OF SEPTEMBER 30, 202363,349,823$6,335 $194,197,741 $(28,503,752)$100,175 $289,248 $166,089,747 
(1) Both the number of shares outstanding and their par value have been retrospectively recast for all prior periods presented to reflect the par value of the outstanding stock of the Abacus Life, Inc. as a result of the successful Business Combination.
The accompanying notes are an integral part of these interim condensed consolidated financial statements.

6

ABACUS LIFE, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
FOR THE SIXNINE MONTHS ENDED JUNESEPTEMBER 30, 2023 AND 2022 (CONT.)
Class A Common StockAdditional
Paid-In
Capital
Retained EarningsAccumulated
Other
Comprehensive
Income
Non-
Controlling
Interests
Total
Shareholders’
Equity
SharesAmountClass A Common StockAdditional
Paid-In
Capital
Retained EarningsAccumulated
Other
Comprehensive
Income
Non-
Controlling
Interests
Total
Shareholders’
Equity
SharesAmount
BALANCE AS OF DECEMBER 31, 2021(1)
BALANCE AS OF DECEMBER 31, 2021(1)
50,369,350 $5,037 $704,963 $205,048 $— $(148,155)$766,893 
BALANCE AS OF DECEMBER 31, 2021(1)
50,369,350 $5,037 $704,963 $205,048 $— $(148,155)$766,893 
DistributionsDistributions— — — (2,400,000)— — (2,400,000)Distributions— — — (2,400,000)— — (2,400,000)
Other comprehensive income— — — — 1,412,291 605,268 2,017,559 
Other Comprehensive IncomeOther Comprehensive Income— — — — 1,127,983 366,493 1,494,476 
Net IncomeNet Income— — — 11,515,698 — 406,641 11,922,339 Net Income— — — 21,507,702 — 770,093 22,277,795 
BALANCE AS OF JUNE 30, 2022(1)
50,369,350 $5,037 $704,963 $9,320,746 $1,412,291 $863,754 $12,306,791 
BALANCE AS OF SEPTEMBER 30, 2022(1)
BALANCE AS OF SEPTEMBER 30, 2022(1)
50,369,350 $5,037 $704,963 $19,312,750 $1,127,983 $988,431 22,139,164 

Class A Common StockAdditional
Paid-In
Capital
Accumulated DeficitAccumulated
Other
Comprehensive
Loss
Non-
Controlling
Interests
Total
Shareholders’
Equity
SharesAmountClass A Common StockAdditional
Paid-In
Capital
Retained Earnings (Accumulated Deficit)Accumulated
Other
Comprehensive
Loss
Non-
Controlling
Interests
Total
Shareholders’
Equity
SharesAmount
BALANCE AS OF DECEMBER 31, 2022 (1)
BALANCE AS OF DECEMBER 31, 2022 (1)
50,369,350 $5,037 $704,963 $25,487,323 $1,052,836 $899,538 $28,149,697 
BALANCE AS OF DECEMBER 31, 2022 (1)
50,369,350 $5,037 $704,963 $25,487,323 $1,052,836 $899,538 $28,149,697 
DistributionsDistributions— — — (34,451,607)— — (34,451,607)Distributions— — — (34,451,607)— — (34,451,607)
Deferred transaction costsDeferred transaction costs— — — (10,841,551)— — (10,841,551)Deferred transaction costs— — — (10,841,551)— — (10,841,551)
Public warrantsPublic warrants— — 4,726,500 (3,765,600)— — 960,900 Public warrants— — 4,726,500 (3,765,600)— — 960,900 
Merger with East Resources Acquisition CompanyMerger with East Resources Acquisition Company12,592,338 1,259 17,849,091 (20,646,575)— (2,796,225)Merger with East Resources Acquisition Company12,980,473 1,298 17,849,052 (20,646,575)— — (2,796,225)
Acquisition of Abacus Settlements, LLCAcquisition of Abacus Settlements, LLC— — 165,361,332 — — — 165,361,332 Acquisition of Abacus Settlements, LLC— — 165,361,332 — — — 165,361,332 
Proceeds received from SPAC trustProceeds received from SPAC trust— — 972,262 — — — 972,262 
Stock based compensationStock based compensation4,583,632 — — — 4,583,632 
Transfer of non-controlling interestTransfer of non-controlling interest— — — (24,751)— 24,751 — 
Other Comprehensive IncomeOther Comprehensive Income— — — — (175,530)(56,446)(231,976)Other Comprehensive Income— — — — (952,661)(295,349)(1,248,010)
Net IncomeNet Income— — — 14,835,648 — (487,303)14,348,345 Net Income— — — 15,739,009 — (339,692)15,399,317 
BALANCE AS OF JUNE 30, 202362,961,688$6,296 $188,641,886 $(29,382,362)$877,306 $355,789 $160,498,915 
BALANCE AS OF SEPTEMBER 30, 2023BALANCE AS OF SEPTEMBER 30, 202363,349,823$6,335 $194,197,741 $(28,503,752)$100,175 $289,248 $166,089,747 
(1) Both the number of shares outstanding and their par value have been retrospectively recast for all prior periods presented to reflect the par value of the outstanding stock of the Abacus Life Inc. as a result of the successful Business Combination.

The accompanying notes are an integral part of these interim condensed consolidated financial statements.
7

Table of Contents
ABACUS LIFE, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE SIXNINE MONTHS ENDED JUNESEPTEMBER 30, 2023 AND 2022 (CONT.)
Six Months Ended June 30,
20232022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income$14,348,345 $11,922,339 
Adjustments to reconcile net income to net cash
provided by (used in) operating activities:
Depreciation2,141 2,141 
Unrealized (gain) loss on investments(798,156)1,054,975 
Unrealized gain on policies(3,319,588)(3,305,505)
Loss on change in fair value of debt2,398,662 375,513 
Deferred income taxes252,659 999,927 
Non-cash lease expense384 — 
Changes in operating assets and liabilities:
Accounts receivable(182,147)— 
Related party receivable125,764 (77,657)
Prepaid expenses and other current assets(193,462)(1,379,579)
Other noncurrent assets(105,655)— 
Accounts payable361,486 — 
Accrued transaction costs(725,685)— 
Other current liabilities402,363 72,938 
Life Settlement Policies purchased, at fair value(39,556,677)(7,211,509)
Life Settlement Policies purchased, at cost(11,374,605)(7,204,753)
Net cash used in operating activities(38,364,171)(4,751,170)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of investments(300,000)(250,000)
Due from affiliates(6,760,627)— 
Net cash used in investing activities(7,060,627)(250,000)
CASH FLOWS FROM FINANCING ACTIVITIES:
Issuance of debt certificates35,206,351 9,463,779 
Transaction costs(10,841,551)— 
Capital distribution to members(23,533,072)(2,400,000)
Proceeds from receipt of SPV purchase and sale note25,000,000 — 
Due to members and affiliates10,151,369 680,375 
Net cash provided by financing activities35,983,097 7,744,154 
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS(9,441,701)2,742,984 
CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE PERIOD30,052,823 102,421 
CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD$20,611,122 $2,845,405 
Nine Months Ended September 30,
20232022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income$15,399,317 $22,277,795 
Adjustments to reconcile net income to net cash
provided by (used in) operating activities:
Depreciation and amortization1,696,994 3,211 
Stock based compensation4,583,632 — 
Deferred financing fees133,211 — 
Unrealized (gain) loss on investments(491,356)1,301,821 
Unrealized (gain) on policies(14,259,665)(3,957,809)
(Gain) loss on change in fair value of debt309,865 (859,519)
Deferred income taxes1,743,079 648,887 
Non-cash interest expense1,064,130 — 
Non-cash lease expense(721)192 
Changes in operating assets and liabilities:
Accounts receivable(929,020)— 
Accounts receivable, related party29,199 (364,931)
Prepaid expenses and other current assets(325,294)(1,920,015)
Other noncurrent assets(634,409)— 
Accounts payable(38,014)44,103,901 
Accrued expenses112,388 — 
Accrued transaction costs(908,256)— 
Contract liabilities - deposits on pending settlement(632,381)— 
Other current liabilities3,089,077 1,352,878 
Life settlement policies, at fair value(55,516,357)(7,105,000)
Life settlement policies, at cost(5,601,493)(61,876,742)
Net cash used in operating activities(51,176,074)(6,395,331)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of other investments(350,000)(250,000)
Purchase of property and equipment(96,721)— 
Due from affiliates3,016,158 (1,682,664)
Net cash provided (used) in investing activities2,569,437 (1,932,664)
8

Table of Contents
ABACUS LIFE, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022 (CONT.)
Nine Months Ended September 30,
20232022
CASH FLOWS FROM FINANCING ACTIVITIES:
Due to owners442,283 2,500,000 
Issuance of debt certificates87,478,232 12,900,291 
Issuance of private warrants943,400 — 
Transaction costs(10,841,551)— 
Capital distribution to members(23,533,073)(2,400,000)
Proceeds received from SPAC trust972,262 — 
Due to affiliates(258,549)(930,630)
Net cash provided by financing activities55,203,004 12,069,661 
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS6,596,367 3,741,666 
CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE PERIOD30,052,823 102,421 
CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD$36,649,190 $3,844,087 
The accompanying notes are an integral part of these interim condensed consolidated financial statements.

8
9

Table of Contents
ABACUS LIFE, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
1.DESCRIPTION OF BUSINESS
Organization and Merger
Abacus Life, Inc. (“the Company”(the “Company”) was formerly known as East Resources Acquisition Company ("ERES”), a blank check company incorporated in Delaware on May 22, 2020. Abacus Life, Inc. conducts its business through its wholly-owned, consolidated subsidiaries, primarily Abacus Settlements, LLC (“Abacus”Abacus Settlements”, or “Abacus”) and Longevity Market Assets, LLC (“LMA”), which are incorporated in the state of Delaware limited liability companies (collectively, the “Companies”). On June 30, 2023, (the “Closing Date”), ERES, Longevity Market Assets, LLCLMA and Abacus Settlements, LLC consummated the combining of the Companies as contemplated by the Merger Agreement dated as of August 30, 2022 (as amended on October 14, 2022 and April 20, 2023) with LMA Merger Sub, LLC, a wholly owned subsidiary of ERES (“LMA Merger Sub”), Abacus Merger Sub, LLC, a wholly owned subsidiary of ERES (“Abacus Merger Sub”), Longevity Market Assets, LLC (“LMA”)LMA and Abacus Settlements, LLC (“Legacy Abacus” and, together(together with LMA, the “Legacy Companies”). Pursuant to the Merger Agreement, on June 30, 2023, (i) LMA Merger Sub merged with and into LMA, with LMA surviving such merger (the “LMA Merger”) and (ii) Abacus Merger Sub merged with and into Legacy Abacus, with Legacy Abacus surviving such merger (the “Abacus Merger” and, together with the LMA Merger, the “Mergers” and, along with the other transactions contemplated by the Merger Agreement, the “Business Combination”) and the Legacy Companies became direct wholly owned subsidiaries of Abacus and ERES changed its name to Abacus Life, Inc.
The condensed consolidated assets, liabilities and statements of operations and comprehensive income prior to the Business Combination are those of legacy LMA. The stocksshares of common stock and corresponding capital amounts and income per stock,share, prior to the Business Combination, have been retroactively restated based on stocksshare reflecting the exchange ratio established in the Business Combination.
The equity structure has been recast in all comparative periods up to the Closing Date to reflect the number of shares of the Company’s common stock, $0.0001 par value per share, issued to legacy LMA’s stockholders in connection with the Business Combination. As such, the shares and corresponding capital amounts and earningsincome per share related to legacy LMA common stock prior to the Business Combination have been retroactively recast as shares reflecting the exchange ratio of 0.8 established in the Business Combination.
Business Activity
The Company, through its LMA subsidiary, is a provider of services pertaining to life insurance settlements and offers policy servicing to owners and purchasers of life settlement assets, as well as consulting, valuation, and actuarial services. The Company is also engaged in buying and selling of life settlement policies in which it uses its own capital, and purchases life settlement contracts with the intent to either hold to maturity to receive the associated death claim payout or to sell to another purchaser of life settlement contracts for a gain on the sale.

10

Table of Contents
The Company, through its Abacus subsidiary, also is an originator of outstanding life insurance policies as a licensed life settlement provider on behalf of investors (“Financing Entities”). Abacus locates and screens policies for eligibility as a commercially desirable life settlement, including verifying that the policy is in force, obtaining consents and disclosures, and submitting cases for life expectancy estimates, also known, collectively, as origination services. When the sale of a policy is completed, this is deemed “settled” and the policy is then referred to as either a “life settlement” in which the insured’s life expectancy is greater than two years or “viatical settlement,” in which the insured’s life expectancy is less
9

Table of Contents
than two years. The Company is not an insurance company, and therefore the Company does not underwrite insurable risks for its own account.
2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation—In connection with the Business Combination, the Merger is accounted for as a reverse recapitalization with ERES in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). Under U.S. GAAP, ERES has been treated as the “acquired” company for financial reporting purposes. This determination was primarily based on the LMA shareholders having a relative majority of the voting power of the Company, the LMA shareholders having the authority to appoint a majority of directors on the Board of Directors, and senior management of LMA comprising the majority of the senior management of the post-combination Company. LMA was then determined to be the “acquirer” for financial reporting purposes based on the relative size of LMA as compared to Abacus, represented by their revenue, equity, gross profit and net income. Accordingly, for accounting purposes, the financial statements of the combined entity will represent a continuation of the financial statements of LMA with the LMA Merger being treated as the equivalent of LMA issuing stock for the net assets of ERES, accompanied by a recapitalization. The net assets of ERES will be stated at historical cost, with no goodwill or other intangible assets recorded.
The Abacus Merger will behas been accounted for using the acquisition method of accounting. Under the acquisition method of accounting, the assets and liabilities of Abacus will bewere recorded at estimatedthe fair value as of the acquisition date. The excess of the purchase price over the estimated fair values of the net assets acquired if applicable, will bewas recognized as goodwill.
As a result of the Business Combination, the Company evaluated if ERES, Abacus, or LMA is the predecessor for accounting purposes.
In considering the foregoing principles of predecessor determination and in light of the Company's specific facts and circumstances, management determined that LMA and Abacus are dual predecessors for accounting purposes. The financial statement presentation for Abacus Life, Inc. includes the purchase accounting effects of the Abacus Merger as of the Closing Date with the financial statements of LMA as the comparative period. The predecessor financial statements for Abacus are included separately within this report.
The accompanying condensed consolidated financial statements of the Company have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission and are prepared in accordance with U.S. GAAP.

11

Table of Contents
Unaudited Condensed Consolidated Financial Statements—The condensed consolidated financial statements have been prepared on a basis consistent with the audited annual financial statements as of and for the year ended December 31, 2022, and, in the opinion of management, reflect all adjustments, consisting solely of normal recurring adjustments, necessary for the fair presentation of the Company’s financial position as of JuneSeptember 30, 2023, and the condensed consolidated statements of operations and comprehensive income for the three months and sixnine months ended JuneSeptember 30, 2023 and 2022, respectively, and the condensed consolidated statements of cash flows for the sixnine months ended JuneSeptember 30, 2023 and 2022, respectively. The condensed consolidated statements of operations and comprehensive income for the three months and sixnine months ended JuneSeptember 30, 2023, are not necessarily indicative of the results to be expected for the full year ending December 31, 2023, or any other period. These interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes for Abacus for the year ended December 31, 2022, and the financial statements and notes for LMA for the year ended December 31, 2022. All references to financial information as of and for the periods ended JuneSeptember 30, 2023, and 2022 in the notes to condensed consolidated financial statements are unaudited.
10

Table of Contents
Refer to this note in the LMA annual financial statements for the full list of the Company’s significant accounting policies. The details in those notes have not changed, except as discussed below and as a result of normal adjustments in the interim periods.
Consolidation of Variable Interest Entities—For entities in which the Company has variable interests, the Company first evaluates whether the entity meets the definition of a variable interest entity (“VIE”) or a voting interest entity (“VOE”). If the entity is a VIE, the Company focuses on identifying whether it has the power to direct the activities that most significantly impact the VIE’s economic performance and whether it has the obligation to absorb losses or the right to receive benefits from the VIE. If the Company is the primary beneficiary of a VIE, the assets, liabilities, and results of operations of the VIE will be included in the Company’s condensed consolidated financial statements. The proportionate share not owned by the Company is recognized as noncontrolling interest and net income attributable to noncontrolling interest on the condensed consolidated balance sheets and condensed consolidated statements of operations and comprehensive income, respectively. If the entity is a VOE, the Company evaluates whether it has the power to control the VOE through a majority voting interest or through other arrangements.
Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 810, Consolidations, (“ASC 810”) requires the Company to separately disclose on its condensed consolidated balance sheets the assets of consolidated VIEs and liabilities of consolidated VIEs as to which there is no recourse against the Company. As of JuneSeptember 30, 2023, total assets and liabilities of consolidated VIEs were $57,577,034 $62,831,856 and $52,474,820,$56,775,736, respectively. As of December 31, 2022, total assets and liabilities of consolidated VIEs were $30,073,972 and $27,116,762, respectively.
On January 1, 2021, the Company entered into an option agreement with two commonly owned full-service origination, servicing, and investment providers (the “Providers”), in which the Company agreed to fund certain capital needs with an option to purchase the outstanding equity ownership of the Providers (the “Option Agreement”).
The Company accounted for its investment in the call options under the Option Agreement as an equity security, pursuant to ASC 321.321, Investments—Equity Securities. In arriving at this accounting conclusion, the Company first considered whether the call options met the definition of a derivative pursuant to ASC 815,Derivatives and Hedging, and concluded that the options do not provide for net settlement and accordingly are not a derivative. The Company also concluded that the call options do not provide the Company with a controlling financial interest in the legal entity pursuant to ASC 810. The call options include material contingencies prior to exercisability that the Company does not anticipate will be resolved; additionally, the call options are in a legal entity for which the share price has no readily determinable fair value. The Company’s basis in the call options, pursuant to ASC 321, is zero and accordingly the call options are not reflected in the statement of financial position.
12

Table of Contents
The Company provided $0 and $127,455$40,800 of funding for the three months ended JuneSeptember 30, 2023 and JuneSeptember 30, 2022, respectively, and provided $29,721 and $242,247$283,047 of funding for the sixnine months ended JuneSeptember 30, 2023 and JuneSeptember 30, 2022, respectively, which is included in other (expense) income on the condensed consolidated statements of operations and comprehensive income. SeeRefer to Note 11 Commitments and Contingencies.for further details.
For the period ended JuneSeptember 30, 2023, and for the year ended December 31, 2022, the Providers were considered to be VIEs, but were not consolidated in the Company’s condensed consolidated financial statements due to a lack of the power criterion or the losses/benefits criterion. As of JuneSeptember 30, 2023, the unaudited financial information for the unconsolidated VIEs are as follows: held assets of $318,178$824,375 and liabilities of $450 and held assets of $483,167 and liabilities of $184,621, respectively.$191,632. As of December 31, 2022, the unaudited financial information for the unconsolidated VIEs are as follows: held assets of $126,040$987,964 and liabilities of $0 and held assets of $861,924 and liabilities of $358,586, respectively.$358,586.
On October 4, 2021, the Company entered into an operating agreement with LMX Series, LLC (“LMX”) and three other unaffiliated investors to obtain a 70% ownership interest in LMX, which was newly formed in August 2021. LMX had no operating activity prior to the operating agreement being signed.
11

Table of Contents
LMX has a wholly owned subsidiary, LMATT Series 2024, Inc., a Delaware C corporation. While the Company and three other investors each contributed $100 to LMX, the Company directs the most significant activities by managing the investment offerings, and sponsoring and creating structured investment grade insurance liabilities, and thus was provided a 70% ownership interest. LMX is a VIE and the Company is the primary beneficiary of LMX. The Company has included the results of LMX and its subsidiaries in its condensed consolidated financial statements for the period ended June 30, 2023.
On March 3, 2022, the Company obtained an 80% ownership interest in Longevity Market Advisors, LLC (“Longevity Market Advisors”). The Longevity Market Advisors legal entity was established primarily for the purpose of acquiring the assets of a broker/dealer, Regional Investment Services, Inc. (“RIS”), an Ohio corporation. Longevity Market Advisors is a VIE and the Company is the primary beneficiary of Longevity Market Advisors. The purchase price payable in exchange for RIS was $60,000. The Company evaluated whether this represented a business combination or an asset acquisition under ASC 805. While the purchase of the RIS represents a business, it was further determined that as RIS was purchased for the primary reason of being registered by the Financial Industry Regulatory Authority (“FINRA”). As there are no tangible or intangible assets of value from the RIS that would meet the capitalization criteria that have standalone value, the Company has expensed the purchase in general and administrative costs. Upon closing of the transaction, Longevity Market Advisors will comprise 100% of the ownership structure of RIS, and RIS will be a wholly owned subsidiary. The Company has included the results of Longevity Market Advisors in its condensed consolidated financial statements for the period ended JuneSeptember 30, 2023.
On November 30, 2022, LMA Series, LLC, a wholly owned subsidiary of the Company, signed an Operating Agreement to be the sole member of a newly created general partnership, LMA Income Series, GP, LLC. Subsequent to that, LMA Income Series, GP, LLC formed a limited partnership, LMA Income Series, LP and issued partnership interests to limited partners in a private placement offering. It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series, LP and thus has fully consolidated the limited partnership in its condensed consolidated financial statements for the sixnine months ended JuneSeptember 30, 2023.
On January 31, 2023, LMA Series, LLC, a wholly owned subsidiary of the Company, signed an Operating Agreement to be the sole member of a newly created general partnership, LMA Income Series II, GP, LLC. Subsequent to that, LMA Income Series II, GP, LLC formed a limited partnership, LMA Income Series II, LP and issued partnership interests to limited partners in a private placement offering. It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series II, LP and thus has fully consolidated the limited partnership in its condensed consolidated financial statements for the sixnine months ended JuneSeptember 30, 2023.
Noncontrolling Interest—Noncontrolling interest represents the share of consolidated entities owned by third parties. At the date of formation or upon acquisition, the Company recognizes noncontrolling interest on the condensed consolidated balance sheets at an amount equal to the noncontrolling interest’s proportionate share of the relative fair value of any assets and liabilities acquired. Noncontrolling interest is subsequently adjusted for the noncontrolling shareholder’s additional contributions, distributions, and the shareholder’s share of the net earnings or losses of each respective consolidated entity.
Net income of a consolidated entity is allocated to noncontrolling interests based on the noncontrolling shareholder’s ownership interest during the period. The net income or loss that is not attributable to the Company is reflected in net income (loss) attributable to noncontrolling interests in the condensed consolidated statements of operations and comprehensive income.

13

Table of Contents
Use of Estimates—The preparation of U.S. GAAP financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and changes therein, disclosure of contingent assets and liabilities at the date of financial statements, and the reports amounts of revenue and expenses during the reporting periods. Company’s estimates, judgments, and
12

Table of Contents
assumptions are continually evaluated based on available information and experience. Because of the use of estimates inherent in the financial reporting process, actual results could differ from the estimates. Estimates are used when accounting for revenue recognition and related costs, purchase price allocation, the selection of useful lives of property and equipment, valuation of other receivables, valuation of life settlement policies, valuation of other investments and available-for-sale securities, valuation of long-term debt, impairment testing, income taxes, and legal reserves.
Life Insurance Settlement Policies—The Company accounts for its holdings of life insurance settlement policies in accordance with ASC 325-30, Investments in Insurance Contracts. TheFor all policies purchased after June 30, 2023, the Company accounts for life settlementthese under the fair value method. For policies purchased that we intendbefore June 30, 2023, the Company elected to hold to maturity atuse either the fair value and life settlement policies that we intend to trade inmethod or the near term at costinvestment method (cost, plus premiums paid.paid). The valuation method is chosen upon contract acquisition and is irrevocable.
The Company follows ASC 820, Fair Value Measurements and Disclosures, in estimating the fair value of its life insurance policies held at fair value. ASC 820 defines fair value as an exit price representing the amount that would be received if an asset were sold or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the guidance establishes a three-level, fair value hierarchy that prioritizes the inputs used to measure fair value. Level 1 relates to quoted prices in active markets for identical assets or liabilities. Level 2 relates to observable inputs other than quoted prices included in Level 1. Level 3 relates to unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Company’s valuation of life settlements is considered to be Level 3, as there is currently no active market where we are able to observe quoted prices for identical assets. The Company’s valuation model incorporates significant inputs that are not observable. SeeRefer to Note 10 “Fair Value Measurements.”for further details. For policies held at fair value, changes in fair value are reflected in the unaudited condensed consolidated statement of operations and comprehensive income under active management revenue in the period the change is calculated.
For policies held under the investment method, the Company tests the impairment if we become aware of information indicating that the carrying value plus undiscounted future premiums of a policy may not be recoverable. This information is gathered initially through extensive underwriting procedures at purchase of the settlement contract, as well as through periodic underwriting review that include medical reports and life expectancy evaluations. The policies held by the Company using the investment method are expected to be owned for a shorter-term, and are actively marketed to potential buyers. The market feedback received through these interactions provides the Company with information related to a potential impairment. If a policy is determined to be impaired, the Company will adjust the carrying value to the fair value determined through the impairment analysis.
The Company accounts for cash proceeds from sale and maturity of life insurance settlement policies, as well as cash outflows for premium payments, as operating activities within the condensed consolidated statements of cash flows.


14

Table of Contents
Goodwill and Intangible Assets—Goodwill and intangible assets are recorded as a result of a business combination. Goodwill represents the excess of the purchase price over the fair value of the assets acquired and liabilities assumed. The Company amortizes identifiable intangible assets with a finite useful life over the period that the intangible asset is expected to contribute directly or indirectly to its future cash flows; however, it does not amortize indefinite lived intangible assets. The Company evaluates goodwill and identifiable intangible assets for recoverability annually in the fourth quarter or on an interim basis should events or changes in circumstances indicate that a carrying amount may not be recoverable.

To test for impairment, a qualitative assessment is performed to determine if it is more likely-than-not that the fair value of a reporting unit is less than its carrying value, including goodwill. This initial assessment includes, among other factors, consideration of: (i) past, current and projected future earnings and equity; (ii) recent trends and market conditions; and (iii) valuation metrics involving similar companies that are publicly traded and acquisitions of similar companies, if available. If the more likely-than-not threshold is met, a quantitative impairment test is performed by comparing the estimated fair value with the carrying value. If the carrying value of the net assets associated with the reporting unit exceeds the fair value of the reporting unit, goodwill is considered impaired and will be determined as the amount by which the reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill.

The Company’s reporting units are at the operating segment level; each operating segment represents a business and discrete financial information is available and reviewed regularly by management. Determining the fair value of its reporting units is subjective in nature and involves the use of significant estimates and assumptions, including projected net cash flows, discount and long-term growth rates.

The Company determines the fair value of its reporting units based on an income approach and market approach, whereby the fair value of the reporting unit is derived from the present value of estimated future cash flows associated with the reporting unit. The assumptions about estimated cash flows include factors such as future premiums, loss and expenses, general and administrative expenses and industry trends. The Company considers historical rates and current market conditions when determining the discount and long-term growth rates to use in its analysis.

The Company considers other valuation methods if the facts and circumstances indicate these methods provide a more representative approximation of fair value. Changes in these estimates based on evolving economic conditions or business strategies could result in material impairment charges in future periods. The Company bases its fair value estimates on assumptions it believes to be reasonable. Actual results may differ from those estimates. As of September 30, 2023, there were no events or changes in circumstances that indicated that a carrying amount of goodwill or intangible asset may not be recoverable. Refer Note 6, Goodwill and Other Intangible Assets, for additional information on goodwill and intangible assets.

Cost of Revenues (excluding Depreciation and Amortization)—Cost of revenue represents the direct costs associated with fulfilling the Company’s obligations to its customers, primarily policy servicing fees, commissions expense, escrow fees, servicing and active management payroll costs, and active management consulting expense.expenses.

Income Taxes—The provision for income taxes is determined using the asset and liability approach of accounting for income taxes. Under this approach, the provision for income taxes represents income taxes paid or payable (or received or receivable) for the current year plus the change in deferred taxes during the year. Deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid, and result from differences between the financial and tax bases of the Company’s assets and liabilities and are adjusted for changes in tax rates and tax laws when enacted.

1315

Table of Contents
Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not (greater than 50%) that a tax benefit will not be realized. In evaluating the need for a valuation allowance, management considers all potential sources of taxable income, including income available in carryback periods, future reversals of taxable temporary differences, projections of taxable income, and income from tax planning strategies, as well as all available positive and negative evidence. Positive evidence includes factors such as a history of profitable operations, projections of future profitability within the carryforward period, including from tax planning strategies, and the Company’s experience with similar operations. Existing favorable contracts are additional positive evidence. Negative evidence includes items such as cumulative losses, projections of future losses, or carryforward periods that are not long enough to allow for the utilization of a deferred tax asset based on existing projections of income. Deferred tax assets for which no valuation allowance is recorded may not be realized upon changes in facts and circumstances, resulting in a future charge to establish a valuation allowance. Existing valuation allowances are re-examined under the same standards of positive and negative evidence. If it is determined that it is more likely than not that a deferred tax asset will be realized, the appropriate amount of the valuation allowance, if any, is released. Deferred tax assets and liabilities are also remeasured to reflect changes in underlying tax rates due to law changes and the granting and lapse of tax holidays.

Tax benefits related to uncertain tax positions taken or expected to be taken on a tax return are recorded when such benefits meet a more likely than not threshold. Otherwise, these tax benefits are recorded when a tax position has been effectively settled, which means that the statute of limitations has expired or the appropriate taxing authority has completed their examination even though the statute of limitations remains open. Interest and penalties related to uncertain tax positions are recognized as part of the provision for income taxes and are accrued beginning in the period that such interest and penalties would be applicable under relevant tax law until such time that the related tax benefits are recognized.
Concentrations—Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, accounts receivable, and available-for-sale securities. The Company maintains its cash in bank deposit accounts with high-quality financial institutions, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts. The Company believes it is not exposed to any significant credit risk on its cash and cash equivalents. For accounts receivable, the Company is exposed to credit risk in the event of nonpayment by customers to the extent of the amounts recorded on the accompanying condensed consolidated balance sheets. The Company extends different levels of credit to its customers and maintains allowance for doubtful accounts based upon the expected collectability of accounts receivable. The Company’s procedures for determining this allowance includes evaluating individual customer receivables, considering a customer’s financial condition, monitoring credit history and current economic conditions, and using historical experience applied to an aging of accounts.
Two related party customers accounted for 12%5% and 13%5% of the total balance of accounts receivable and related party receivables as of JuneSeptember 30, 2023, respectively, and two related party customers accounted for 75% and 16% of the total accounts receivable and related party receivables as of December 31, 2022, respectively. The largest receivables balances are from related parties where the exposed credit risk is estimated to be low. As such, there is no allowance for doubtful accounts as of JuneSeptember 30, 2023, and December 31, 2022.
One customer accounted for 27%13% of active management revenue for the three months ended JuneSeptember 30, 2023. Two related party customers each accounted for 20%39% and 20%39% of the portfolio servicing revenue for the three months ended JuneSeptember 30, 2023. One customer accounted for 26%

16

Table of the total revenues for the three months ended June 30, 2022.Contents
One customer accounted for 29%22% of active management revenue, while 16%9% of revenue related to 2 policies that matured that were accounted for under the investment method and 1 policy that matured that was accounted for under the fair-value method for the sixnine months ended JuneSeptember 30, 2023. Two related party customers each accounted for 25%36% and 27%37% of the portfolio servicing revenue for the sixnine months
14

Table of Contents
ended JuneSeptember 30, 2023. One customerTwo customers accounted for 71%44% and 29% of the total revenues for the sixnine months ended JuneSeptember 30, 2022.

Warrants—The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) ASC 480, Distinguishing Liabilities from Equity (“ASC 480”), and ASC 815, Derivatives and Hedging (“ASC 815”).815. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, whether they meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the condensed consolidated statements of operations and comprehensive income.

Stock-Based Compensation—We account for stock-based compensation in accordance with ASC 718, Compensation - Stock Compensation, which requires that we measure the expense of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award. Generally, stock-based awards granted to our employees vest ratably over a three-year period. For stock-based awards with service only vesting conditions, we record compensation expense on a straight-line basis over the requisite service period. We account for forfeitures when they occur. The fair value of stock-based awards, granted or modified, is determined on the grant date (or modification dates, if applicable) at fair value, using appropriate valuation techniques. For stock-based awards granted to non-employee directors, we recognize compensation expense on the grant date based on the fair value of the awards as of that date.

17

Table of Contents

3.BUSINESS COMBINATION
Merger consideration conveyed of $531.8 million was allocated between the Companies based on relative values derived through both the discounted cash flow method within the income approach and the guideline public company method within the market approach. Within the discounted cash flow method, the present values of cash flows reasonably expected to be produced by the Companies from their operations were summed to produce an estimate of the Companies’ business enterprise values on a controlling, marketable basis. The cash flows used in the discounted cash flow analysis were discounted at the weighted average cost of capital of 14.5% for LMA and 16.5% for Abacus. The discounted cash flow method resulted in a business enterprise value range of $380.0 million to $460.0 million for LMA and $180.0 million to $195.0 million for Abacus. Within the market approach, Company applied the guideline public company method, which employs market multiples derived from market prices of stocks of Companies that are engaged in the same or similar lines of business as the Companies and that are actively traded on a free and open market. The guideline public company method resulted in a business enterprise value range of $400.0 million to $440.0 million for LMA and $180.0 million to $190.0 million for Abacus. Management concluded on a business enterprise value of $165.4 million for Abacus and $366.4 million for LMA based upon the relative fair value of the Companies allocated to the consideration transferred.
The preliminary purchase price was allocated among the identified assets to be acquired. The primary area of the acquisition accounting that is not yet finalized is our estimate of the impact of acquisition accounting on deferred income taxes. An estimate of deferred income taxes has been recorded in the Company’s books based on information available as of JuneSeptember 30, 2023. As the initial acquisition accounting is based on our preliminary assessments, actual values may differ when final information becomes available. We believe that the information gathered to date provides a reasonable basis for estimating the preliminary values of deferred taxes recorded. We will continue to evaluate this item until it is satisfactorily resolved and adjust our acquisition accounting accordingly, within the allowable measurement period, as defined by ASC Topic 805, Business Combinations, (“ASC 805”). Transaction costs incurred as a result of the Business Combination were recognized within retained earnings/(accumulatedearnings / (accumulated deficit) on the condensed consolidated balance sheet ending JuneSeptember 30, 2023.


All valuation procedures related to existing assets as no new assets were identified as a result of procedures performed. Goodwill was recognized as a result of the acquisition, which represents the
15

Table of Contents
excess fair value of consideration over the fair value of the underlying net assets, largely arising from the extensive industry expertise that has been established by Abacus. This was considered appropriate based on the determination that the Abacus Merger would be accounted for as a business acquisition under ASC 805.
18

Table of Contents
Net Assets IdentifiedFair Value
Intangibles$32,900,000 
Goodwill140,287,000 
Current Assets1,280,100 
Non-Current Assets901,337 
Deferred Tax Liabilities(8,310,966)
Accrued Expenses(524,400)
Other Liabilities(1,171,739)
Total Fair Value$165,361,332 
Value ConveyedAmount
Abacus Purchase Consideration$165,361,332 
LMA Business Enterprise Value$366,388,668 
Total Consideration$531,750,000 
Intangible assets were comprised of the following:
Asset TypeFair ValueUseful LifeValuation Methodology
Customer Relationships-Agents$12,600,000 5 yearsMulti-period excess earnings method
Customer Relationships-Financing Entities11,000,000 8 yearsMulti-period excess earnings method
Internally Developed and Used Technology-APA1,600,000 2 yearsRelief from royalty method
Internally Developed and Used Technology-Marketplace100,000 3 yearsReplacement cost method
Trade Name900,000 IndefiniteRelief from royalty method
Non-Compete Agreements4,000,000 2 yearsWith and without method
State Insurance Licenses2,700,000 IndefiniteReplacement cost method
Total Fair Value$32,900,000 
Useful lives for customer relationships were developed using attrition data for agents and financing entities which resulted in a useful life of 5 years and 8 years, respectively. Estimates over the useful lives of internally developed and used technology contemplates the period in which the Company expects to utilize the technology and the length of time the technology is expected to maintain recognition and value in the market without significant investment.Non-competeinvestment. Non-compete agreements have a useful life commensurate with the executed non-compete agreements in place as a result of the Business Combination.

19

Table of Contents
The supplemental pro forma financial information in the table below summarizes the combined results of operations for the Business Combination as if the Companies were combined as of
16

Table of Contents
January 1, 2022. The unaudited supplemental pro forma financial information as presented below is for illustrative purposes and does not purport to represent what the results of operations would actually have been if the business combinations occurred as of the date indicated or what the results would be for any future periods.

Three Months Ended June 30,Six Months Ended June 30,
2023202220232022
Proforma revenue$18,263,455 $14,090,817 $34,769,650 $31,290,963 
Proforma net income6,432,047 4,589,315 13,373,444 11,788,486 

Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Proforma revenue$21,120,930 $17,538,734 $55,890,580 $48,830,191 
Proforma net income1,050,972 10,232,457 14,424,416 22,427,585 


4.LIFE INSURANCE SETTLEMENT POLICIES
As of JuneSeptember 30, 2023, the Company holds 167240 life settlement policies, of which 122228 are accounted for under the fair value method and 4512 are accounted for using the investment method (cost, plus premiums paid). Aggregate face value of policies held at fair value is $195,205,585$303,605,030 as of JuneSeptember 30, 2023, with a corresponding fair valuevalue of $56,685,617. Aggregate$83,585,374. The aggregate face value of policies accounted for using the investment method is $39,520,877$37,300,000 as of JuneSeptember 30, 2023, with a corresponding carrying value of $9,889,610.$4,116,499.
As of December 31, 2022, the Company held 53 life settlement policies, of which 35 were accounted for under the fair value method and 18 were accounted for using the investment method (cost, plus premiums paid). Aggregate face value of policies held at fair value was $40,092,15440,092,154 as of December 31, 2022, with a corresponding fair value of $13,809,352. Aggregate13,809,352. The aggregate face value of policies accounted for using the investment method was $42,330,00042,330,000 as of December 31, 2022, with a corresponding carrying value of $8,716,111.8,716,111.
At JuneSeptember 30, 2023, the Company did not have any contractual restrictions on its ability to sell policies, including those held as collateral for the issuance of long-term debt. See footnoteRefer to Note 11, Long-Term Debt.Debt, for further details.
Life expectancy reflects the probable number of years remaining in the life of a class of persons determined statistically, affected by such factors as heredity, physical condition, nutrition, and occupation. It is not an estimate or an indication of the actual expected maturity date or indication of the timing of expected cash flows from death benefits. The following tables summarize the Company’s life insurance policies grouped by remaining life expectancy as of JuneSeptember 30, 2023:
Policies Carried at Fair Value
Remaining Life Expectancy (Years)Remaining Life Expectancy (Years)PoliciesFace ValueFair ValueRemaining Life Expectancy (Years)PoliciesFace ValueFair Value
0-10-10$— $— 0-10$— $— 
1-21-21012,314,000 6,855,769 1-2810,639,000 8,018,927 
2-32-31116,886,778 10,530,949 2-31326,725,000 8,912,395 
3-43-41033,631,467 9,174,200 3-43669,378,938 28,670,576 
4-54-51318,755,193 7,564,469 4-52622,391,998 8,115,654 
ThereafterThereafter78113,618,147 22,560,230 Thereafter145174,470,094 29,867,822 
228$303,605,030 $83,585,374 
122$195,205,585 $56,685,617 
1720

Table of Contents
Policies accounted for using the investment method—
Remaining Life Expectancy (Years)Remaining Life Expectancy (Years)Number of Life
Insurance
Policies
Face ValueCarrying ValueRemaining Life Expectancy (Years)Number of Life Insurance PoliciesFace ValueCarrying Value
0-10-10$— $— 0-10$— $— 
1-21-20— — 1-21500,000 329,714 
2-32-324,400,000 2,131,679 2-321,500,000 437,775 
3-43-444,100,000 1,281,524 3-418,000,000 82,869 
4-54-541,362,000 518,736 4-52500,000 320,110 
ThereafterThereafter35 29,658,877 5,957,671 Thereafter626,800,000 2,946,031 
12$37,300,000 $4,116,499 
45$39,520,877 $9,889,610 
Estimated premiums to be paid by the Company for its portfolio accounted for using the investment method during each of the five succeeding calendar years and thereafter as of JuneSeptember 30, 2023, are as follows:
2023 remaining2023 remaining$1,024,151 2023 remaining$59,184 
202420241,243,423 2024411,445 
202520251,310,936 2025403,224 
202620261,044,640 202697,789 
2027202771,775 
ThereafterThereafter3,288,619 Thereafter654,558 
TotalTotal$7,911,769 Total$1,697,975 
The Company is required to pay premiums to keep its portion of life insurance policies in force. The estimated total future premium payments could increase or decrease significantly to the extent that actual mortalities of insureds differ from the estimated life expectancies.
For policies accounted for under the investment method, the Company has not been made aware of information causing a material change to assumptions relating to the timing of realization of life insurance settlement proceeds. We have also not been made aware of information indicating impairment to the carrying value of policies.
5.PROPERTY AND EQUIPMENT—NET
Property and equipment—net composed of the following:
June 30,
2023
December 31,
2022
September 30,
2023
December 31,
2022
Computer equipmentComputer equipment$144,202 $— Computer equipment$240,922 $— 
Furniture and fixturesFurniture and fixtures34,300 19,444 Furniture and fixtures28,144 19,444 
Leasehold improvementsLeasehold improvements8,299 5,902 Leasehold improvements7,726 5,902 
Property and equipment—grossProperty and equipment—gross186,801 25,346 Property and equipment—gross276,792 25,346 
Less: accumulated depreciationLess: accumulated depreciation(14,911)(6,729)
Property and equipment—netProperty and equipment—net$261,882 $18,617 
1821

Table of Contents
Less: accumulated depreciation(8,870)(6,729)
Property and equipment—net$177,931 $18,617 
Depreciation expense for the three months ended JuneSeptember 30, 2023 and 2022, was $1,098$12,770 and $1,098,$1,070, respectively and depreciation expense for the sixnine months ended JuneSeptember 30, 2023, and 2022, was $2,141$14,911 and $2,141,$3,211, respectively.
6.GOODWILL AND OTHER INTANGIBLE ASSETS
Goodwill of $140,287,000 was recognized as a result of the Business Combination, which represents the excess fair value of consideration over the fair value of the underlying net assets, largely arising from the extensive industry expertise that has been established by Abacus. This was considered appropriate based on the determination that the Abacus Merger would be accounted for as a business acquisition under ASC 805. The estimates of fair value are based upon preliminary valuation assumptions believed to be reasonable, but which are inherently uncertain and unpredictable. Refer to footnoteNote 3, Business Combination, for further details.

The changes in the carrying amount of goodwill by reportable segments were as follows:

Abacus Settlements, LLC
Portfolio ServicingActive ManagementOriginations
Goodwill at January 1, 20222023$— $— $— 
Additions— 
Goodwill at June 30, 2022$— 
140,287,000 
Goodwill at January 1,September 30, 2023$— 
Additions140,287,000 $— 
Goodwill at June 30, 2023$140,287,000 
Intangible Assets Acquired comprised of the following:
Asset TypeFair ValueUseful LifeValuation Methodology
Customer Relationships - Agents$12,600,000 5 yearsMulti-period excess-earnings method
Customer Relationships - Financial Relationships11,000,000 8 yearsMulti-period excess-earnings method
Internally Developed and Used Technology—APA1,600,000 2 yearsRelief from Royalty Method
Internally Developed and Used Technology—Market Place100,000 3 yearsReplacement Cost Method
Trade Name900,000 IndefiniteRelief from Royalty Method
Non-Compete Agreements4,000,000 2 yearsWith or Without Method
State Insurance Licenses2,700,000 IndefiniteReplacement Cost Method
$32,900,000 
Intangible assets and related accumulated amortization as of September 30, 2023 and December 31,2022 are as follows:

22

Table of Contents
September 30, 2023
Definite Lived Intangible Assets:Gross ValueAccumulated AmortizationNet Book Value
Customer Relationships - Agents$12,600,000 $630,000 $11,970,000 
Customer Relationships - Financial Relationships11,000,000 343,750 10,656,250 
Internally Developed and Used Technology—APA1,600,000 200,000 1,400,000 
Internally Developed and Used Technology—Market Place100,000 8,333 91,667 
Non-Compete Agreements4,000,000 500,000 3,500,000 
Balance at September 30, 2023$29,300,000 $1,682,083 $27,617,917 
Indefinite Lived Intangible Assets:
Trade Name900,000 — 900,000 
State Insurance Licenses2,700,000 — 2,700,000 
Total Intangible Asset Balance at September 30, 2023$32,900,000 $1,682,083 $31,217,917 
Substantially all intangible assets with finite useful lives are subject to amortization when they are available for their intended use. Amortization expense for definite lived intangible assets was $1,682,083 and $0 for the three months ended September 30, 2023 and 2022, respectively, and $1,682,083 and $0 for the nine months ended September 30, 2023 and 2022, respectively.
Estimated annual amortization of intangible assets for the next five years ending December 31 and thereafter is as follows:
Remainder of 2023$1,682,083 
20246,728,333 
20255,328,333 
20263,911,667 
20273,895,000 
Thereafter6,072,501 
Total$27,617,917 
7.AVAILABLE-FOR-SALE SECURITIES, AT FAIR VALUE
Convertible Promissory Note—The Company holds a convertible promissory note in a separate unrelated insurance technology company. In November 2021, the Company purchased a $250,000 note and then purchased an additional note in January 2022 for $250,000 as part of the Tranche 5 offering (“Tranche 5
19

Table of Contents
Promissory Note”). The Tranche 5 Promissory Note pays 6% interest per annum. The Tranche 5 Promissory Note matures on November 12, 2023 (“Maturity Date”) and will be paid in full as to outstanding principal and accrued interest on the Maturity Date unless the Tranche 5 Promissory Note converts prior to the 2023 Maturity Date. Conversion into preferred shares occurs if the technology company engages in an additional equity financing event that yields gross cash proceeds in excess of $1,000,000 (“Next Equity Financing”).

23

Table of Contents
In October 2022, the Company purchased an additional convertible promissory note in the same unrelated insurance technology company for $500,000 as part of the Tranche 6 offering (“Tranche 6 Promissory Note” and collectively, the “Convertible Promissory Notes”). The Tranche 6 Promissory Note pays eight percent (8)% interest per annum and matures September 30, 2024 (“2024 Maturity Date”) and will be paid in full as to outstanding principal and accrued interest on the 2024 Maturity Date unless the Tranche 6 Promissory Note converts prior to the 2024 Maturity Date. Conversion into preferred shares occurs if the technology company engages in an additional equity financing event that yields gross cash proceeds in excess of $5,000,000 (“Next Round Securities”).
The Company applies the available-for-sale method of accounting for its investment in the Convertible Promissory Note, which is a debt investment. The Convertible Promissory Note does not qualify for either the held-to-maturity method due to the Convertible Promissory Note’s conversion rights or the trading securities method because the Company holds the Convertible Promissory Note as a long-term investment. The Convertible Promissory Notes are measured at fair value at each reporting period-end. Unrealized gains and losses are reported in other comprehensive income until realized. As of December 31, 2022 and JuneSeptember 30, 2023, the Company evaluated the fair value of its investment and determined that the fair value approximates the carrying value of $1,000,000 and there was no unrealized gain or loss recorded.
8.OTHER INVESTMENTS AND OTHER NONCURRENT ASSETS
Other Investments:
Convertible Preferred Stock Ownership—The Company owns convertible preferred stock in two entities, further described below.
On July 22, 2020, the Company purchased 224,551 units of an unrelated insurance technology company’s Series Seed Preferred units for $750,000 (“Seed Units”). During December 2022, the Company agreed to purchase 119,760 Series Seed Preferred Units for $400,000 in cash consideration by way of eight monthly payments of $50,000 starting December 15, 2022, resulting in a total of $950,000 investment as of March 31, 2023, and $1,100,000 investment as of June 30, 2023 and $1,150,000 investment at September 30, 2023. Upon conversion, the Seed Units held by the Company would represent 8.6% control in the technology company.
On December 21, 2020, the Company purchased 207,476 shares of a separate unrelated insurance technology company’s Series B-1 preferred stock for $500,000 (“Preferred Shares”). The Preferred Shares are convertible into voting common stock of insured consent at the option of the Company. Upon conversion, the Preferred Shares would represent less than 1% control in the technology company.
The Company applies the measurement alternative for its investments in the Seed Units and Preferred Shares because these investments are of an equity nature, and the Company does not have the ability to exercise significant influence over operating and financial policies of entities even in the event of conversion of the Seed Units or Preferred Shares. Under the measurement alternative, the Company records the investment based on original cost, less impairments, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the investee. The Company’s share of income or loss of such companies is not included in the Company’s condensed consolidated statements of operations and comprehensive income. The Company tests its investments for impairment whenever circumstances indicate that the carrying value of the investment may not be recoverable. No impairment of investments occurred for the three and nine months ended September 30, 2023 and 2022.

2024

Table of Contents
may not be recoverable. No impairment of investments occurred for the three and six months ended June 30, 2023 and 2022.
Other Noncurrent Assets- at fair value:
S&P OptionsThe Company is long S&P 500 call options and short S&P 500 put options which were purchased and sold through a broker as an economic hedge related to the market-indexed debt instruments included in the long-term debt note. The value is based on shares owned and quoted market prices in active markets. Changes in fair value are recorded in the Unrealized Loss on Investments line item on the condensed consolidated statements of operations and comprehensive income.
9.CONSOLIDATION OF VARIABLE INTEREST ENTITIES
The Company consolidates VIEs for which it is the primary beneficiary or VOEs for which it controls through a majority voting interest or other arrangement. See Note 2 for more information on how the Company evaluates an entity for consolidation.
The Company evaluated any entity in which it had a variable interest upon formation to determine whether the entity should be consolidated. The Company also evaluated the consolidation conclusion during each reconsideration event, such as changes in the governing documents or additional equity contributions to the entity. During the sixnine months ended JuneSeptember 30, 2023, the Company’s consolidated VIEs, LMA Income Series II LP, LMX Series LLC (LMATT Series 2024, Inc.), Longevity Market Advisors, Regional Investment Services and LMA Income Series, LP, had total assets of $57,577,034$62,831,856 and liabilities of $52,474,820.$56,775,736. For the year ended December 31, 2022, the Company’s consolidated VIEs, LMATT Series 2024, Inc., Longevity Market Advisors, Regional Investment Services and LMA Income Series, LP, had total assets and liabilities of $30,073,972 and $27,116,762, respectively. The Company did not deconsolidate any entities during the period ended JuneSeptember 30, 2023, or during the year ended December 31, 2022.
As of JuneSeptember 30, 2023, the Company held total assets of $801,345$824,375 and liabilities of $185,071,$191,632, in unconsolidated VIEs. As of December 31, 2022, the Company held total assets of $987,964 and liabilities of $358,586 in unconsolidated VIEs.

10.SEGMENT REPORTING
Segment Information—The Company organizes itsBusiness Combination that took place on June 30, 2023, where ERES, LMA and Abacus Settlements consummated the combining of the Companies, triggered a re-organization of Abacus Life Inc., where the legacy Abacus Settlements business intoand legacy LMA business would both operate under Abacus Life, Inc. subsequent to the Business Combination date. Abacus Settlement’s historically had one operating segment one reportable segment, Originations. LMA historically had two reportableoperating segments, (1) Portfolio Servicing and (2) Active Management. As the Business Combination did not occur until the last day of the second quarter, income activity related to Abacus Settlements had not yet been reported by Abacus Life, Inc. as the businesses did not begin operating as a combined Company until July 1, 2023. As such, beginning in the third quarter, the Company now organizes its business into three reportable segments (1) Portfolio Servicing, (2) Active Management and (3) Originations, which all generate revenue and incur expenses in different manners.

25

Table of Contents
This segment structure reflects the financial information and reports used by the Company’s management, specifically its chief operating decision maker (CODM), to make decisions regarding the Company’s business, including resource allocations and performance assessments, as well as the current operating focus in compliance with ASC 280, Segment Reporting. The Company’s CODM is the President and Chief Executive Officer. The Company’s reportable segments are not aggregated.
The Portfolio Servicing segment generates revenues by providing policy services to customers on a contract basis.
The Active Management segment generates revenues by buying, selling, and trading policies and maintaining policies until receipt of death benefits.
The Company’s reportable segmentsOriginations segment generates revenue by originating life insurance policy settlements between investors or buyers, and the sellers, who is often the original policy owner. The policies are not aggregated.purchased from owners or other providers through advisors, brokers or directly through the owner.

The Company’s method for measuring profitability on a reportable segment basis is gross profit. The CODM does not review asset information related to investments nor expenditures incurred for long-lived assets given the Company’s investments are recognized using the measurement alternative, and the Company’s long-lived assets are immaterial to the condensed consolidated financial statements.
21

Table of Contents
Revenue related to the Company’s reporting segments for the three-month and six-monthnine-month periods ended JuneSeptember 30, 2023, and JuneSeptember 30, 2022, is as follows:
Three Months Ended June 30,Six Months Ended June 30,
2023202220232022
Portfolio servicing$354,366 $419,422 $590,057 $990,328 
Active management11,024,399 7,979,479 20,994,917 17,285,971 
Total revenue$11,378,765 $8,398,901 $21,584,974 $18,276,299 

Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Portfolio servicing$224,569 $382,245 $814,626 $1,372,573 
Active management18,926,144 11,125,503 39,921,061 28,411,475 
Originations10,214,489 — 10,214,489 — 
Segment revenue (including inter-segment)29,365,202 11,507,748 50,950,176 29,784,048 
    Inter-segment elimination(8,244,272)— (8,244,272)— 
Total revenue$21,120,930 $11,507,748 $42,705,904 $29,784,048 

26

Table of Contents
Information related to the Company’s reporting segments for the three-month and six-monthnine-month periods ended JuneSeptember 30, 2023 and JuneSeptember 30, 2022 is as follows:
Three Months Ended June 30,Six Months Ended June 30,
2023202220232022Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Portfolio servicingPortfolio servicing$(76,705)$280,303 $(166,128)$668,752 Portfolio servicing$(626,045)$(106,817)$(792,173)$561,935 
Active managementActive management10,482,070 7,452,479 20,288,152 15,521,472 Active management13,856,637 9,859,671 34,144,789 25,381,144 
OriginationsOriginations4,525,381 — 4,525,381 — 
Total gross profitTotal gross profit10,405,365 7,732,782 20,122,024 16,190,224 Total gross profit17,755,973 9,752,854 37,877,997 25,943,079 
Sales and marketingSales and marketing(683,841)(1,019,498)(1,412,845)(1,649,498)Sales and marketing(1,704,154)(14,905)(3,116,999)(1,664,403)
General, administrative and other(577,539)(5,499)(1,274,431)(646,705)
Depreciation(1,098)(1,098)(2,141)(2,141)
General and administrative (including stock based compensation of $4,583,632)General and administrative (including stock based compensation of $4,583,632)(9,838,951)(59,816)(11,113,382)(706,523)
Depreciation and amortization expenseDepreciation and amortization expense(1,694,853)(1,071)(1,696,994)(3,211)
Other (expense) incomeOther (expense) income121,601 (127,455)(21,651)(242,247)Other (expense) income20,086 42,289 (1,565)(199,958)
Loss on change in fair value of warrant liabilityLoss on change in fair value of warrant liability(943,400)— (943,400)— 
Interest expenseInterest expense(584,075)(934,001)Interest expense(2,679,237)— (3,620,695)— 
Loss on change in fair value of debt(1,445,229)(333,879)(2,398,662)(375,513)
Unrealized gain (loss) on investments672,936 (1,039,022)798,156 (1,054,975)
Interest incomeInterest income63,826 — 71,283 — 
Gain (Loss) on change in fair value of debtGain (Loss) on change in fair value of debt2,088,797 1,235,032 (309,865)859,519 
Unrealized (loss) gain on investmentsUnrealized (loss) gain on investments(306,800)(246,846)491,356 (1,301,821)
Provision for income taxesProvision for income taxes(1,184,571)(120,132)(528,104)(296,806)Provision for income taxes(1,710,315)(352,081)(2,238,419)(648,887)
Less: Net loss attributable to non-controlling interests26,596 (406,641)487,303 (406,641)
Less: Net gain (loss) attributable to non-controlling interestsLess: Net gain (loss) attributable to non-controlling interests(147,611)(363,452)339,692 (770,093)
Net income attributable to Abacus Life, Inc.Net income attributable to Abacus Life, Inc.$6,750,145 $4,679,558 $14,835,648 $11,515,698 Net income attributable to Abacus Life, Inc.$903,361 $9,992,004 $15,739,009 $21,507,702 
Segment gross profit is defined as revenues less cost of sales, excluding depreciation and amortization. Expenses below the gross profit line are not allocated across operating segments, as they relate primarily to the overall management of the consolidated entity.
As of September 30, 2023 and 2022, our operations are confined to the United States. Therefore, we have not generated significant revenues or made significant capital expenditures in any geographic areas outside of the United States.
11.COMMITMENTS AND CONTINGENCIES
Legal Proceedings—Occasionally, the Company may be subject to various proceedings such as lawsuits, disputes, or claims. The Company assesses these proceedings as they arise and accrues a liability when losses are probable and reasonably estimable. Although legal proceedings are inherently unpredictable, the Company is currently not aware of any matters that, if determined adversely to the Company, would individually, or taken together, have a material adverse effect on the Company’s business, financial position, results of operations, or cash flows.
Commitment—The Company has entered into a Strategic Services and Expenses Support Agreement (“ExpenseSSES” or “Expense Support Agreement”) with two commonly owned full-service origination, servicing, and investmentthe Providers in exchange for an option to purchase the outstanding equity ownership of the Providers.providers (the “Providers”). Pursuant to the Expense Support Agreement, Abacus Life, Inc. provides financial support and advice for the expenses of the Providers incurred in connection with their life settlement transactions
2227

Table of Contents
incurred in connection with their life settlement transactions businesses and the Providers are required to hire a life settlement transactions operations employee of an affiliate of Abacus Life, Inc. No later than December 1 of each calendar year, Abacus Life, Inc. provides a budget for the Providers, in which Abacus Life, Inc. commits to extend financial support for all operating expenses up to the budgeted amount. “Operating Expenses” for purposes of the Expense Support Agreement means all annual operating expenses of the Providers incurred in the ordinary course of business, excluding the premiums paid for the Providers insurance coverages that are allocable to the insurance coverage provided to Institutional Life Holdings, LLC (“ILS”), which owns all the outstanding membership interests of the Providers if unrelated to the Providers settlement business.
For the three months ended JuneSeptember 30, 2023, Abacus Life, Inc. did not incur expenses related to the Expense Support Agreement. For the sixnine months ended JuneSeptember 30, 2023, Abacus Life, Inc. incurred $29,721 of expenses, related to the Expense Support Agreement, which is included in the Other (expense) line of the condensed consolidated statements of operations and comprehensive income and have not been reimbursed by the Providers.
12.FAIR VALUE MEASUREMENTS
The Company determines fair value based on assumptions that market participants would use in pricing an asset or a liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:
Level 1 inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date.
Level 2 inputs: Other than quoted prices in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.
Level 3 inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at the measurement date.
2328

Table of Contents
Recurring Fair Value Measurements—The assets and liabilities measured at estimated fair value on a recurring basis and their corresponding placement in the fair value hierarchy are presented in the tables below.
Fair Value HierarchyFair Value Hierarchy
As of June 30, 2023Level 1Level 2Level 3Total
As of September 30, 2023As of September 30, 2023Level 1Level 2Level 3Total
Assets:Assets:Assets:
Life settlement policiesLife settlement policies$— $— $56,685,617 $56,685,617 Life settlement policies$— $— $83,585,374 $83,585,374 
Available-for-sale securities, at fair valueAvailable-for-sale securities, at fair value— — 1,000,000 1,000,000 Available-for-sale securities, at fair value— — 1,000,000 1,000,000 
Other investmentsOther investments— — 1,600,000 1,600,000 Other investments— — 1,650,000 1,650,000 
S&P 500 optionsS&P 500 options1,794,640 — — 1,794,640 S&P 500 options1,494,744 — — 1,494,744 
Other assetsOther assets7,246 — — 7,246 Other assets998,469 — — 998,469 
Total assets held at fair valueTotal assets held at fair value$1,801,886 $— $59,285,617 $61,087,503 Total assets held at fair value$2,493,213 $— $86,235,374 $88,728,587 
Liabilities:Liabilities:Liabilities:
Long-term debtLong-term debt$— $— $66,165,396 $66,165,396 Long-term debt$— $— $59,544,907 $59,544,907 
Private placement warrantsPrivate placement warrants— — 2,438,600 2,438,600 Private placement warrants— — 3,382,000 3,382,000 
Total liabilities held at fair value:Total liabilities held at fair value:$— $— $68,603,996 $68,603,996 Total liabilities held at fair value:$— $— $62,926,907 $62,926,907 
Fair Value Hierarchy
As of December 31, 2022Level 1Level 2Level 3Total
Assets:
Life settlement policies$— $— $13,809,352 $13,809,352 
Available-for-sale securities, at fair value— — 1,000,000 1,000,000 
Other investments— — 1,300,000 1,300,000 
S&P 500 options890,829 — — 890,829 
Total assets held at fair value$890,829 $— $16,109,352 $17,000,181 
Liabilities:
Long-term debt$— $— $28,249,653 $28,249,653 
Total liabilities held at fair value:$— $— $28,249,653 $28,249,653 
Life Settlement PoliciesTheFor all policies purchased after June 30, 2023, the Company separately accounts for each owned life settlement policy using the fair value method. Prior to June 30, 2023, the Company elected to use either the fair value method or the investment method (cost, plus premiums paid). The valuation method is chosen upon contract acquisition and is irrevocable.


29

Table of Contents
For policies carried at fair value, the Company utilizes valuation services of a third-party actuarial firm, who values the contracts using Level 3 unobservable inputs, including actuarial assumptions, such as life expectancies and cash flow discount rates. The valuation model is based on a discounted cash flow analysis and is sensitive to changes in the discount rate used. The Company utilized a discount rate of 16%18% for the policies with face values under $2 million and a discount rate of 24% for the policies with face values of $2 million and over at June 30,2023September 30, 2023 and 12% for all policies at December 31, 2022, respectively, for policy valuation, which is based on economic and company-specific factors.
24

Table The Company re-evaluates its discount rates at the end of Contents
Subsequentevery reporting period in order to reflect the estimated discount rates that could reasonably be used in a market transaction involving the Company’s portfolio of life settlements. The determination to use a higher discount rate at September 30, 2023 for policies with face values over $2 million is due to the reporting date,inherent risk in larger face value policies during the Company sold 3 policies carried at fair value. As of Junethree months ended September 30, 2023, the Company valued these 3 policies using the price at the time of sale. Valuing these 3 policies using the takeout price resulted in a decrease in valuation of $231,775 compared to the third-party valuation.
For life settlement policies carried using the investment method, the Company measures these at the cost of the policy plus premiums paid. The policies accounted for using the investment method totaled $9,889,610 at June 30, 2023 and $8,716,111 at December 31, 2022, respectively.2023.
Discount Rate SensitivityChanges in22% was determined to be the 16%weighted average discount rate on the death benefit and premiums used to estimate the policies issued under LMATT Series 2024 Inc., LMATT Growth Series 2.2024 Inc., LMATT Growth and Income Series 1.2026, Inc., LMA Income Series, LP and LMA Income Series II, LP (“LMATT Policies”) fair value has been analyzed.of policies held by LMA and its investment funds. If the discount rate increased or decreased by 2 percentage points and the other assumptions used to estimate fair value remained the same, the change in estimated fair value as of JuneSeptember 30, 2023, would be as follows:
As of June 30, 2023Fair ValueChange in
Fair Value
As of September 30, 2023As of September 30, 2023Fair ValueChange in
Fair Value
Rate AdjustmentRate AdjustmentFair ValueChange in
Fair Value
Rate Adjustment
+2%+2%+2%$78,288,612 $(5,296,762)
No changeNo change56,685,617 No change83,585,374 
-2%-2%59,857,879 3,172,262 -2%89,102,871 5,517,497 
Credit Exposure to Insurance Companies—The following table provides information about the life insurance issuer concentrations that exceed 10% of total face value or 10% of total fair value of the Company’s life insurance policies as of JuneSeptember 30, 2023:
CarrierCarrierPercentage of
Face Value
Percentage of
Fair Value
Carrier
Rating
CarrierPercentage of
Face Value
Percentage of
Fair Value
Carrier
Rating
American General Life Insurance CompanyAmerican General Life Insurance Company14.0 %11.0 %AAmerican General Life Insurance Company11.0 %13.0 %A+
ReliaStar Life Insurance Company6.0 %12.0 %A
Lincoln National Life Insurance Company14.0 %12.0 %A
Transamerica Transamerica14.0 %16.0 %A
The following table provides a roll forward of the fair value of life insurance policies for the sixnine months-ended JuneSeptember 30, 2023:
Fair value at December 31, 2022$13,809,352 
Policies purchased58,543,580116,053,728 
Realized gain (loss) on matured/sold policies1,898,9589,688,422 
Premiums paid(879,462)(2,500,623)
Unrealized gain(loss) on held policies3,319,58814,259,665 
Change in estimated fair value4,339,08421,447,464 
Matured/sold policies(20,885,861)(70,225,793)
Premiums paid879,4622,500,623 
Fair value at JuneSeptember 30, 2023$56,685,61783,585,374 
2530

Table of Contents
Long-Term Debt—See Note 13. “Long-Term Debt”13 for background information on the market-indexed debt. The Company has elected the fair value option in accounting for the instruments. Fair value is determined using Level 3 inputs. The valuation methodology is based on the Black-Scholes-Merton option-pricing formula and a discounted cash flow analysis. Inputs to the Black-Scholes-Merton model include (i) the S&P 500 Index price, (ii) S&P 500 Index volatility, (iii) a risk-free rate based on data published by the US Treasury, and (iv) a term assumption based on the contractual term of the LMATT Notes. The discounted cash flow analysis includes a discount rate that is based on the implied discount rate developed by calibrating a valuation model to the purchase price on the initial investment date. The implied discount rate is evaluated for reasonableness by benchmarking it to yields on actively traded comparable securities.

The total change in fair value of the debt resulted in a loss of $760,457. This loss is comprised of $777,131, net of tax, which is included within accumulated other comprehensive income and $238,902 net of tax, which is included in equity of noncontrolling interests resulting from risk-adjusted valuation scenarios. The Company recognized a gain of $2,088,797 on the change in fair value of the debt resulting from risk-free valuation scenarios, which is included within (Gain)/loss on change in fair value of debt within the condensed consolidated statement of operations and comprehensive income for the three months ended September 30, 2023.
The total change in fair value of the debt resulted in a gain of $1,602,042.$1,945,461. This gain is comprised of $90,148,$952,661, net of tax, which is included within accumulated other comprehensive income and $29,515$295,348 net of tax, which is included in equity of noncontrolling interests resulting from risk-adjusted valuation scenarios. The Company recognized a loss of $1,445,229$309,865 on the change in fair value of the debt resulting from risk-free valuation scenarios, which is included within Change(Gain) loss on change in fair value of debt within the condensed consolidated statement of operations and comprehensive income for the threenine months ended June 30, 2023.
The total change in fair value of the debt resulted in a gain of $2,705,918. This gain is comprised of $175,530, net of tax, which is included within accumulated other comprehensive income and $56,446 net of tax, which is included in equity of noncontrolling interests resulting from risk-adjusted valuation scenarios. The Company recognized a loss of $2,398,662 on the change in fair value of the debt resulting from risk-free valuation scenarios, which is included within Change in fair value of debt within the condensed consolidated statement of operations and comprehensive income for the six months ended JuneSeptember 30, 2023.
The following table provides a roll forward of the fair value of the issued notes for the sixnine months ended JuneSeptember 30, 2023:
Fair value at December 31, 2022$28,249,653 
Debt issued to third parties35,209,82588,618,714 
Unrealized loss on change in fair value (risk-free)2,398,662309,865 
Unrealized gainloss on change in fair value (credit-adjusted) included in OCI307,2561,635,596 
Change in estimated fair value resulted into gain2,705,9181,945,461 
Fair value at JuneSeptember 30, 2023$66,165,396118,813,828 
Private Placement Warrants—Simultaneously with the closing of the Initial Public Offering, ERES consummated the sale of 8,900,0008,900,000.00 warrants (the “Private Placement Warrants”) to East Sponsor, LLC (the “Sponsor”), which included the sale of an additional 900,000900,000.00 Private Placement Warrants in connection with the full exercise by the underwriters of their over-allotment option on August 25, 2020, at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $8,900,000.8,900,000.00. Each Private Placement Warrant is exercisable for one share of Class A common stock at a price of $11.50 per share, subject to adjustment.


31

Table of Contents
The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that (x) the Private Placement Warrants and the shares of Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or
26

Table of Contents
salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, (y) the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees and (z) the Private Placement Warrants and the shares of Class A common stock issuable upon exercise of the Private Placement Warrants will be entitled to registration rights. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
Private Placement Warrants were accounted for as liabilities in accordance with ASC 815-40. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented separately in the condensed consolidated statements of operations.

The Private Placement Warrants were considered a Level 3 fair value measurement using a binomial lattice model in a risk-neutral framework. The binomial lattice model’s primary unobservable input utilized in determining the fair value of the Private Placement Warrants is the expected volatility of the common stock. The implied volatility as of the reporting date was derived from observable public warrant traded price provided by Bloomberg LP.

The following table presents the key assumptions in the analysis:
Private Placement Warrants
Expected implied volatilityde minimis
Risk-free interest rate4.09%
Term to expiration5.0 years
Exercise price$11.50
Common Stock Price$10.03
Dividend Yield—%
Other Noncurrent Assets: S&P 500 Options—In February 2022, LMATT Series 2024, Inc., which the Company consolidates for financial reporting, purchased and sold S&P 500 call and put options through a broker. The Company purchased and sold additional S&P 500 call options through a broker in June 2022 through their 100% owned and fully consolidated subsidiaries LMATT Growth Series 2.2024, Inc. and LMATT Growth and Income Series 1.2026, Inc. The options are exchange traded, and fair value is determined using Level 1 inputs of quoted market prices as of the condensed consolidated balance sheets dates. Changes in fair value are classified as unrealized (gain)/loss on investments within the condensed consolidated statements of operations and comprehensive income.
Financial Instruments Measured at Fair Value on a Nonrecurring Basis—The following financial assets, composed of equity securities without readily determinable fair values, are adjusted to fair value when observable price changes are identified, or an impairment charge is recognized. Such fair value measurements are based predominantly on Level 3 inputs.

32

Table of Contents
Available-for-Sale Investment—The Convertible Promissory Note is classified as an available-for-sale security. Available-for-sale investments are subsequently measured at fair value. Unrealized holding gains and losses are excluded from earnings and reported in other comprehensive income until realized. The Company determines fair value of its available-for-sale investments using unobservable inputs by considering the initial investment value, next round financing, and the likelihood of conversion or settlement based on the contractual terms in the agreement. The Company initially purchased a $250,000 convertible promissory note from the issuer in 2021 and then on January 7, 2022, the Company purchased an additional $250,000 convertible promissory note from the same issuer and then an additional $500,000 in October 2022. As of JuneSeptember 30, 2023 and December 31, 2022, the Company
27

Table of Contents
evaluated the fair value of its Promissory Note and determined that the fair value approximates the carrying value of $1,000,000 and $1,000,000, respectively.

Other Investments—The Company determines fair value using Level 3 inputs under the measurement alternative. These investments are recorded at cost, minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Impairment is assessed qualitatively. As of JuneSeptember 30, 2023, and December 31, 2022, the Company did not identify any impairment indicators and determined that the carrying value of $1,600,000$1,650,000 and $1,300,000 is the fair value for these equity investments in privately held companies, given that there have been no observable price changes.
Financial Instruments Where Carrying Value Approximates Fair Value—The carrying value of cash, cash equivalents, accounts receivables, and due to affiliates approximates fair value due to the short-term nature of their maturities.

13.LONG-TERM DEBT
Outstanding principal balances of Long-term debt comprises of the following:
Six Months Ended
June 30, 2023
Year Ended
December 31, 2022
September 30, 2023December 31, 2022
CostFair valueCostFair valueCostFair valueCostFair value
Market-indexed notes:Market-indexed notes:Market-indexed notes:
LMATT Series 2024, Inc.LMATT Series 2024, Inc.$9,866,900 $9,621,141 $9,866,900 $8,067,291 LMATT Series 2024, Inc.$9,866,900 $9,311,800 $9,866,900 $8,067,291 
LMATT Series 2.2024, Inc.LMATT Series 2.2024, Inc.2,333,391 3,446,527 2,333,391 2,354,013 LMATT Series 2.2024, Inc.2,333,391 3,027,681 2,333,391 2,354,013 
LMATT Growth & Income Series 1.2026, IncLMATT Growth & Income Series 1.2026, Inc400,000 459,553 400,000 400,000 LMATT Growth & Income Series 1.2026, Inc400,000 427,284 400,000 400,000 
Secured borrowing:Secured borrowing:Secured borrowing:
LMATT Income Series, LP21,889,444 22,124,676 17,428,349 17,428,349 
LMATT Income Series II, LP20,041,851 20,041,851 — — 
LMA Income Series, LPLMA Income Series, LP21,889,444 22,242,291 17,428,349 17,428,349 
LMA Income Series II, LPLMA Income Series II, LP24,535,851 24,535,851 — — 
Unsecured borrowing:Unsecured borrowing:Unsecured borrowing:
Owl Rock Credit FacilityOwl Rock Credit Facility25,000,000 25,000,000 — — 
SPV Purchase and Sale NoteSPV Purchase and Sale Note25,750,000 25,750,000 — — 
Sponsor PIK NoteSponsor PIK Note10,471,648 10,471,648 — — Sponsor PIK Note10,785,778 10,785,778 — — 
Deferred Financing CostDeferred Financing Cost(2,266,858)(2,266,858)— — 
Total long-term debtTotal long-term debt$65,003,234 $66,165,396 $30,028,640 $28,249,653 Total long-term debt$118,294,506 $118,813,827 $30,028,640 $28,249,653 
SPV purchase and sale note$25,000,000 $25,000,000 — — 
Owl Rock Credit Facility
On July 5, 2023 (the “Owl Rock Closing Date”), the Company entered into that certain Credit Agreement (the “Owl Rock Credit Facility”), among the Company, as borrower, the several banks and other persons from time to time party thereto (the “Owl Rock Lenders”), and Owl Rock Capital Corporation, as
33

Table of Contents
administrative and collateral agent for the Owl Rock Lenders thereunder. The Owl Rock Credit Facility provides credit extensions for (i) an initial term loan in an aggregate principal amount of $25.00 million upon the closing of the Owl Rock Credit Facility and (ii) optional delayed draw term loans in an aggregate principal amount of up to $25.00 million available for 180 days after the Owl Rock Closing Date, subject to the requirement that on each delayed draw date, the proceeds may be used for working capital and the business requirements of the enterprise, and to fund acquisitions, investments and other transactions permitted by the loan documentation. It provides a delayed draw commitment fee rate of 0.50% per annum applicable to undrawn commitments during the Delayed Draw Term Loan Availability Period and matures on July 5, 2028, the date that is five years after the closing of the Owl Rock Credit Facility.
The Owl Rock Credit Facility, among other things:
requires the Company and certain subsidiaries of the Company to guarantee the loans provided under the Owl Rock Credit Facility pursuant to separate loan documentation;
is secured by a first-priority security interest in substantially all of the assets of the Company and the subsidiary guarantors. No pledge of any equity interests in the Company is required by any holder of such equity interests;
provides for interest to accrue on the loans drawn under the Owl Rock Credit Facility at the election of the Company, by reference to either (i) an alternative base rate (such loans, “ABR Loans”) or (ii) an adjusted term Secured Overnight Financing Rate (SOFR) rate (such loans, “SOFR Loans”) plus an applicable margin. The adjusted term SOFR rate is determined by the applicable term SOFR for a relevant interest period plus a credit spread adjustment of 0.10%, 0.15% and 0.25% per annum for interest periods of one, three and six months, respectively. The applicable margin for each type of loan is (i) 6.25% per annum for any ABR Loans and (ii) 7.25% per annum for any SOFR Loans, with interest periods for SOFR Loans of one, three or six months (or other periods if agreed by all lenders);
provides a default rate that will accrue at 2.00% per annum over the rate otherwise applicable;
provides for amortization payments based on the initial principal amount of the loans outstanding of 1.0% per year (0.25% due per quarter), with adjustments made to the overall amortization amount upon the incurrence of any delayed draw loans;
contains provisions requiring mandatory prepayment of the initial term loans and delayed draw term loans with 100% of the proceeds of (a) indebtedness not permitted by the Owl Rock Credit Facility and (b) certain specified asset dispositions and payments (including in respect of settlements) in respect of property, casualty insurance claims or condemnation proceedings, with the proceeds received under this clause (b) subject to certain specified reinvestment rights and procedures set forth in the Owl Rock Credit Facility. The Owl Rock Credit Facility permits voluntary prepayments of outstanding loans at any time;
provides for financial covenants such that (i) a consolidated net leverage ratio cannot exceed 2.50 to 1.00 as of the last day of any fiscal quarter and (ii) a liquid asset coverage ratio cannot be less than 1.80 to 1.00;
34

Table of Contents
contains affirmative covenants related to, among other things, delivery of certain financial reports and compliance certificates, maintenance of existence, compliance with laws, material contracts, payment of taxes, property and insurance matters, inspection of property, books and records, notices, collateral matters and future subsidiaries, in each case, subject to specified limitations and exceptions;
contains an affirmative representation and corresponding covenant that the Company and certain subsidiaries of the Company do not, and will not during the term of the Owl Rock Facility (or if the term of the Owl Rock Credit Facility continues for longer than a year, during the Company’s and certain subsidiaries of the Company’s most recent fiscal year), derive more than fifteen percent (15%) of their aggregate gross revenues from securities related activities;
contains negative covenants related to, among other things, incurrence of debt, creation of liens, mergers, acquisitions and certain other fundamental changes, conditions concerning the creation of new subsidiaries, conditions concerning opening of new accounts, disposition of assets, dividends and other restricted payments, prepayment of certain indebtedness, transactions with affiliates, investments and limitations on lines of business, in each case, subject to specified limitations and exceptions; and
provides for certain specified events of default upon the occurrence and during the continuation of certain events or conditions (subject to specified exceptions, grace periods or cure rights, as applicable) each as set forth in the Owl Rock Credit Facility, which includes among other things, defaults with respect to nonpayment, breaches of representations and warranties, failure to comply with covenants, cross-default to other material indebtedness, bankruptcy and insolvency matters, ERISA matters, material judgments, collateral and perfection matters, the occurrence of a change of control and subordination matters with respect to certain specified indebtedness. The occurrence and continuance of an event of default that is not cured or waived will enable the agent and/or the lenders, as applicable, to accelerate the loans or take other remedial steps as provided in the Owl Rock Credit Facility and the other loan documents.
Sponsor PIK Note
On the June 30, 2023, in connection with the consummation of the Business Combination and as contemplated by the Merger Agreement, East Sponsor, LLC, a Delaware limited liability company (“Sponsor”), made an unsecured loan to the Company in the aggregate amount of $10,471,648 (the “Sponsor PIK Note”). with an interest rate of 12% per annum compounding semi-annually. Accrued interest is payable in arrears quarterly starting on September 30, 2023 by adding it to the outstanding principal balance. As of September 30, 2023, $314,130 in non-cash interest expense was added to the outstanding principal balance. The Sponsor PIK Note matures on June 30, 2028 (the “Maturity Date”) and may be prepaid at any time in accordance with its terms without any premium or penalty.
LMATT Series 2024, Inc. Market-Indexed Notes:
On March 31, 2022, LMATT Series 2024, Inc., which the Company consolidates for financial reporting, issued $10,166,900 in market-indexed private placement notes. The note, titled the Longevity Market Assets Target-Term Series (LMATTS) 2024, is a market-indexed instrument designed to provide upside performance exposure of the S&P 500 Index, while limiting downward exposure. Upon maturity of the note in 2024, the principal, plus the return based upon the S&P 500 Index must be paid. The note has a
28

Table of Contents
feature to protect debt holders from market downturns, up to 40%. Any subsequent losses below the 40% threshold will reduce the note on a one-to-one basis. As of JuneSeptember 30, 2023, $9,866,900 of the principal amount remained outstanding.
The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third party. As of JuneSeptember 30, 2023, the fair value of the LMATT Series 2024, Inc. notes were $9,621,141.was $9,311,800.
35

Table of Contents
The notes are secured by the assets of the issuing entities, which includes cash, S&P 500 options, and life settlement policies totaling $11,195,701$10,358,537 as of JuneSeptember 30, 2023. The notes’ agreements do not restrict the trading of life settlement contracts prior to maturity of the note, as total assets of the issuing companies are considered as collateral. There are also no restrictive covenants associated with the notes with which the entities must comply.
LMATT Series 2.2024, Inc. Market-Indexed Notes:
On September 16, 2022, LMATTS Series 2.2024, Inc., a 100% owned subsidiary which the Company consolidates for financial reporting issued $2,333,391 in market-indexed private placement notes. The note, titled the Longevity Market Assets Target-Term Growth Series 2.2024, Inc. (“LMATTSTMLMATTSTM Series 2.2024, Inc.”) is a market-indexed instrument designed to provide upside performance exposure of the S&P 500 Index, while limiting downward exposure. Upon maturity of the note in 2024, the principal, plus the return based upon the S&P 500 Index must be paid. The note has a feature to provide upside performance participation that is capped at 120% of the performance of the S&P 500. A separate layer of the note has a feature to protect debt holders from market downturns by up to 20% if the index price experiences a loss during the investment period. After the underlying index has decreased in value by more than 20%, the investment will experience all subsequent losses on a one-to-one basis. . As of JuneSeptember 30, 2023, the entire principal amount remained outstanding.
The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third party. As of JuneSeptember 30, 2023, the fair value of the LMATT Series 2.2024, Inc. notes were $3,446,527.$3,027,681.
The notes are secured by the assets of the issuing entity, LMATT Series 2.2024, Inc., which includes cash, S&P 500 options, and life settlement policies totaling $3,331,872$2,983,754 as of JuneSeptember 30, 2023. The note agreements do not restrict the trading of life settlement contracts prior to maturity of the note, as total assets of the issuing company are considered as collateral. There are also no restrictive covenants associated with the note with which the entity must comply.
LMATT Growth and Income Series 1.2026, Inc. Market-Indexed Notes:
Additionally, on September 16, 2022, LMATTS Growth and Income Series 1.2026, Inc., a 100% owned subsidiary which the Company consolidates for financial reporting issued $400,000 in market-indexed private placement notes. The note, titled the Longevity Market Assets Target-Term Growth and Income Series 1.2026, Inc (“LMATTSTMLMATTSTM Growth and Income Series 1.2026, Inc.”) is a market-indexed instrument designed to provide upside performance exposure of the S&P 500 Index, while limiting downward exposure. Upon maturity of the note in 2026, the principal, plus the return based upon the S&P 500 Index must be paid. The note has a feature to provide upside performance participation that is capped at 140% of the performance of the S&P 500. A separate layer of the note has a feature to protect debt holders from market downturns by up to 10% if the index price experiences a loss during the investment period. After the underlying index has decreased in value by more than 10%, the investment will experience all subsequent losses on a one-to-one basis. This note also includes 4% dividend feature that will be paid annually. As of JuneSeptember 30, 2023, the entire principal amount remained outstanding.
29

Table of Contents
The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third party. As of JuneSeptember 30, 2023, the fair value of the LMATT Growth and Income Series 1.2026, Inc., notes were $459,553.$427,284.
The notes are secured by the assets of the issuing entity, LMATTS Growth and Income Series 1.2026, Inc., which includes cash, S&P 500 options, and life settlement policies totaling $517,218$369,253 as of JuneSeptember 30, 2023. The note agreements do not restrict the trading of life settlement contracts prior to maturity of the note, as total assets of the issuing company are considered as collateral. There are also no restrictive covenants associated with the note with which the entity must comply.
36

Table of Contents
See additional fair value considerations within footnoteNote 12.
LMA Income Series, LP and LMA Income Series, GP LLC Secured Borrowing
LMA Income Series, GP, LLC, wholly owned and controlled by that LMA Series, LLC, formed a limited partnership, LMA Income Series, LP and issued partnership interests to limited partners in a private placement offering. The initial term of the offering is three years with the ability to extend for two additional one-year periods at the discretion of the general partner, LMA Income Series, GP, LLC. The limited partners will receive an annual dividend of 6.5% paid quarterly and 25% of returns in excess of a 6.5% internal rate of return capped at 9% which would require a 15% net internal rate of return. The General Partner will receive 75% of returns in excess of a 6.5% internal rate of return to limited partners then 100% in excess of a 15% net internal rate of return.
It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series, LP and thus has fully consolidated the limited partnership in its consolidated financial statements for the sixthree and nine months ended JuneSeptember 30, 2023.
The private placement offerings proceeds will be used to acquire an actively managedmanage a large and diversified portfolio of financial assets. LMA, through its consolidated subsidiaries, serves as the portfolio manager for the financial asset portfolio, which includes investment sourcing and monitoring. In this role, LMA has the unilateral ability to acquire and dispose of any of the above investments. As the partnership does not represent a business in accordance with ASC 810 and is a consolidated subsidiary that only holds financial assets, this represents a transfer subject to ASC 860-10. As the financial assets are not transferred outside the consolidated group, the proceeds from the offering shall be classified as a liability unless it meets the definition of a participating interest and the derecognition criteria in ASC 860 are met. The transferred interest did not meet the definition of a participating interest as LMA possesses the unilateral ability to direct the sale of the financial assets (ASC 860-10-50-6A(d)). In accordance with ASC 860-30-25-2, as the transfer of the financial assets did not meet the definition of a participating interest, LMA shall recognize the proceeds received from the offering as a secured borrowing.
LMA elected to account for the secured borrowing at fair value under the collateralized financing entity guidance within ASC 810-10-30. As of JuneSeptember 30, 2023, the fair value of the secured borrowing was $22,124,676.$22,242,291.
LMA Income Series II, LP and LMA Income Series II, GP LLC Secured Borrowing
LMA Income Series II, GP, LLC, wholly owned and controlled by that LMA Series, LLC, formed a limited partnership, LMA Income Series II, LP and issued partnership interests to limited partners in a private placement offering. The initial term of the offering is three years with the ability to extend for two additional one-year periods at the discretion of the general partner, LMA Income Series II, GP, LLC. The limited partners will receive annual dividends equal to the Preferred Return Amounts as follows: Capital commitment less than $500,000, 7.5%; between $500,000 and $1,000,000, 7.75%; over $1,000,000, 8%. Thereafter, 100% of the excess to be paid to the General Partner.
30

Table of Contents
It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series, LP and thus has fully consolidated the limited partnership in its consolidated financial statements for the three and sixnine months ended JuneSeptember 30, 2023.

37

Table of Contents
The private placement offerings proceeds will be used to acquire an actively managedmanage a large and diversified portfolio of financial assets. LMA, through its consolidated subsidiaries, serves as the portfolio manager for the financial asset portfolio, which includes investment sourcing and monitoring. In this role, LMA has the unilateral ability to acquire and dispose of any of the above investments. As the partnership does not represent a business in accordance with ASC 810 and is a consolidated subsidiary that only holds financial assets, this represents a transfer subject to ASC 860-10. As the financial assets are not transferred outside the consolidated group, the proceeds from the offering shall be classified as a liability unless it meets the definition of a participating interest and the derecognition criteria in ASC 860 are met. The transferred interest did not meet the definition of a participating interest as LMA possesses the unilateral ability to direct the sale of the financial assets (ASC 860-10-50-6A(d)). In accordance with ASC 860-30-25-2, as the transfer of the financial assets did not meet the definition of a participating interest, LMA shall recognize the proceeds received from the offering as a secured borrowing.
LMA elected to account for the secured borrowing at fair value under the collateralized financing entity guidance within ASC 810-10-30. As of JuneSeptember 30, 2023, the fair value of the secured borrowing was $20,041,851.$24,535,851.

SPV Purchase and Sale Note

On July 5, 2023, the Company entered into an Asset Purchase Agreement (the “Policy APA”) to acquire certain insurance policies with an aggregate fair market value of $10.0 million from Abacus Investment SPV, LLC, a Delaware limited liability company (“SPV”), in exchange for a payable obligation owingowed by the Company to the SPV (such acquisition transaction under the Policy APA, the “SPV Purchase and Sale”).
The payable obligation owingowed by the Company to the SPV in connection with the SPV Purchase and Sale is evidenced by a note issued by the Company underto SPV in connection with the SPV Investment Facility, as defined below, (the “SPV Purchase and Sale Note”) in an original principal amount equal to the aggregate fair market value of the acquired insurance policies. The SPV Purchase and Sale Note has the same material terms and conditions as the other credit extensions under the SPV Investment Facility (as defined below).Facility.
SPV Investment Facility
On July 5, 2023, the Company entered into that certain SPV Investment Facility (the “SPV Investment Facility”),a credit agreement between the Company, as borrower, and the SPV, as lender.lender (the “SPV Investment Facility”) whereby the Company is able to borrow additional funds from SPV.
The SPV Investment Facility provides, among other things:things, for the following:
requires that certain subsidiaries of the Company to guarantee the credit extensions provided under the SPV Investment Facility pursuant to separate documentationdocumentation;
is unsecured without collateral security provided in favor of the SPV and subordinated in right of payment to the Company’s obligations under the Owl Rock Credit Facility, subject to limited specified exceptions and circumstances for permitting early payment;
provides for certain credit extensions in an aggregate principal amount of $25.0 million including:recorded in the SPV purchase and sale note line item on the condensed consolidated balance sheets, which includes: (i) an initial credit extension in an original principal amount of $15.0 million that was funded upon the closing of the SPV Investment Facility, and (ii) the SPV Purchase and Sale Note in favor offor the SPV in an original principal amount of $10.0 million to finance the purchase of the insurance policies under the Policy APA;
provides for proceeds from the SPV Investment Facilityto be used for payment of certain transaction expenses, general corporate purposes and any other purposes not prohibited by the agreement or applicable law;
3138

Table of Contents
matures on July 5, 2026, three years after the closing of the SPV Investment Facility, subject to two automatic extensions of one year each without any amendment of the relevant documentation, but also subject to applicable subordination restrictions in relation to the Owl Rock Credit Facility;
provides for interest to accrue on the SPV Investment Facility at a rate of 12.00%12% per annum, payable quarterly, all of which is to be paid in-kind by the Company by increasing the principal amount of the SPV Investment Facility owing to the SPV on each interest payment date;date. As of September 30, 2023, $750,000 in non-cash interest expense was added to the outstanding principal balance;
provides a default rate that will accrue at 2.00% per annum (subject to applicable subordination restrictions) over the rate otherwise applicable. If cash payment is not permitted due to applicable subordination restrictions or otherwise, such default interest shall be paid in-kind;
provides that no amortizationprincipal payments shall be required prior to maturity;
contains financial and other covenants substantially similar and not materially worse than those contained in the Owl Rock Credit Facility from the perspective of the Company; and
provides for certain specified events of default (including certain events of default subject to grace or cure periods), with the occurrence and during the continuance of such events of default enabling the lender under the SPV Investment Facility to accelerate the obligations under the SPV Investment Facility, among other rights or remedies, subject to applicable subordination restrictions.

The SPV’s investment resulting from credit extensions underCompany paid $0 interest expense during the SPV Investment Facility is treated by the Company as debt for U.S. GAAP accounting purposes. While the timing of the Policy APAnine month ended September 30, 2023 and SPV Investment Facility occurred on July 5, 2023, such amounts are included within the condensed consolidated balance sheet as cash was received prior to June 30, 2023.2022.
14.SHAREHOLDERS’ EQUITY
The Company is authorized to issue up to 200,000,000 shares of common stock, par value $0.0001 per share, and 1,000,000 shares of preferred stock, par value $0.0001 per share. No shares of preferred stock are issued or outstanding. Holders of the Company’s common stock are entitled to one vote for each share. As of JuneSeptember 30, 2023, there were 62,961,68863,349,823 shares of common stock issued and outstanding. Holders of shares were entitled to receive, in the event of a liquidation, dissolution or winding up, ratably the assets available for distribution to the shareholders after payment of all liabilities.
The equity structure has been recast in all comparative periods up to the Closing Date to reflect the number of shares of the Company’s common stock, $0.00010.0001 par value per share, issued to legacy LMA’s stockholders in connection with the Business Combination. As such, the shares and corresponding capital amounts and earnings per share related to legacy LMA common stock prior to the Business Combination have been retroactively recast as shares reflecting the exchange ratio of 0.8 established in the Business Combination. As of December 31, 2022, this resulted in 50,369,350 shares of common stock issued and outstanding.


39

Table of Contents
Public Warrants

As of JuneSeptember 30, 2023, the Company has 17,250,00017,249,984 Public Warrants outstanding. Each redeemable whole Public Warrant entitles the holder thereof to purchase one share of common stock at a price of $11.50 per full share, subject to adjustment as described. The Public Warrants represent a freestanding financial instrument as it is traded on the Nasdaq under the symbol “ABLLW” and legally detachable and separately exercisable from the related underlying shares of the Company’s common stock. Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Proposed
32

Table of Contents
Offering. The Public Warrants will expire five years from the completion of a Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.

The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act with respect to the shares of Class A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable and the Company will not be obligated to issue a share of Class A common stock upon exercise of a warrant unless the share of Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.

Redemption of Warrants for Cash - Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants for cash:
in whole and not in part;
at a price of $0.01 per Public Warrant;
upon not less than 30 days’ prior written notice of redemption to each warrant holder; and
if, and only if, the last sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.

If and when the Public warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. However, the Company will not redeem the warrants unless an effective registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the warrants is effective and a current prospectus relating to those shares of Class A common stock is available throughout the 30-day redemption period, except if the warrants may be exercised on a cashless basis and such cashless exercise is exempt from registration under the Securities Act.

Redemption of Warrants for Shares of Class A Common Stock - Once the Public warrants become exercisable, the Company may redeem the outstanding warrants for shares of Class A common stock:
in whole and not in part;
at a price equal to a number of shares of Class A common stock to be determined by reference to the agreed table set forth in the warrant agreement based on the redemption date and the “fair market value” of the Class A common stock;
upon not less than 30 days’ prior written notice of redemption to each warrant holder; and
if, and only if, the last sale price of the Class A common stock equals or exceeds $10.00 per share (as adjusted per share splits, share dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
40

Table of Contents

In addition, if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of the Company’s initial Business Combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by our board of directors), (y) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Price”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of Market Price and the newly issued price. Further, the $10.00 and
33

Table of Contents
$18.00 $18.00 per share redemption trigger prices will be adjusted to be equal to 100% and 180%, respectively, of the higher of the market value and the newly issued price.

If the Company elects to redeem all of the Public Warrants or the common stock is at the time of any exercise of a Public Warrant not listed on a national securities exchange, management has the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. In such event, each holder would pay the exercise price by surrendering the whole warrants for that number of shares of common stock equal to the quotient obtained by dividing (x) the product of the number of shares of common stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” shall mean the average reported last sale price of the common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. However, in no instance can the warrant holder unilaterally decide to exercise its Public Warrant on a cashless basis.

Upon the Business Combination, the Company accounted for the Public Warrants issued with the IPO as equity instruments. The Company accounted for the warrant as an expense of the IPO resulting in a charge directly to stockholders’ equity. The Company estimates that the fair value of the warrants upon the Business Combination is approximately $4.73 million, or $0.274 per Public Warrant, using the binomial lattice model. The fair value of the warrants is estimated as of the date of grant using the following assumptions: (1) risk-free interest rate of 4.09%, (2) term to expiration of 5.05.00 years, (3) exercise price of $11.50 and (4) stock price of $10.03.

15.STOCK- BASED COMPENSATION
CEO Restriction Agreement:

Effective upon Business Combination close, the Chief Executive Officer (“CEO”) entered into a Restriction Agreement with Abacus Life, Inc. that provides terms for the CEO’s ownership interest grant that were assigned to him from the three original founders of Abacus Settlements. As of the Closing Date as provided in the Merger Agreement amended on April 21, 2023, the CEO shall receive 4,569,922 shares of Restricted Stock.

Vesting Conditions. The Company shall issue the shares of Restricted Stock either (a) in certificate form or (b) in book entry form, registered in the CEO’s name, referring to the terms, conditions and restrictions applicable to the shares as outlined below. The CEO’s Ownership Interest Grant (“Restricted Stock”) shall vest as follows:

i. 50% of the shares on the 25th month following the Effective Date,
ii. 50% of the shares on the 30th month following the Effective Date,
iii. Additionally, the Restricted Stock will become fully vested upon the first to occur of one of the following events: (i) separation from service due to disability, (ii) death, (iii) separation from service without cause; or (iv) separation from service for good reason.
41

Table of Contents

CEO Stock-based compensation expense is summarized as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Stock-based compensation expense$4,583,632 $— $4,583,632 $— 

Restricted Stock activity relative to the CEO for the nine months ended September 30, 2023 is summarized as follows:
Number of SharesWeighted Average Grant Date Fair Value
Outstanding at December 31, 2022— $— 
Granted4,569,922 10.03 
Forfeited— — 
Settled— — 
Outstanding at September 30, 20234,569,922 $10.03 
As of September 30, 2023, unamortized stock-based compensation expense for unvested Restricted Stock relative to the CEO was $41,252,686 with a remaining contractual life of 2.3 years.
16.EMPLOYEE BENEFIT PLAN
The Company has a defined contribution plan in the U.S. intended to qualify under Section 401(k) of the Internal Revenue Code (the “401(k) Plan”). The 401(k) Plan covers substantially all employees who meet minimum age and service requirements and allows participants to defer up to 100% of their annual compensation on a pretax basis. For the year ended December 31, 2022, the Company elected to match 50% of employee contributions up to a maximum of 4% of eligible employee compensation. For the three months ended JuneSeptember 30, 2023 and 2022, the Company recognized expenses related to the 401(k) Plan amounting to $13,075$61,586 and $2,577,$4,511, respectively and for the sixnine months ended JuneSeptember 30, 2023 and 2022, the Company recognized expenses related to the 401(k) Plan amounting to $25,315$86,901 and $8,048,$12,559, respectively.
16.17.INCOME TAXES
Before June 30, 2023, the Company elected to file as an S corporation for Federal and state income tax purposes, as such, the Company incurred no Federal or state income taxes, except for income taxes recorded related to some of their consolidated variable interest entities and subsidiaries which are taxable C corporations. These VIE’s and subsidiaries include LMATT Series 2024, Inc., the wholly owned subsidiary of LMX, which is consolidated into LMA as a VIE, as well as LMATT Growth Series 2.2024, Inc., a wholly owned subsidiary of LMATT Growth Series, Inc., and LMATTS Growth and Income Series 1.2026, Inc., a wholly owned subsidiary of LMATT Growth and Income Series, Inc., all of which are 100% owned subsidiaries and fully consolidated. Accordingly, the provision for income taxes was attributable to amounts for LMATT Series 2024, Inc, LMATT Growth Series, Inc. and LMATT Growth and Income Series, Inc.


42

Table of Contents
For the three months ended JuneSeptember 30, 2023 and 2022, the Company recorded provision for income taxes of $1,184,571$1,710,315 and $120,132,$352,081, respectively. The effective tax rate is 15.0%61.9% for the three months ended JuneSeptember 30, 2023.2023 primarily driven by non-deductible equity compensation expense and the impact of non-taxable flow-through entities. The effective rate for the three months ended JuneSeptember 30, 2022 was 12.0%3.3% due to the impact of state income taxes and the release of the Company’s valuation allowance, as there was sufficient evidence of the Company’s ability to generate future taxable income at JuneSeptember 30, 2022.
34

Table of Contents
For the sixnine months ended JuneSeptember 30, 2023 and 2022, the Company recorded provision for income taxes of $528,104$2,238,419 and $296,806,$648,887, respectively. The effective tax rate is 3.6%12.7% for the sixnine months ended JuneSeptember 30, 2023. The existence of non-taxable flow-through entities within the Company as well as a change in tax status of certain entities upon the Business Combination caused the effective tax rate to be significantly lower thanvary from the statutory rate. The effective rate for the sixnine months ended JuneSeptember 30, 2022 was 18%2.8% due to the impact of state income taxes and the release of the Company’s valuation allowance, as there was sufficient evidence of the Company’s ability to generate future taxable income at JuneSeptember 30, 2022.
The Company did not have any unrecognized tax benefits relating to uncertain tax positions as of JuneSeptember 30, 2023, and December 31, 2022, and did not recognize any interest or penalties related to uncertain tax positions as of JuneSeptember 30, 2023, and December 31, 2022.

17.18.RELATED-PARTY TRANSACTIONS
As of JuneSeptember 30, 2023 and December 31, 2022, $10,415,154$5,236 and $263,785, respectively, were due to members and affiliates primarily for reimbursable transaction costs as well as distributions to owners of $717,429 as a part of the Business Combination as of JuneSeptember 30, 2023. As of JuneSeptember 30, 2023 and December 31, 2022, $10,473,748$772,545 and $2,904,646, respectively, was due from affiliates, respectively. The amount to be received as of June 30, 2023 is due from the Sponsor as part of the Sponsor PIK Note. Additionally, the SPV purchasePurchase and sale noteSale Note for $25,000,000 as of June 30, 2023 was also recorded as a related party transaction given the transfer of cash and policies between the Company and the SPV. Also, the sponsor PIK Note is also recorded as a related party transaction given the relationship between the Sponsor and the Company. Refer to footnoteNote 13, Long-Term Debt, for more information.
The Company has a related-party relationship with Nova Trading (US), LLC (“Nova Trading”), a Delaware limited liability company and Nova Holding (US) LP, a Delaware limited partnership (“Nova Holding” and collectively with Nova Trading, the “Nova Funds”). The Company also earns service revenue related to policy and administrative services on behalf of Nova Funds. The servicing fee is equal to 50 basis points (0.50%) times the monthly invested amount in policies held by Nova Funds divided by 12. The Company earned $197,629$168,899 and $205,224, respectively,$132,220 in service revenue related to Nova Funds for the three months ended JuneSeptember 30, 2023 and 2022, respectively, and earned $411,076$711,975 and $406,129, respectively,$752,379 in service revenue related to Nova Funds for the sixnine months ended JuneSeptember 30, 2023 and 2022.
Prior to the Merger, LMA used Abacus to originate life settlement policies that it accounts for under the investment method. For the three and six months ended June 30, 2023, the Company incurred $837,975 and $1,627,975, respectively in origination costs for life settlement policies that were originated by Abacus. These costs are capitalized on the condensed consolidated balance sheets as life settlement policies, at cost.2022, respectively.
As of JuneSeptember 30, 2023, and December 31, 2022, there were $72,600$174,875 and $196,289, respectively owed from the Nova Funds, which are included as related-party receivables in the accompanying condensed consolidated balance sheets.
The Company also originates policies for the Nova Funds. For the three months ended September 30, 2023, the Company originated 7 policies for the Nova Funds with a total value of $46,650,000. For its origination services to the Nova Funds, the Company earns origination fees equal to the lesser of (i) 2% of the net death benefit for the policy or (ii) $20,000. In addition to the Nova Funds, the Company also has other affiliated investors that provide origination services. For the three and nine months ended September 30, 2022, the Company did not earn any related party origination revenue for the Nova Funds.
43

Table of Contents
For the three and nine months ended September 30, 2023, revenue earned, and contracts originated are below.

Three and Nine Months Ended
September 30, 2023
Origination fee revenue$254,517 
Transaction reimbursement revenue— 
Total$254,517 
Cost$7,981 
Face value46,650,000 
Total policies
Average Age70

18.19.LEASES
The Company’s right-of-use assets and lease liabilities for its operating lease consisted of the following amounts as of JuneSeptember 30, 2023 and December 31, 2022:
Six Months Ended
June 30, 2023
Year Ended
December 31, 2022
Assets:
Operating lease right-of-use assets$240,816 $77,011 
Liabilities:
35

Table of Contents
Nine Months Ended
September 30, 2023
Year Ended
December 31, 2022
Assets:Assets:
Operating lease right-of-use assetsOperating lease right-of-use assets$171,295 $77,011 
Liabilities:Liabilities:
Operating lease liability, currentOperating lease liability, current227,561 48,127 Operating lease liability, current173,799 48,127 
Operating lease liability, non-currentOperating lease liability, non-current16,864 29,268 Operating lease liability, non-current— 29,268 
Total lease liabilityTotal lease liability$244,425 $77,395 Total lease liability$173,799 $77,395 
The Company recognizes lease expense for its operating leases within general, administrative, and other expenses on the Company’s condensed consolidated statements of operations and comprehensive income. The Company’s lease expense for the periods presented consisted of the following:
Three Months Ended June 30,Six Months Ended June 30,Three Months Ended September 30,Nine Months Ended September 30,
20232022202320222023202220232022
Operating lease costOperating lease cost$12,471 $11,921 $24,942 $23,842 Operating lease cost$69,904 $12,471 $94,846 $36,313 
Variable lease costVariable lease cost7,704 612 8,925 1,223 Variable lease cost20,540 1,221 29,465 2,444 
Total lease costTotal lease cost$20,175 $12,533 $33,867 $25,065 Total lease cost$90,444 $13,692 $124,311 $38,757 

44

Table of Contents
The following table shows supplemental cash flow information related to lease activities for the periods presented:
Six Months Ended June 30,Nine Months Ended September 30,
2023202220232022
Cash paid for amounts included in the measurement of the lease liabilityCash paid for amounts included in the measurement of the lease liabilityCash paid for amounts included in the measurement of the lease liability
Operating cash flows from operating leasesOperating cash flows from operating leases$24,557 $23,842 Operating cash flows from operating leases$96,891 $36,121 
ROU assets obtained in exchange for new lease liabilitiesROU assets obtained in exchange for new lease liabilities— — ROU assets obtained in exchange for new lease liabilities— — 
The table below shows a weighted-average analysis for lease terms and discount rates for all operating leases for the periods presented:
Six Months Ended
June 30, 2023
Year Ended December 31, 2022Nine Months Ended
September 30, 2023
Year Ended December 31, 2022
Weighted-average remaining lease term (in years)Weighted-average remaining lease term (in years)1.001.58Weighted-average remaining lease term (in years)0.801.58
Weighted-average discount rateWeighted-average discount rate3.54 %3.36 %Weighted-average discount rate3.42 %3.36 %

Future minimum noncancellable lease payments under the Company’s operating leases on an undiscounted basis reconciled to the respective lease liability at JuneSeptember 30, 2023 are as follows:
Operating leasesOperating leases
Remaining of 2023Remaining of 2023$130,176 Remaining of 2023$117,527 
20242024118,057 2024118,058 
20252025— 2025— 
20262026— 2026— 
20272027— 2027— 
ThereafterThereafter— Thereafter— 
Total operating lease payments (undiscounted)Total operating lease payments (undiscounted)248,233 Total operating lease payments (undiscounted)235,585 
Less: Imputed interestLess: Imputed interest(3,808)Less: Imputed interest(61,786)
Lease liability as of June 30, 2023$244,425 
Lease liability as of September 30, 2023Lease liability as of September 30, 2023$173,799 

19.20. EARNINGS PER SHARE
36

Table of Contents
Basic earnings per share (“EPS”) represents income available to ordinary shareholders divided by the weighted average number of ordinary shares outstanding during the reported period. Net income per ordinary share is computed by dividing net income by the weighted-average number of ordinary shares outstanding during the period. The Company has not considered the effect of the Public and Private Placement Warrants to purchase an aggregate of 26,150,000 shares in the calculation of diluted income per ordinary share, since the average market price of the Company’s Class A common shares for the three and sixnine months ended JuneSeptember 30, 2023 was below the warrants’ $11.50 exercise price. As a result, diluted income per share is the same as basic net income per share for the period presented.


45

Table of Contents
Basic and diluted weighted average shares outstanding and earnings per share were as follows:

Three Months EndedSix Months EndedThree Months EndedNine Months Ended
June 30, 2023June 30, 2022June 30, 2023June 30, 2022September 30, 2023September 30, 2022September 30, 2023September 30, 2022
Net income attributable to Longevity Market AssetsNet income attributable to Longevity Market Assets$6,750,145 $4,679,558 $14,835,648 $11,515,698 Net income attributable to Longevity Market Assets$903,361 $9,992,004 $15,739,009 $21,507,702 
Weighted-average shares used in computing net income per share, basic and dilutedWeighted-average shares used in computing net income per share, basic and diluted50,507,728 50,369,350 50,438,921 50,369,350 Weighted-average shares used in computing net income per share, basic and diluted63,349,823 50,369,350 54,632,826 50,369,350 
Basic and diluted earnings per share:Basic and diluted earnings per share:$0.13 $0.09 $0.29 $0.23 Basic and diluted earnings per share:$0.01 $0.20 $0.29 $0.43 

20.21. SUBSEQUENT EVENTS
The Company evaluated subsequent events and transactions from the condensed consolidated balance sheet date through the date at which the condensed consolidated financial statements were issued.
Owl Rock Credit FacilityFixed Rate Senior Unsecured Notes

On July 5,November 6, 2023, (the “Owl Rock Closing Date”), the Company entered into that certain Credit Agreement (the “Owl Rock Credit Facility”), amongfiled a prospectus on Form S-1 to issue and sell fixed rate senior unsecured notes up to $40,000,000 aggregate principal amount of the Company, as borrower, the several banks and other persons from time to time party thereto (the “Owl Rock Lenders”Company’s senior unsecured promissory notes (“Fixed Unsecured Notes”), and Owl Rock Capital Corporation, as administrative and collateral agent for the Owl Rock Lenders thereunder.
which closed on November 10, 2023. The Owl Rock Credit Facility, among other things:
requires the Company and certain subsidiaries ofnet proceeds after related debt issue costs, were used by the Company to guarantee the loans provided underrepay the Owl Rock Credit Facility, pursuantwith the remaining to separate loan documentation;
provides credit extensions for (i) an initial term loan in an aggregate principal amount of $25.0 million upon the closing of the Owl Rock Credit Facility and (ii) optional delayed draw term loans (which can be drawn on multiple drawing dates) in an aggregate principal amount of up to $25.0 million available for one hundred eighty (180) days after the Owl Rock Closing Date (the “Delayed Draw Term Loan Availability Period”), subject to the requirement that on each delayed draw date, the liquid asset coverage ratio shall not be less than 1.80 to 1.00, together with other specified conditions to drawings, the proceeds of which may be used for working capitalgeneral corporate purposes. This loan is based on a fixed interest rate of 9.875%, provides for quarterly interest payments beginning on February 15, 2024, and has a term of five years with a maturity date of November 15, 2028. The Company has the business requirementsoption to redeem the Fixed Unsecured Notes in whole or in part at a price of 100% of the enterprise,outstanding principal balance on or after November 15, 2027. The notes will be senior unsecured obligations of the Company and will rank equal in right of payment to fund acquisitions, investmentsall of the Company’s other senior unsecured indebtedness from time to time outstanding.

Long-term Incentive Plan

In October of 2023, the Compensation Committee approved the issuance of 2,468,500 restricted stock units (“RSU’s”) to executives, employees and other transactions permitted bydirectors as part of the loan documentation;Company’s 2023 Long-Term Equity Compensation Incentive Plan (“Long-term Incentive Plan”) This plan provides for equity-based awards, including restricted stock units, performance stock units (“PSU”), stock options and unrestricted shares of common stock, may be granted to officers, key employees and directors of the Company. The Company has granted RSUs that provide the right to receive, subject to service based vesting conditions, shares of common stock pursuant to the Equity Plan. After the issuance, 621,500 shares of common stock remained available for issuance of the 3,090,000 shares that are authorized for issuance under the Long-term Incentive Plan. The expense associated with the awards will be based on the fair value of the shares as of the grant date, where the Company will elect to straight line recognition over the vesting period, which is three years.

provides a delayed draw commitment fee rate of 0.50% per annum applicable to undrawn commitments during the Delayed Draw Term Loan Availability Period
3746

Table of Contents
Each RSU entitles the unit holder to one share of common stock when the restriction expires. RSUs
have service conditions associated with them that range from onematures on July 5, 2028, to three years. In our plan, subject
to continuous employment, 10% of the Initial Annual Award will vest at 12 months following the date
of grant and 90% of the Initial Annual Award will vest at 36 months following the date that is five years after the closing of the Owl Rock Credit Facility;grant. A
is secured by a first-priority security interest in substantially allminimum of 10% of the assetsInitial Annual Award will vest if termination by the Employer without cause or
by the executive for good reason occurs within the first 12 months of the Company andgrant. After satisfying the subsidiary guarantors. No pledge of any equity interests in
above vesting conditions, the Company is required by any holder of such equity interests;
provides for interest to accrue on the loans drawn under the Owl Rock Credit Facility at the election of the Company, by reference to either (i) an alternative base rate (such loans, “ABR Loans”) or (ii) an adjusted term SOFR rate (such loans, “SOFR Loans”) plus an applicable margin. The adjusted term SOFR rate is determined by the applicable term SOFR for a relevant interest period plus a credit spread adjustment of 0.10%, 0.15% and 0.25% per annum for interest periods of one, three and six months, respectively. The applicable margin for each type of loan is (i) 6.25% per annum for any ABR Loans and (ii) 7.25% per annum for any SOFR Loans, with interest periods for SOFR Loans of one, three or six months (or other periods if agreed by all lenders);
provides a default rate that will accrue at 2.00% per annum over the rate otherwise applicable;
provides for amortization payments based on the initial principal amount of the loans outstanding of 1.0% per year (0.25% due per quarter), with adjustments made to the overall amortization amount upon the incurrence of any delayed draw loans;
contains provisions requiring mandatory prepayment of the initial term loans and delayed draw term loans with 100% of the proceeds of (a) indebtedness not permitted by the Owl Rock Credit Facility and (b) certain specified asset dispositions and payments (including in respect of settlements) in respect of property, casualty insurance claims or condemnation proceedings, with the proceeds received under this clause (b) subject to certain specified reinvestment rights and procedures set forth in the Owl Rock Credit Facility. The Owl Rock Credit Facility permits voluntary prepayments of outstanding loans at any time;
provides for a prepayment premium equal to (a) 4.00% of the principal amount of such loans prepaid on or prior to the first anniversary of the closing of the Owl Rock Credit Facility, (b) 3.00% of the principal amount of such loans prepaid after the first anniversary of the closing of the Owl Rock Credit Facility but on or prior to the second anniversary of the closing of the Owl Rock Credit Facility and (c) 2.00% of the principal amount of such loans prepaid after the second anniversary of the closing of the Owl Rock Credit Facility but on or prior to the third anniversary of the closing of the Owl Rock Credit Facility. No prepayment premiumparticipants will be applicable for any such prepayment made afterfully entitled to their shares of Class A common
stock. Shares that are issued upon vesting are newly issued shares from the third anniversary of the closing of the Owl Rock Credit Facility. The prepayment premium is applicable to voluntary prepayments Long-term Incentive Plan
and certain specified mandatory prepayment during such applicable periods;are not issued from treasury stock. Forfeitures are recorded as they occur.

provides for financial covenants such that (i) a consolidated net leverage ratio cannot exceed 2.50 to 1.00 as of the last day of any fiscal quarter and (ii) a liquid asset coverage ratio cannot be less than 1.80 to 1.00;
contains affirmative covenants related to, among other things, delivery of certain financial reports and compliance certificates, maintenance of existence, compliance with laws, material contracts, payment of taxes, property and insurance matters, inspection of property, books and records, notices, collateral matters and future subsidiaries, in each case, subject to specified limitations and exceptions;
contains an affirmative representation and corresponding covenant that the Company and certain subsidiaries of the Company do not, and will not during the term of the Owl Rock Facility (or if the term of the Owl Rock Credit Facility continues for longer than a year, during the Company’s and certain subsidiaries of the Company’s most recent fiscal year), derive more than fifteen percent (15%) of their aggregate gross revenues from securities related activities;
contains negative covenants related to, among other things, incurrence of debt, creation of liens, mergers, acquisitions and certain other fundamental changes, conditions concerning the creation of new subsidiaries, conditions concerning opening of new accounts, disposition of assets, dividends and other restricted payments, prepayment of certain indebtedness, transactions with
38

Table of Contents
affiliates, investments and limitations on lines of business, in each case, subject to specified limitations and exceptions; and
provides for certain specified events of default upon the occurrence and during the continuation of certain events or conditions (subject to specified exceptions, grace periods or cure rights, as applicable) each as set forth in the Owl Rock Credit Facility, which includes among other things, defaults with respect to nonpayment, breaches of representations and warranties, failure to comply with covenants, cross-default to other material indebtedness, bankruptcy and insolvency matters, ERISA matters, material judgments, collateral and perfection matters, the occurrence of a change of control and subordination matters with respect to certain specified indebtedness. The occurrence and continuance of an event of default that is not cured or waived will enable the agent and/or the lenders, as applicable, to accelerate the loans or take other remedial steps as provided in the Owl Rock Credit Facility and the other loan documents.


































*****
39

Table of Contents
ABACUS SETTLEMENTS, LLC
4047

Table of Contents
ABACUS SETTLEMENTS, LLC
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2023 AND THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022
Three Months Ended
June 30
Six Months Ended
June 30
Three Months Ended
June 30
Three Months Ended
September 30
Six Months Ended
June 30
Nine Months Ended
September 30
20232022202320222023202220232022
Origination revenueOrigination revenue$1,689,088 $743,388 $3,252,738 $3,185,068 Origination revenue$1,689,088 $1,766,853 $3,252,738 $4,951,921 
Related party revenueRelated party revenue5,195,602 4,948,528 9,931,938 9,829,596 Related party revenue5,195,602 4,264,628 9,931,938 14,094,223 
Total revenueTotal revenue6,884,690 5,691,916 13,184,676 13,014,664 Total revenue6,884,690 6,031,481 13,184,676 19,046,144 
Cost of revenueCost of revenue1,505,333 956,625 2,734,949 3,265,313 Cost of revenue1,505,333 933,089 2,734,949 4,198,402 
Related party cost of revenueRelated party cost of revenue3,392,647 2,615,307 6,558,354 5,522,312 Related party cost of revenue3,392,647 2,930,990 6,558,354 8,453,302 
Total cost of revenueTotal cost of revenue4,897,980 3,571,932 9,293,303 8,787,625 Total cost of revenue4,897,980 3,864,079 9,293,303 12,651,704 
Gross ProfitGross Profit1,986,710 2,119,984 3,891,373 4,227,039 Gross Profit1,986,710 2,167,402 3,891,373 6,394,440 
OPERATING EXPENSES:OPERATING EXPENSES:OPERATING EXPENSES:
General and administrative expensesGeneral and administrative expenses2,297,577 2,208,051 4,848,580 3,948,358 General and administrative expenses2,297,577 2,284,061 4,848,580 6,232,419 
DepreciationDepreciation2,561 3,048 5,597 5,988 Depreciation2,561 3,161 5,597 9,149 
Total operating expensesTotal operating expenses2,300,138 2,211,099 4,854,177 3,954,346 Total operating expenses2,300,138 2,287,222 4,854,177 6,241,568 
Income (Loss) from operationsIncome (Loss) from operations(313,428)(91,115)(962,804)272,693 Income (Loss) from operations(313,428)(119,820)(962,804)152,872 
OTHER INCOME (EXPENSE)OTHER INCOME (EXPENSE)OTHER INCOME (EXPENSE)
Interest incomeInterest income1,193 599 1,917 1,147 Interest income1,193 358 1,917 1,505 
Interest (expense)Interest (expense)(5,863)(11,725)Interest (expense)(5,863)(2,954)(11,725)(2,954)
Other incomeOther income273 273 Other income273 
Total other income (expense)Total other income (expense)(4,670)872 (9,808)1,420 Total other income (expense)(4,670)(2,596)(9,808)(1,176)
Income (Loss) before provision for income taxesIncome (Loss) before provision for income taxes(318,098)(90,243)(972,612)274,113 Income (Loss) before provision for income taxes(318,098)(122,417)(972,612)151,696 
Provision for income taxesProvision for income taxes2,289 1,325 Provision for income taxes582 2,289 1,907 
NET INCOME (LOSS) AND COMPREHENSIVENET INCOME (LOSS) AND COMPREHENSIVE$(318,098)$(90,243)$(974,901)$272,788 NET INCOME (LOSS) AND COMPREHENSIVE$(318,098)(122,999)$(974,901)149,789 
WEIGHTED-AVERAGE UNITS USED IN COMPUTING NET INCOME (LOSS) PER UNIT:WEIGHTED-AVERAGE UNITS USED IN COMPUTING NET INCOME (LOSS) PER UNIT:WEIGHTED-AVERAGE UNITS USED IN COMPUTING NET INCOME (LOSS) PER UNIT:
BasicBasic$400 400400400Basic400 400400400
DilutedDiluted$400 400400400Diluted400 400400400
NET INCOME/(LOSS) PER UNIT:NET INCOME/(LOSS) PER UNIT:NET INCOME/(LOSS) PER UNIT:
Basic earnings per unitBasic earnings per unit$(795.25)$(225.61)$(2,437.25)$681.97 Basic earnings per unit$(795.25)$(307.50)$(2,437.25)$374.47 
Diluted earnings per unitDiluted earnings per unit$(795.25)$(225.61)$(2,437.25)$681.97 Diluted earnings per unit$(795.25)$(307.50)$(2,437.25)$374.47 
See accompanying notes to interim condensed consolidated financial statements.

4148

Table of Contents
ABACUS SETTLEMENTS, LLC
UNAUDITED CONDENSED STATEMENTS OF CHANGES IN MEMBERS' EQUITY
FOR THREE AND SIX MONTHS ENDED JUNE 30, 2023 AND 2022
Common unitsAdditional
Paid-In Capital
Retained
Earnings
TotalCommon UnitsAdditional
Paid-In Capital
Retained
Earnings
Total
UnitsAmountUnitsAmount
BALANCE—March 31, 2023BALANCE—March 31, 2023400$4,000 $80,000 $1,270,334 $1,354,334 BALANCE—March 31, 2023400$4,000 $80,000 $1,270,334 $1,354,334 
Net incomeNet income-(318,098)(318,098)Net income-(318,098)(318,098)
DistributionsDistributions-(442,283)(442,283)Distributions-(442,283)(442,283)
BALANCE—June 30, 2023BALANCE—June 30, 2023400$4,000 $80,000 $509,953 $593,953 BALANCE—June 30, 2023400$4,000 $80,000 $509,953 $593,953 
Common unitsAdditional
Paid-In Capital
Retained
Earnings
TotalCommon UnitsAdditional
Paid-In Capital
Retained
Earnings
Total
UnitsAmountUnitsAmount
BALANCE—December 31, 2022BALANCE—December 31, 2022400$4,000 $80,000 $1,927,137 2,011,137 BALANCE—December 31, 2022400$4,000 $80,000 $1,927,137 2,011,137 
Net lossNet loss-(974,901)(974,901)Net loss-(974,901)(974,901)
DistributionsDistributions-(442,283)(442,283)Distributions-(442,283)(442,283)
BALANCE—June 30, 2023BALANCE—June 30, 2023400$4,000 $80,000 $509,953 $593,953 BALANCE—June 30, 2023400$4,000 $80,000 $509,953 $593,953 
See accompanying notes to interim condensed financial statements.
4249

Table of Contents
ABACUS SETTLEMENTS, LLC
UNAUDITED CONDENSED STATEMENTS OF CHANGES IN MEMBERS' EQUITY
FOR SIXTHREE AND NINE MONTHS ENDED JUNESEPTEMBER 30, 2023 AND 2022
Common unitsAdditional
Paid-In Capital
Retained
Earnings
TotalCommon UnitsAdditional
Paid-In Capital
Retained
Earnings
Total
UnitsAmountUnitsAmount
BALANCE—December 31, 2021400$4,000 $80,000 $2,638,995 $2,722,995 
BALANCE—June 30, 2022BALANCE—June 30, 2022400$4,000 $80,000 $2,251,914 $2,335,914 
Net incomeNet income-272,788 272,788 Net income-(122,999)(122,999)
DistributionsDistributions-(659,869)(659,869)Distributions-(1,439)(1,439)
BALANCE—June 30, 2022400$4,000 $80,000 $2,251,914 $2,335,914 
BALANCE—September 30, 2022BALANCE—September 30, 2022400$4,000 $80,000 $2,127,476 $2,211,476 
Common unitsAdditional
Paid-In Capital
Retained
Earnings
Total
UnitsAmount
BALANCE—December 31, 2022400$4,000 $80,000 $1,927,137 2,011,137 
Net loss---$(974,901)(974,901)
Distributions---$(442,283)(442,283)
BALANCE—June 30, 2023400$4,000 $80,000 $509,953 $593,953 
Common UnitsAdditional
Paid-In Capital
Retained
Earnings
Total
UnitsAmount
BALANCE—December 31, 2021400$4,000 $80,000 $2,638,995 2,722,995 
Net income---149,789 149,789 
Distributions---(661,308)(661,308)
BALANCE—September 30, 2022400$4,000 $80,000 $2,127,476 $2,211,476 
See accompanying notes to interim condensed financial statements.
4350

Table of Contents
ABACUS SETTLEMENTS, LLC
UNAUDITED INTERIM CONDENSED STATEMENTS OF CASH FLOWS
FOR SIX MONTHS ENDED JUNE 30, 2023 AND 2022
Six Months Ended June 30,Six Months Ended June 30,Nine Months Ended September 30,
2023202220232022
CASH FLOWS FROM OPERATING ACTIVITIES:CASH FLOWS FROM OPERATING ACTIVITIES:CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)Net income (loss)$(974,901)$272,788 Net income (loss)$(974,901)$149,789 
Adjustments to reconcile net income to net cash used in operating activities:Adjustments to reconcile net income to net cash used in operating activities:Adjustments to reconcile net income to net cash used in operating activities:
Depreciation expenseDepreciation expense19,157 10,751 Depreciation expense19,157 17,807 
Amortization expenseAmortization expense40,278 37,952 Amortization expense40,278 60,000 
Amortization of deferred financing feesAmortization of deferred financing fees11,725 — Amortization of deferred financing fees11,725 1,954 
Non-cash lease expenseNon-cash lease expense1,210 — Non-cash lease expense1,210 815 
Changes in operating assets and liabilities:Changes in operating assets and liabilities:Changes in operating assets and liabilities:
Related party receivablesRelated party receivables397,039 — Related party receivables397,039 — 
Other receivablesOther receivables101,203 (202,491)Other receivables101,203 (641,951)
Prepaid expensesPrepaid expenses(198,643)71,038 Prepaid expenses(198,643)(33,192)
Other current assetsOther current assets(26,211)(20,111)Other current assets(26,211)(2,561)
Certificate of depositCertificate of deposit— 656,250 Certificate of deposit— 656,250 
Accrued payroll and other expensesAccrued payroll and other expenses(17,466)155,994 Accrued payroll and other expenses(17,466)41,934 
Contract liability—deposits on pending settlementsContract liability—deposits on pending settlements659,067 (1,427,291)Contract liability—deposits on pending settlements659,067 (1,096,041)
Accounts payableAccounts payable(36,750)(7,247)Accounts payable(36,750)(30,696)
Net cash used in operating activitiesNet cash used in operating activities(24,292)(452,367)Net cash used in operating activities(24,292)(875,892)
CASH FLOWS FROM INVESTING ACTIVITIES:CASH FLOWS FROM INVESTING ACTIVITIES:CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expendituresCapital expenditures(108,394)(32,212)Capital expenditures(108,394)(57,546)
Purchase of intangible assetPurchase of intangible asset— (15,000)Purchase of intangible asset— (15,000)
Due to/from members and affiliates(74,134)11,525 
Due from members and affiliatesDue from members and affiliates(74,134)(58,275)
Net cash used in investing activitiesNet cash used in investing activities(182,528)(35,687)Net cash used in investing activities(182,528)(130,821)
CASH FLOWS FROM FINANCING ACTIVITIES:CASH FLOWS FROM FINANCING ACTIVITIES:CASH FLOWS FROM FINANCING ACTIVITIES:
Due to membersDue to members(1,411)(11,857)Due to members(1,411)(11,857)
Distributions to membersDistributions to members(442,283)(659,869)Distributions to members(442,283)(661,308)
Net cash used in financing activitiesNet cash used in financing activities(443,694)(671,726)Net cash used in financing activities(443,694)(673,165)
NET DECREASE IN CASH AND CASH EQUIVALENTSNET DECREASE IN CASH AND CASH EQUIVALENTS(650,514)(1,159,780)NET DECREASE IN CASH AND CASH EQUIVALENTS(650,514)(1,679,878)
CASH AND CASH EQUIVALENTS:CASH AND CASH EQUIVALENTS:CASH AND CASH EQUIVALENTS:
Beginning of periodBeginning of period1,458,740 2,599,302 Beginning of period1,458,740 2,599,302 
End of periodEnd of period$808,226 $1,439,522 End of period$808,226 $919,424 
See accompanying notes to interim condensed financial statements.
4451

Table of Contents
ABACUS SETTLEMENTS, LLC
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
1.DESCRIPTION OF THE BUSINESS
Abacus Settlements, LLC d/b/a Abacus Life (the “Company”(“Abacus”) was formed in 2004 in the state of New York. In 2016, the Company obtained its licensure in Florida and re-domesticated to that state. On June 13, 2023, the Company re-domesticated to Delaware.
The CompanyAbacus acts as a purchaser of outstanding life insurance policies (“Provider”) on behalf of investors (“Financing Entities”) by locating policies and screening them for eligibility for a life settlement, including verifying that the policy is in force, obtaining consents and disclosures, and submitting cases for life expectancy estimates, also known as origination services. When the sale of a policy is completed, this is deemed “settled” and the policy is then referred to as either a “life settlement” in which the insured’s life expectancy is greater than two years or “viatical settlement,” in which the insured’s life expectancy is less than two years.
The CompanyAbacus is not an insurance company, and therefore the CompanyAbacus does not underwrite insurable risks for its own account. On August 30, 2022, the CompanyAbacus entered into an Agreement and Plan of Merger (the “Merger Agreement”) with East Resources Acquisition Company (“ERES”), which was subsequently amended on October 14, 2022. As part of the Merger Agreement, the holders of the Company’sAbacus’ common units together with the holders of Longevity Markets Assets, LLC (“LMA”), a commonly owned affiliate, will receive aggregate consideration of approximately $531,750,000, payable in a number of newly issued shares of ERES Class A common stock, par value $0.0001 per share (“ERES Class A common stock”), with a value ascribed to each share of ERES Class A common stock of $10.00 and, to the extent the aggregate transaction proceeds exceed $200.0 million, at the election of the Company’sAbacus’ and LMA’s members, up to $20.0 million of the aggregate consideration will be payable in cash to the Company’sAbacus’ and LMA’s members. The transaction closed on June 30, 2023 upon shareholder approval and customary closing conditions.
2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
The condensed balance sheet as of June 30, 2023, was derived from amounts included in the Company’sAbacus’ annual financial statements for the year ended December 31, 2022. Such amounts are included within the condensed consolidated financial statements of Abacus Life, Inc. (the “Company”). Capitalized terms used herein without definition have the meanings ascribed to them in the Company’sAbacus’ financial statements for the year ended December 31, 2022. Refer to this note in the annual financial statements for the full list of the Company’s significant accounting policies. The details in those notes have not changed except as discussed below and as a result of normal adjustments in the interim periods.
Basis of Presentation—The accompanying condensed financial statements are presented in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) and are prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).
Unaudited Condensed Financial Statements—The condensed financial statements have been prepared on a basis consistent with the audited annual financial statements as of and for the year ended December 31, 2022, and, in the opinion of management, reflect all adjustments, consisting solely of normal recurring adjustments, necessary for the fair presentation of the Company’sAbacus’ financial position as of June 30, 2023, and the condensed results of its operations and comprehensive income/(loss) and cash flows for the three and six months ended June 30, 2023 and the three and nine months ended September 30, 2022. The condensed results of operations and comprehensive income/(loss) and cash flows for the period January 1, 2023 to June 30, 2023, are not necessarily indicative of the results to be expected for the full year ending December 31, 2023, or any other period.
4552

Table of Contents
Use of Estimates—The preparation of US GAAP financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and changes therein, and disclosure of contingent assets and liabilities at the date of financial statements and the reports amounts of revenue and expenses during the reporting periods. Company’sAbacus’ estimates, judgments, and assumptions are continually evaluated based on available information and experience. Because of the use of estimates inherent in the financial reporting process, actual results could differ from the estimates. Estimates are used when accounting for revenue recognition and related costs, the selection of useful lives of property and equipment, impairment testing, valuation of other receivables from clients, income taxes, and legal reserves.
Going Concern—Management evaluates at each annual and interim period whether there are conditions or events, considered in the aggregate, that raise substantial doubt about Company’sAbacus’ ability to continue as a going concern within one year after the date that the financial statements are issued. Management’s evaluation is based on relevant conditions and events that are known and reasonably knowable at the date that the financial statements are issued. Management has concluded that there are no conditions or events, considered in the aggregate, that raise substantial doubt about the Company’sAbacus’ ability to continue as a going concern within one year after the date these financial statements were issued.
Other receivables—Other receivables include origination fees for policies in which the recissionrescission period has ended, but the funds have not been received yet from financing entities. These fees were collected in the subsequent month.
The CompanyAbacus provides an allowance for credit losses equal to the estimated collection losses that will be incurred in collection of all receivables. Management determines the allowance for credit losses based on a review of outstanding receivables, historical collection experience, current economic conditions, and reasonable and supportable forecasts. Account balances are charged off against the allowance for credit losses after all means of collection have been exhausted and the potential for recovery is deemed remote. The CompanyAbacus does not have any material allowance for credit losses as of June 30, 2023 or December 31, 2022.
If the financial condition of the Company’sAbacus’ customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. The CompanyAbacus did not record material allowance for credit losses as of June 30, 2023, and December 31, 2022, respectively.
Concentrations—All of the Company’sAbacus’ revenues are derived from life settlement transactions in which the CompanyAbacus represents Financing Entities that purchased existing life insurance policies. One financing entity, a company in which the Company’sAbacus’ members own interests, represented 23% and 66%63% of the Company’sAbacus’ revenues in six months ended June 30, 2023 and nine months ended September 30, 2022, respectively. The CompanyAbacus originates policies through three different channels: Direct to Consumer, Agent, and Broker. Two brokers represented the sellers for over 10% of the Company’sAbacus’ life settlement commission expense during the period six months ended June 30, 2023. No brokerssingle broker represented the sellers for over 10% of the Company’sAbacus’ life settlement commission expense during the period sixnine months ended JuneSeptember 30, 2022. The CompanyAbacus maintains cash deposits with a major financial institution, which from time to time may exceed federally insured limits. The CompanyAbacus periodically assesses the financial condition of the institution and believes that the risk of loss is minimal.
Advertising—All advertising expenditures incurred by the CompanyAbacus are charged to expense in the period to which they relate and are included in general and administrative expenses on the accompanying condensed statements of operations and comprehensive income/(loss). Advertising expense totaled $367,418 and $286,695$421,088 for three months ended June 30, 2023 and September 30, 2022, respectively. Advertising expense totaled $741,789 and $554,802$975,890 for six months ended June 30, 2023 and nine months ended September 30, 2022, respectively.
4653

Table of Contents
3.SEGMENT REPORTING
Operating as a centrally led life insurance policy intermediary, the Company’sAbacus’ president and chief executive officer is the chief operating decision maker who allocates resources and assesses financial performance based on financial information presented for the CompanyAbacus as a whole. As a result of this management approach, the CompanyAbacus is organized as a single operating segment.
4.REVENUE
Disaggregated Revenue—The following table presents a disaggregation of the Company’sAbacus’ revenue by major sources for three months ended June 30, 2023 and 2022, and for six months ended June 30, 2023 and 2022:
Three Months Ended
June 30,
Six Months Ended
June 30,
Three Months Ended
June 30,
Three Months Ended
September 30,
Six Months Ended
June 30,
Nine Months Ended
September 30,
20232022202320222023202220232022
AgentAgent$3,334,402 $2,717,512 $7,143,016 $5,690,701 Agent$3,334,402 $2,982,371 $7,143,016 $8,673,072 
BrokerBroker2,809,499 2,247,953 4,675,973 5,727,970 Broker2,809,499 2,128,912 4,675,973 7,856,882 
Client directClient direct740,789 726,451 1,365,687 1,595,993 Client direct740,789 920,197 1,365,687 2,516,190 
TotalTotal$6,884,690 $5,691,916 $13,184,676 $13,014,664 Total$6,884,690 $6,031,480 $13,184,676 $19,046,144 
5.INCOME TAXES
Since the CompanyAbacus elected to file as an S corporation for federal and State income tax purposes, the CompanyAbacus incurred no federal or state income taxes. Accordingly, provision for income taxes is attributable to minimum state tax payments that are due regardless of their S corporation status and income position.
For the three months ended June 30, 2023, and 2022, the companyAbacus did not record provision for income taxes. For the three months ended September 30, 2022, Abacus recorded provision for income taxes of $582. For the six months ended June 30, 2023 and nine months ended September 30, 2022, the companyAbacus recorded provision for income taxes of $2,289 and $1,325,$1,907, respectively, which consist of state minimum taxes for state taxes that have been paid and settled during the period. The effective tax rate was approximately (0.24%) for the six months ended June 30, 2023, compared to 0.48%1.26% for the sixnine months ended JuneSeptember 30, 2022.
Given the company'sAbacus' S Corporation status, temporary book and tax differences do not create a deferred tax asset or liability on the balance sheets. Accordingly, an assessment of realizability of any deferred tax asset balances is not relevant.
6.RETIREMENT PLAN
The CompanyAbacus provides a defined contribution plan to its employees, Abacus Settlements LLC 401(k) Profit Sharing Plan & Trust (the “Plan”). All eligible employees are able to participate in voluntary salary reduction contributions to the Profit-Sharing Plan. All employees who have completed one year of service with the CompanyAbacus are eligible to receive employer-matching contributions. The CompanyAbacus may match contributions to the Plan, up to 4% of compensation. For the three months ended June 30, 2023 and September 30, 2022, and for six months ended June 30, 2023 and nine months ended September 30, 2022, the CompanyAbacus made no discretionary contribution to the Plan.
54

Table of Contents

7.RELATED-PARTY TRANSACTIONS
The CompanyAbacus has a related-party relationship with Nova Trading (US), LLC (“Nova Trading”), a Delaware limited liability company and Nova Holding (US) LP, a Delaware limited partnership (“Nova Holding” and collectively with Nova Trading, the “Nova Funds”) as the owners of Abacus jointly own 11% of the Nova
47

Table of Contents
Funds. For the three months ended June 30, 2023 and September 30, 2022, the CompanyAbacus originated 38 and 9282 policies, respectively, for the Nova Funds with a total value of $56,688,680 and $102,307,954,$93,605,072, respectively. For the six months ended June 30, 2023 and nine months ended September 30, 2022, the CompanyAbacus originated 72 and 183265 policies, respectively, for the Nova Funds with a total value of $96,674,080 and $282,804,838,$376,409,910, respectively. For its origination services to the Nova Funds, the CompanyAbacus earns origination fees equal to the lesser of (i) 2% of the net death benefit for the policy or (ii) $20,000. For three months ended June 30, 2023 and 2022, and for the six months ended June 30, 2023 and nine months ended September 30, 2022, revenue earned, and contracts originated are as follows:

Three Months Ended
June 30,
Six Months Ended
June 30,
2023202220232022
Origination fee revenue$1,504,532 $4,164,107 $2,952,837 $8,569,034 
Transaction reimbursement revenue75,332 152,221 140,960 306,361 
Total$1,579,864 $4,316,328 $3,093,797 $8,875,395 
Cost$5,290,504 $25,201,256 $11,656,637 $50,738,202 
Face value56,688,680 102,307,954 96,674,080 282,804,838 
Total policies38 92 72 183 
Average Age017575
Three Months Ended
June 30,
Three Months Ended
September 30,
Six Months Ended
June 30,
Nine Months Ended
September 30,
2023202220232022
Origination fee revenue$1,504,532 $8,008,816 $2,952,837 $8,008,816 
Transaction reimbursement revenue75,332 235,455 140,960 235,455 
Total$1,579,864 $8,244,271 $3,093,797 $8,244,271 
Cost$5,290,504 $4,511,346 $11,656,637 $4,511,346 
Face value56,688,680 93,605,072 96,674,080 376,409,910 
Total policies38 82 72 265 
Average Age76757575
In addition to the Nova Funds, the CompanyAbacus also has another affiliated investor that they provide origination services for. Total revenue earned related to the other affiliated investor was $3,615,738 and $589,700,$1,155,000, of which $3,615,739 and $470,200$955,000 related to Longevity Market Assets, LLC (“LMA”)LMA for the three months ended June 30, 2023 and September 30, 2022, respectively. Total cost of sales related to the other affiliated investor was $2,623,201 and $363,700,$1,055,000, of which $2,623,201 and $326,200$875,000 related to LMA for three months ended June 30, 2023 and September 30, 2022, respectively.

Total revenue earned related to the other affiliated investor was $6,838,141 and $911,700,$2,066,700, of which $6,794,641 and $470,200$1,425,200 related to LMA, for the six months ended June 30, 2023 and nine months ended September 30, 2022, respectively. Total cost of sales related to the other affiliated investor was $5,020,603 and $612,700,$1,667,700, of which $5,012,103 and $326,200$1,201,200 related to LMA for the six months ended June 30, 2023 and the nine months ended September 30, 2022, respectively. In addition, there is a related party receivable due from LMA related to transaction expenses of $19,246 and $0$190,805 as of June 30, 2023 and September 30, 2022, respectively, which is included as due from members and affiliates in the accompanying condensed balance sheets.
55

Table of Contents


8. SUBSEQUENT EVENT

On June 30, 2023, the CompanyAbacus consummated the merger with LMA. The CompanyAbacus has evaluated its subsequent events through August 14, 2023, the date that the financial statements were issued and determined that there were no events that occurred that required disclosure.






































*****
48
56

Table of Contents
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations Add from Filing
4957

Table of Contents
ABACUS LIFE, INC. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis provides information that management believes is relevant to an assessment and understanding of Abacus Life, Inc.’s financial condition and results of operations. This discussion should be read in conjunction with Abacus Life, Inc.’s financial statements and related notes thereto that appear elsewhere in this quarterly Quarterly Report on Form 10-Q.

The statements contained in this Quarterly Report on Form 10-Q that are not purely historical are forward-looking statements within the meaning of Section27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding our expectations, hopes, intentions or strategies regarding the future. In addition to historical financial analysis, this discussion and analysis contains forward-looking statements based upon current expectations that involve risks, uncertainties, and assumptions, as described under the heading “Cautionary Note Regarding Forward-Looking Statements.All forward-looking statements included in this document are based on information available to us on the date hereof, and we assume no obligation to update any such forward-looking statements. Actual results and timing of selected events may differ materially from those anticipated in these forward-looking statements as a result of various factors, including, but not limited to: the potential impact of our business relationships, including with our employees, customers and competitors; changes in general economic, business and political conditions, including changes in the financial markets; weakness or adverse changes in the level of activity in our sector or the sectors of our affiliated companies, which may be caused by, among other things, high or increasing interest rates, or a weak U.S. economy; significant competition that our operating subsidiaries face; compliance with extensive government regulation; and other risks detailed in the those set forth under “Risk Factors” or elsewhere in this quarterly statement. Unless the context otherwise requires, references in this “Abacus Life, Inc. Management’s Discussion and Analysis of Financial Condition and Results of Operations” to “we,” “us,” “our,” and “Abacus Life, Inc.”“Company” are intended to mean the business and operations of Abacus Life, Inc..

Overview
Abacus Life, Inc. (“Company”) was formerly known as East Resources Acquisition Company ("ERES”), a blank check company incorporated in Delaware on May 22, 2020. Abacus Life, Inc. conducts its business through its wholly-owned, consolidated subsidiaries, primarily Abacus Settlements LLC (“ Abacus Settlements” or “Abacus”) and Longevity Market Assets, LLC (“LMA”), which are Delaware limited liability companies and headquartered in Orlando, Florida.

Abacus Life, Inc.The Company, through its LMA subsidiary, directly acquires life insurance policies in a mutual beneficial transaction for both us and the underlying insured. With meaningful support from our proprietary risk rating heat map, we consistently evaluate policies (at origination and throughout the lifecycle) to generate essentially uncorrelated risk adjusted returns. Additionally, we provide a range of services for owners of life settlement assets.

Upon acquiring a policy, we have the option to either (i) trade that policy to a third-party institutional investor (i.e., generating a spread on each trade) or (ii) hold that policy on our balance sheet until maturity (i.e., paying the premiums over time and receiving the final claim / payout). This process is predicated on driving the best economics for Abacus Life, Inc. and we categorize this revenue as “Trading” or “Active management revenue.”    

58

Table of Contents
Additionally, Abacus Life, Inc.the Company, through its LMA subsidiary, provides a wide range of services to owners and purchasers of life settlements assets (i.e., acquired policies). More specifically, Abacus Life, Inc. provides consulting, valuation, actuarial services, and perform administrative work involved in keeping a policy in force and at the premium level most advantageous to the owner. We have experience servicing a large number of policies for highly sophisticated institutions, including policies for large institutional life settlement funds. We generate revenue on these services by charging a base servicing fee of approximately 0.5% of total asset value of the portfolio or flat rate per policy. We categorize this revenue as “Servicing” or “Portfolio servicing revenue.”

In 2021, we shifted our focus from a service based only business model and began directly acquiringThe Company, through its Abacus Settlements subsidiary, originates life insurance policies. We have seen rapid growth in this segmentpolicy settlement contracts as we have continueda licensed life settlement provider on behalf of third-party institutional investors (“Financing Entities”) and for the Company to dedicate capital and resources towards our marketing and diversified origination channels. Such items are appropriately
50

Table of Contents
reflectedinvest in the operating expenses sectionlife settlement asset class. Specifically, the Company originates policies through three primary origination channels (Agents/Financial Advisors, Direct-to-Consumers, Life Settlement Brokers) and Third-Party Intermediaries, screens them for eligibility by verifying that the policy is in force, obtaining consents and disclosures, and submitting cases for life expectancy estimates. This process is characterized as our origination services, which averages a fee of the accompanying financial statements for the period ended June 30, 2023.

Abacus Life, Inc. was formed as Abacus Life Services, LLC in the stateapproximately 2% of Florida in February 2017. Subsequently, in February 2022, we changed our name to Longevity Market Assets, LLC. We are headquartered in Orlando, Florida.face value (“Origination Revenue”).

Our Business Model

As mentioned in the above Overview section, Abacus Life, Inc. generates revenue in twothree main ways. The first channel is through our active portfolio management strategy (“Active management revenue”), whereby we can (i) generate a spread on traded policies, (ii) hold policies on our balance sheet (paying premiums over time and receiving the payout/claim), or (iii) generate unrealized gains or losses on policies purchased by our Structured Note Offerings (LMATT Series 2024, Inc., LMATT Growth Series 2.2024, Inc., and LMATT Growth and Income Series 1.2026, Inc.) and Income Funds (LMA Income Series, LP, and the LMA Income Series II, LP). The second channel is from portfolio and policy servicing activities (“Portfolio servicing revenue”), whereby we provide a range of services to life settlement asset owners. The third channel is from origination services rendered by serving as a life settlement provider when purchasing outstanding life insurance policies.

Active management revenue derives from buying and selling policies; and the receipt of death benefits proceeds on policies we hold where the insured dies. Of the purchased policies, some are purchased with the intent to hold to maturity, while others are held for trading to be sold for a gain. We historically elected to account for each investment in life settlement contracts using either the investment method or the fair value method. Once the accounting method is elected for each policy, it cannot be changed. Abacus Life, Inc.The Company accounts for life settlement policies purchased through the structured note and fund offerings on a fair value basis, and life settlement policies that we intend to trade in the near terminvestment method basis at cost plus premiums paid. AtFor all policies purchased after June 30, 2023, the time that this election was made, this wasCompany accounts for these under the result of a cost-benefit analysis: because of our intentionfair value method. For policies purchased before June 30, 2023, the Company elected to holduse either the instruments for a relatively short period, we believed thatfair value method or the investment method provided a more cost effective(cost, plus premiums paid). The valuation method is chosen upon contract acquisition and is irrevocable.


59

Table of accounting for the instruments and did not believe that, in the course of the short period, the fair value would differ materially from the accumulated cost. Contents
For the life settlement policies accounted for under the fair value method, these policies are part of the collateral consideration for the market linked structured notes issued under LMX Series, LLC and LMA Series, LLC subsidiaries where quarterly valuations are a condition of the private placement memorandum. Given that there is a valuation requirement stipulated in the notes, management has elected to use the fair value method for these policies as the information is readily available and also captures the change in fair value within the income statement when those changes occur as opposed to when the policies are sold or mature. For policies held at fair value, changes in fair value are reflected in operations in the period the change is calculated. Under the investment method, investments in contracts are recorded at investment price plus all initial direct costs. Continuing costs (e.g., policy premiums, statutory interest and direct external costs, if any) to keep the policy in force are capitalized. Gains/losses on sales of such are recorded at the time of sale or maturity. Under the fair value method, we record the initial investment of the transaction price and remeasure the investment at fair value at each subsequent reporting period. Changes in fair value are reported in revenue when they occur, including those related to life insurance proceeds (policy maturities) and premium payments. Upon sale of a life settlement contract, we record revenue (gain/loss) for the difference between the agreed-upon purchase price with the buyer, and the carrying value of the contract.

Generating Portfolio servicing revenue involves the provision of services to one affiliate by common ownership, and third parties, which own life insurance policies. Portfolio servicing revenue is derived from services related to maintaining these settled policies pursuant to agreement with investors in settled policies (“Service Agreement(s)”). Additionally, also included in servicing revenue are fees for limited consulting services related to the evaluation of policies that we perform for third parties. Portfolio servicing revenue is recognized ratably over the life of the Service Agreements, which range from one month to ten years. The duties performed by the company under these arrangements are considered a single
51

Table of Contents
performance obligation that is satisfied ratably as the customer simultaneously receives and consumes the benefit provided by us. As such, revenue is recognized for services provided for the corresponding month.

Portfolio servicing revenue also consists of revenue related to consulting engagements. We provide consulting services for the owners of life settlement contracts who are often customers of the servicing business line, or customers of Abacus, an affiliated entity.the origination channel. These consulting engagements are comprised of valuation, actuarial services, and overall policy assessments related to life settlement contracts and are short-term in nature. The performance obligations are typically identified as separate services with a specific deliverable or a group of deliverables to be provided in tandem, as agreed to in the engagement letter or contract. Each service provided under a contract is considered as a performance obligation and revenue is recognized at a point in time when the deliverable or group of deliverables is transferred to the customer.

As a life settlement provider, the Company serves as a purchaser of outstanding life insurance policies. When serving as a purchaser, the Company’s primary purpose in the transaction is to connect buyers and sellers through an origination process. The origination process is core to the Company’s business and drives its economics. The Company averages approximately 2% of face value in origination fees on policies and has developed three high quality origination channels which include agents and Financial Advisors, direct to consumer and Life Settlements Brokers. The Company also originates policies with Third-Party Intermediaries. Generally, diversification across multiple origination channels lowers average policy acquisition costs and increases estimated returns. The Company finds sellers through its origination channels using strategic marketing practices in its core markets, with the purpose of finding policy owners who want to capitalize on their investments prior to death by extracting value from their policies through the sale of such policies to Financing Entities.

Key Factors Affecting Our Performance

The markets for our consulting and portfolio servicing are affected by economic, regulatory, and legislative changes, technological developments, and increased competition from established and new competitors. We believe that the primary factors in selecting Abacus Life, Inc. include reputation, the ability to provide measurable increases to shareholder value and return on investment, global scale, quality of service and the ability to tailor services to each client’s specific needs. In that regard, with our ability to leverage the technology developed by the
60

Table of Contents
Companies, we are focused on developing and implementing data and analytic solutions for both internal operations and for maintaining industry standards and meeting client needs.

Results of Operations

The following tables set forth our results of operations for the periods presented. The period-to-period comparison of financial results is not indicative of future results:

Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Portfolio servicing revenue
Related party service revenue$168,899$132,220$711,975$752,379
Portfolio servicing55,670250,025102,651620,194
Total portfolio servicing revenue224,569382,245814,6261,372,573
Active management revenue
Investment Income from life insurance policies held using investment method1,817,76410,629,97818,473,59724,610,444
Change in fair value of life insurance policies (policies held using fair value method)17,108,380495,52521,447,4643,801,031
Total active management revenue18,926,14411,125,50339,921,06128,411,475
Origination revenue
Related Party origination revenue254,517254,517
Origination Revenue1,715,70001,715,700
Total origination revenue1,970,21701,970,217
Total revenues21,120,93011,507,74842,705,90429,784,048
Cost of revenue (excluding depreciation and amortization stated below)
Total cost of revenue3,364,9571,754,8944,827,9073,840,969
Gross Profit17,755,9739,752,85437,877,99725,943,079
Operating expenses
Sales and marketing1,704,154 14,9053,116,999 1,664,403
General and administrative (including stock based compensation of $4,538,632)9,838,951 59,81611,113,382 706,523
Unrealized loss (gain) on investments306,800 246,846(491,356)1,301,821
(Gain) loss on change in fair value of debt(2,088,797)(1,235,032)309,865 (859,519)
Depreciation and amortization expense1,694,8531,0711,696,994 3,211
52
61

Table of Contents
Three Months Ended June 30,Six Months Ended June 30,
2023202220232022
Portfolio Servicing Revenue
Related party servicing revenue$329,629$419,253$543,076$620,159
Portfolio servicing revenue 24,737169 46,981370,169
Total portfolio servicing revenue 354,366 419,422 590,057 990,328
Active management revenue
Investment income from life insurance policies held using investment method8,263,4995,965,466 16,655,83313,980,466
Change in fair value of life insurance policies (policies held using fair value method)2,760,900 2,014,013 4,339,084 3,305,505
Total active management revenue 11,024,399 7,979,479 20,994,917 17,285,971
Total Revenue11,378,7658,398,90121,584,97418,276,299
Cost of revenues (excluding depreciation stated below)973,400666,119 1,462,9502,086,075
Gross profit 10,405,365 7,732,782 20,122,024 16,190,224
Operating expenses
Sales and marketing 683,8411,019,498 1,412,8451,649,498
General, administrative and other 577,5395,499 1,274,431646,705
Unrealized loss (gain) on investments (672,936)1,039,022 (798,156)1,054,975
Loss on change in fair value of debt 1,445,229333,879 2,398,662375,513
Depreciation expense1,0981,098 2,1412,141
Total operating expenses 2,034,771 2,398,996 4,289,923 3,728,832
Operating income8,370,594 5,333,78615,832,101 12,461,392
Other (expense) income
Other income (expense) 121,601(127,455) (21,651)(242,247)
Interest (expense) (584,075)- (941,458)-
Interest income-- 7,457-
Net income before provision for income taxes 7,908,120 5,206,331 14,876,449 12,219,145
Provision for income taxes(1,184,571)(120,132) (528,104)(296,806)
Net income 6,723,549 5,086,199 14,348,345 11,922,339
Less: Net income (loss) attributable to noncontrolling interest (26,596)406,641 (487,303)406,641
Net income attributable to Abacus Life, Inc.$6,750,145$4,679,558$14,835,648$11,515,698



53

Table of Contents
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Total operating expenses11,455,961(912,394)15,745,8842,816,439
Operating Income6,300,012 10,665,24822,132,113 23,126,640
Other income (expense)
Loss on change in fair value of warrant liability(943,400)(943,400)
Other income (expense)20,086 42,289(1,565)(199,958)
Interest (expense)(2,679,237)(3,620,695)
Interest income63,82671,283 
Net income before provision for income taxes2,761,28710,707,53717,637,73622,926,682
Income tax expense1,710,315 352,0812,238,419 648,887
Net income1,050,97210,355,45615,399,31722,277,795
Less: Net income (loss) attributable to noncontrolling interest147,611 363,452(339,692)770,093
Net income attributable to Abacus Life, Inc.$903,361$9,992,00415,739,009$21,507,702

Revenue

Related Party Services

We have a related-party relationship with Nova Trading (US), LLC (“Nova Trading”), a Delaware limited liability company and Nova Holding (US) LP, a Delaware limited partnership (“Nova Holding” and collectively with Nova Trading, the “Nova Funds”) as some of the owners of Abacus Life, Inc. and certain members of management jointly own 11% of the Nova Funds. We enter into service agreements with the owners of life settlement contracts and are responsible for maintaining the policies, managing processing of claims in the event of death of the insured and ensuring timely payment of optimized premiums computed to derive maximum return on maturity of the policy. We neither assume the ownership of the contracts nor undertake the responsibility to make the associated premium payments. The duties that we perform under these arrangements are considered a single performance obligation that is satisfied over time and revenue is recognized for services provided for the corresponding time period. We earn servicing revenue related to policy and administrative services on behalf of Nova Funds portfolio (the “Nova Portfolio”). The servicing fee is equal to 50 basis points (0.50%) times the monthly invested amount in policies held by Nova Funds divided by 12.
Three Months Ended September 30,
20232022$ Change% Change
Related party servicing revenue$168,899$132,220$36,67927.7%

Three Months Ended June 30,$ Change% Change
20232022
Related party servicing revenue$329,629$419,253$(89,624)(21.4)%
Related party servicing revenue increased by $36,679, or 27.7%, for the three months ended September 30, 2023 compared to the three months ended September 30, 2022. The increase in related party servicing revenue is primarily due to servicing more policies owned by the joint venture for the three months at September 30, 2023.
62

Table of Contents
   Nine Months Ended September 30,
20232022$ Change% Change
Related party servicing revenue$711,975$752,379 $(40,404)(5.4)%

Related party servicing revenue decreased by $89,624,$40,404, or 21%5.4%, for the threenine months ended JuneSeptember 30, 2023 compared to the threenine months ended JuneSeptember 30, 2022. The decrease in related party servicing revenue is primarily due to the joint venture (“JV”) owningservicing less policies for the Nova Portfolio at JuneSeptember 30, 2023. Total policy count for the Nova Portfolio was 353320 and 413 for400 for the periods ended JuneSeptember 30, 2023 and JuneSeptember 30, 2022, respectively. This translated to total invested dollars of $151,738,261$144,635,789 and $162,162,124$153,272,988 as of JuneSeptember 30, 2023 and JuneSeptember 30, 2022, respectiverespectively.ly.
   Six Months Ended June 30,
20232022$ Change% Change
Related party servicing revenue$543,076$620,159$(77,083)(12.4)%

Three Months Ended June 30,
20232022$ Change% Change
Portfolio servicing revenue$24,737$169$24,56814,537.3%
Three Months Ended September 30,
20232022$ Change% Change
Portfolio servicing revenue$55,670 $250,025 $(194,355)(77.7)%

Portfolio servicing revenue increaseddecreased by $24,568,$194,355 or 14,537%77.7%, for thethe three months ended JuneSeptember 30, 2023 compared to the three months ended JuneSeptember 30, 2022. The increasedecrease in portfolio servicing revenue is primarily attributableattributable to servicing more external fundsa reduction in the non-recurring consulting projects during the three months ended JuneSeptember 30, 2023 compared to the three months ended JuneSeptember 30, 2022. There were zerono new non-recurring consulting projects in Q2, 2023.initiated during the third quarter 2023 to servicing more external funds.
mor3.
Nine Months Ended September 30,
20232022$ Change% Change
Portfolio servicing revenue$102,651 $620,194 $(517,543)(83.4)%

Six Months Ended June 30,
20232022$ Change% Change
Portfolio servicing revenue$46,981$370,169$(323,188)(87.3)%

54

Table of Contents
Portfolio servicing revenue decreased by $323,188,$517,543, or 87%83.4%, for the sixnine months ended JuneSeptember 30, 2023 compared to the sixnine months ended JuneSeptember 30, 2022. The decrease in portfolio servicing revenue is primarily attributable to a reduction in the non-recurring consulting projects in 2023.

Active management revenue

Active management revenue is generated by buying, selling, and trading policies and maintaining policies through to receipt of maturity or death benefits. Policies are accounted for under both the investment method and fair value method. We have elected on an instrument-by-instrument basis to account for these policies under the investment method, pursuant to ASC 323-30-25-2. Abacus Life, Inc. engages in direct buying and selling of life settlement policies whereby each potential policy is independently researched to determine if it would be a profitable investment. PoliciesNewly acquired policies purchased under Abacus Life, Inc. are typically purchased with the intention to sell within twelve months and are measured for under the investment method given that the purchase dates are recent, and policies turn fairly quickly. Policies purchased under LMATT Series 2024, Inc. or LMATT Growth Series 2.2024, Inc. (the “LMATT subsidiaries”) are measured under the fair value method and will either be sold or held until the policies mature. Upon sale of a life settlement contract, the company will record revenue (gain/loss) for the difference between the agreed-upon purchase price with the buyer, and the carrying value of the contract.
Three Months Ended September 30,$ Change% Change
20232022
Active management revenue
Policies accounted for under the investment method$1,817,764$10,629,978 $(8,812,214)(82.9)%
Policies accounted for under the fair value method17,108,380 495,525 16,612,855 3,352.6%
Total active management revenue$18,926,144$11,125,503$7,800,64170.1%
63


Table of Contents
Three Months Ended June 30,$ Change% Change
20232022
Active management revenue
Policies accounted for under the investment method$8,263,499$5,965,466$2,298,03338.5%
Policies accounted for under the fair value method 2,760,900 2,014,013 746,88737.1%
Total active management revenue$11,024,399$7,979,479$3,044,92038.2%

Total active management revenue increased by $3,044,920,$7,800,641, or 38%70.1%, for the threemonths ended JuneSeptember 30, 2023 compared to the three months ended JuneSeptember 30, 2022. The increase in active management revenue was primarily attributable to maturities of policies accounted for under the investment method.an increase in active management services. As of JuneSeptember 30, 2023, Abacus Life, Inc. holds 167240 policies, of which 122228 are accounted for under the fair value method and 4512 are accounted for using the investment method (cost, plus premiums paid). Policies recorded under the investment method represent those policies purchased by Abacus Life, Inc. with the intent to sell within the next 12 months. Policies recorded under the investment method resulted in a revenue increase indecrease of $2,298,033,$8,812,214 or 39%. Aggregate82.9%, which is due to the Company electing to use the fair value method for all policies purchased subsequent to June 30, 2023. The aggregate face value of policies accounted for using the investment method is $39,592,392$37,300,000 as of JuneSeptember 30, 2023, with a corresponding carrying value of approximately $9,889,610.$4,116,499. Additional information regarding policies accounted for under the investment method is as follows:
Three Months Ended June 30,
20232022
Investment method:
Policies bought7952
Policies sold8820
Policies matured00
Average realized gain (loss) on policies sold16.7%11.1%
Number of external counter parties that purchased policies113

Three Months Ended September 30,
20232022
Investment method:
Policies bought010
Policies sold344
Policies matured01
Average realized gain (loss) on policies sold29.2%13.5%
Number of external counter parties that purchased policies54

Policies accounted for under the fair value method, resulted in a revenue incrincrease of ease of $746,887, w$16,612,855hich was driven primarily by a realized gain on the sale of 2278 policies of $1,297,702 $7,789,464 for the three months ended JuneSeptember 30, 2023. In thethree months period ended JuneSeptember 30, 2023, an unrealized gain of $2,126,723$10,940,077 was
55

recorded on 54 policies purchased.149 policies purchased. For the policies held at fair value, the unrealized gain on policies of $2,126,723$10,940,077 represents a change in fair value of the aforementioned policies. Abacus Life, Inc.The Company realized a gain of $1,297,702 $7,789,464 for thethree months ended JuneSeptember 30, 2023 for 978 policies that sold that were included in the change in fair value of life insurance policies held using the fair value method and made premium payments of $663,424,$1,621,161, which were also included in the same line item. Additional information regarding policies accounted for under the fair value method is as follows:follows:

Three Months Ended June 30,Three Months Ended September 30,
2023202220232022
Fair value method:Fair value method:Fair value method:
Policies boughtPolicies bought5431Policies bought1490
Policies soldPolicies sold9-Policies sold780
Policies maturedPolicies matured1-Policies matured01
Average realized gain (loss) on policies soldAverage realized gain (loss) on policies sold14.7%-Average realized gain (loss) on policies sold12.7%0
Number of external counter parties that purchased policiesNumber of external counter parties that purchased policies3-Number of external counter parties that purchased policies100

Six Months Ended June 30,$ Change% ChangeNine Months Ended September 30,$ Change% Change
2023202220232022
Active management revenueActive management revenueActive management revenue
Policies accounted for under the investment methodPolicies accounted for under the investment method$16,655,833$13,980,466$2,675,36719 %Policies accounted for under the investment method$18,473,597$24,610,444$(6,136,847)(24.9)%
Policies accounted for under the fair value methodPolicies accounted for under the fair value method 4,339,084 3,305,505 1,033,57931 %Policies accounted for under the fair value method21,447,464 3,801,031 17,646,433464.3%
Total active management revenueTotal active management revenue$20,994,917$17,285,971$3,708,94621 %Total active management revenue$39,921,061$28,411,475$11,509,58640.5 %

64

Table of Contents
Total active management revenue increased by $3,708,946,$11,509,586, or 21%40.5%, for the sixnine months ended JuneSeptember 30, 2023 compared to the sixnine months ended JuneSeptember 30, 2022. The increase in active management revenue was primarily attributable to an increase in policy salespurchase and maturities. As of June 30, 2023, Abacus Life, Inc. holds 167 policies, of which 122 are accounted forsale activity. Policies recorded under the fair value method and 45 are accounted for using the investment method (cost, plus premiums paid). Policies recorded under the investment method represent those policies purchased by Abacus Life, Inc. with the intent to sell within the next 12 months. Policies recorded under the investment method resulted in an increase of $2,675,367,$17,646,433, or 19%464.3%. Aggregate face value of policies accounted for using the investment method is $39,520,877$14,575,000 as of JuneSeptember 30, 2023, with a corresponding carrying value of approximately $9,889,610. Additional information regarding policies accountedaccounted for under the investment method is as follows:

Six Months Ended June 30,Nine Months Ended September 30,
2023202220232022
Investment method:Investment method:Investment method:
Policies boughtPolicies bought16580Policies bought16590
Policies soldPolicies sold12748Policies sold16152
Policies maturedPolicies matured20Policies matured21
Average realized gain (loss) on policies soldAverage realized gain (loss) on policies sold16.3%13.5%Average realized gain (loss) on policies sold19.0%13.5%
Number of external counter parties that purchased policiesNumber of external counter parties that purchased policies154Number of external counter parties that purchased policies158

PoliciesPolicies accounted for under the fair value method with the intention to hold to maturity, resulted in an increase in revenue of $1,033,579 $17,646,433 driven primarily by a realized gain on life settlement policies of $1,898,958 $9,688,422 for the sixnine months ended JuneSeptember 30, 2023, compared to the sixnine months ended JuneSeptember 30, 2022. Aggregate face value of policies held at fair valuevalue is $195,205,585 $303,605,030 as of JuneSeptember 30, 2023, with a corresponding
56

Table of Contents
fair value of $56,685,617.$83,585,374. For the policies held at fair value, the unrealized gain recorded on 69on 218 purchased policies as of $3,319,588$14,259,665 represents a change in fair value of the aforementioned policies. Abacus Life, Inc.The Company realized a gain of $ 1,898,958$9,688,422 for the sixnine months ended JuneSeptember 30, 2023 for 1189 sold policies that were included in the change in fair value of life insurance policies held using the fair value method and made premium payments of $879,461,$2,500,623, which were also included in the same line item.item. Additional information regarding policies accounted for under the fair value method is as follows:

      Six Months Ended June 30,Nine Months Ended September 30,
2023202220232022
Fair value method:Fair value method:Fair value method:
Policies boughtPolicies bought6932Policies bought21832
Policies soldPolicies sold11-Policies sold890
Policies maturedPolicies matured1-Policies matured11
Average realized gain (loss) on policies soldAverage realized gain (loss) on policies sold10.4%-Average realized gain (loss) on policies sold12.5%—%
Number of external counter parties that purchased policiesNumber of external counter parties that purchased policies5-Number of external counter parties that purchased policies100

Origination Revenue

Through the origination segment, the Company originates life insurance policy settlement contracts as a licensed life settlement provider on behalf of third-party institutional investors interested in investing in the life settlement asset class. Specifically, Company originates policies through three primary origination channels (agents/financial advisors, direct-to-consumers, life settlement brokers and third-party intermediaries), screens them for eligibility by verifying that the policy is in force, obtaining consents and disclosures, and submitting cases for life expectancy estimates. The Company has a related party relationship with Nova Trading (US), LLC (“Nova Trading”), a Delaware limited liability company and Nova Holding (US) LP, a Delaware limited partnership (“Nova Holding” and collectively with Nova Trading, the “Nova Funds”) as the owners of the Company jointly own 11% of the Nova Funds. The pricing for origination fees is governed by origination contracts that have been negotiated by both parties and are considered to be arms-length and consistent with origination fees charged to third party customers. For its origination services to the Nova Funds, the Company earns origination fees equal to the lesser of (i) 2% of the net death benefit for the policy or (ii) $20,000.

65

Table of Contents
Three Months Ended September 30,$ Change% Change
20232022
Related Party origination revenue$254,517$—$254,517100%

Related party origination revenue increased to$254,517 from $0, for the three months ended September 30, 2023 compared to the three months ended September 30, 2022. Revenue from originations arose due to Business Combination of LMA and Abacus Settlements on June 30, 2023 as this stream of revenue comes from Abacus Settlements LLC business.

Three Months Ended September 30,$ Change% Change
20232022
Origination Revenue$1,715,700$—$1,715,700100%

Origination Revenue increased to $1,715,700 from $0, for the three months ended September 30, 2023 compared to the three months ended September 30, 2022. Origination Revenue occurred due to Business Combination of LMA and Abacus Settlements on June 30, 2023 as this stream of revenue comes from the Abacus Settlements business.

Cost of Revenues (Excluding Depreciation)Depreciation and Amortization) and Gross Profit

Cost of revenues (excluding depreciation)depreciation and amortization) primarily consists of servicing fees, escrow fees, payroll costs for employees who service and actively managed policies, and consulting expenses for discretionary commissions directly related to active management trading revenue. CostAlso, it includes the stock-based compensation expense and the third-party commissions, which includes third-party sales and marketing commission fees, as well as transaction costs that are reimbursed as part of revenues excludes depreciation expense as Abacus Life, Inc. does not hold any material property and equipment that is directly used to support the servicing or trading of life settlement policies.origination activity. The payroll costs related to policy servicing are for recurring and non-recurring projects where the time incurred for servicing policies is measurable and directly correlates to revenue earned. Similarly, consulting expenses are for discretionary commissions earned directly related to revenue generated as part of the Active management revenue stream.

Three Months Ended June 30,
20232022$ Change% Change
Cost of revenue (excluding depreciation)$973,400$666,119$307,28146 %
Three Months Ended September 30,
20232022$ Change% Change
Cost of revenue (excluding depreciation and amortization)$3,364,957$1,754,894$1,610,06391.7%

Cost of revenues (excluding depreciation)depreciation and amortization) increased by $$1,610,063,307,281 or 91.7%,, or 46%, for the threethree months ended JuneSeptember 30, 2023 compared to the three months ended JuneSeptember 30, 2022. The increase in cost of revenues is primarily due to an increased cost of revenue for Abacus Settlement primarily for third party commissions for origination activity, increase of payroll expenses related to increased headcount, changes to various benefit packages, and the expansion of active management services in 2023.

Nine Months Ended September 30,
20232022$ Change% Change
Cost of revenue (excluding depreciation and amortization)$4,827,907$3,840,969$986,93825.7%

66

Table of Contents
Cost of revenues (excluding depreciation and amortization) increased by $986,938, or 25.7%, for the nine months ended September 30, 2023 compared to the nine months ended September 30, 2022. The increase in cost of revenues is primarily due to an increase of payroll expenses related to increased headcount, and changes to various benefit packages, cost of revenue for Abacus Settlement primarily for third party commissions for origination activity, the issuance of stock-based compensation expense and expansion of active management services in 2023.Related party cost of revenue of $7,981is associated with third party commission expense for related party origination activity, which is now included within the consolidated financial statements for the Company subsequent to the Business Combination that took place on June 30, 2023.

Six Months Ended June 30,
20232022$ Change% Change
Cost of revenue (excluding depreciation)$1,462,950$2,086,075$(623,125)(30)%

Cost of revenues (excluding depreciation) decreased by $623,125, or 30%, for the six months ended June 30, 2023 compared to the six months ended June 30, 2022. The decrease in cost of revenues is primarily due to a $1,057,735 decrease in consulting expenses primarily represents discretionary commissions for individuals directly related to active management trading revenue and bonuses paid out during the first quarter of 2022. The bonuses and commissions did not recur during 2023. The decrease in consulting expenses offset by a $427,380 increase in wages related to policy servicing activity as a result of increased headcount of 4 people and changes to various benefit packages in 2023.

57

Table of Contents
Three Months Ended June 30,
20232022$ Change% Change
Gross profit$10,405,366$7,732,782$2,672,584(35)%
Three Months Ended September 30,
20232022$ Change% Change
Gross profit$17,755,973$9,752,854$8,003,11982.1%

Gross profit increased by $2,672,584,$8,003,119, or 35%82.1%, for the threemonths ended JuneSeptember 30, 2023 compared to the threemonths ended JuneSeptember 30, 2022. The increase in gross profit is primarily due to the decreasean increase in theactive management services and origination revenue, offset by an increase in cost of revenue by $307,281, or 46% which was attributable to reductions in consulting expenses. The expansion of the active management business resulted in increased revenues of $3,044,920, or 38%, of the total increase in revenues of $2,979,864 or 35%.revenues.

Six Months Ended June 30,
20232022$ Change% Change
Gross profit$20,122,024$16,190,224$3,931,80024 %
Nine Months Ended September 30,
20232022$ Change% Change
Gross profit$37,877,997$25,943,079$11,934,91846.0 %

Gross profit increased by $3,931,800,by $11,934,918, or 24%46.0%, for the sixnine months ended JuneSeptember 30, 2023 compared to the sixnine months ended JuneSeptember 30, 2022. The increaseincrease in gross profit is primarily due to decrease ofan increase in active management services, offset by an increase in cost of revenue by $623,125, or 30% and the expansion of the active management business which resulted in increased revenues of $ 3,708,946 , or 21%, of the total increase in revenues of $3,308,675, or 18%, offset by a decrease of portfolio servicing revenue of $323,188, or 87%.revenues.

Operating Expenses

Sales and Marketing Expenses

Sales and marketing expenses primarily consist of advertising and marketing related expenses.

Three Months Ended June 30,$ Change% Change
20232022
Sales and marketing expenses$683,841$1,019,498$(335,657)(33)%
Three Months Ended September 30,$ Change% Change
20232022
Sales and marketing expenses$1,704,154$14,905$1,689,24911,333.4 %

Sales and marketing expenses decreasedincreased by $335,657$1,689,249 or 333%11,333.4%, for the three months ended JuneSeptember 30, 2023 compared to the three months ended JuneSeptember 30, 2022. The decreaseincrease in sales and marketing expense was attributable to reductionan increase in television advertising costs.

Six Months Ended June 30,$ Change% Change
20232022
Sales and marketing expenses$1,412,845$1,649,498$(236,653)(14)%
Nine Months Ended September 30,$ Change% Change
20232022
Sales and marketing expenses$3,116,999$1,664,403$1,452,59687.3 %

Sales and marketing expenses decreasedincreased by $236,653,$1,452,596, or 14%87.3%, for the sixnine months ended JuneSeptember 30, 2023, compared to the sixnine months ended JuneSeptember 30, 2022. The decrease is attributable to reduction in advertising costs. The increase in 2022sales and marketing expense was attributable to marketingan increase in television advertising costs in the last nine months of the new active management segment. Sales and marketing expense relates to sponsoring a sports organization and are not directly attributable to revenue generating activity, therefore these expenses do not represent cost of revenue.2023.


67

Table of Contents
General, Administrative, and Other

General, administrative, and other primarily consists of compensation and benefits related costs associated with our finance, legal, human resources, information technology, and administrative functions. General, administrative and other costs also consist of third-party professional service fees for external
58

Table of Contents
legal, accounting and other consulting services, rent and lease charges, insurance costs, and software expense.

Three Months Ended June 30,$ Change% Change
20232022
General, administrative and other$577,539$5,499$572,04010,403 %
Three Months Ended September 30,$ Change% Change
20232022
General and administrative (including stock based compensation of $4,583,632)$9,838,951$59,816$9,779,13516,348.7 %

General, administrative, and other increased by $9,779,135, or $572,040, or 10,403%16,348.7%, for the three months ended JuneSeptember 30, 2023 compared to the three months ended JuneSeptember 30, 2022.The increase of $284,588 and $40,060 in general, administrative and other of is related to launchingvarious expenses, included but not limited to increases in stock based compensation of $4,583,632, payroll expenses of $2,197,564, legal consulting fees of $682,273 in connection with the new income funds: LMA Income Series, LPMerger Agreement, Life Expectancy report fees of $515,903, medical record consulting fees of $279,591, Directors and LMA Income Series II GP LLC, respectively, which did not exist during the three months ended June 30, 2022.Officers insurance of $185,377, financing charges related to debt issuance of $133,211, due to expansion of active management services. The remaining difference is attributable to other various consolidated entities pertaining to policy servicing and administrator expenses,, and accounting legal, and bank fees as we finalizedin connection with the SPAC.Business Combination.

Six Months Ended June 30,
20232022$ Change% Change
General, administrative and other$1,274,431$646,705$627,72697 %
Nine Months Ended September 30,
20232022$ Change% Change
General and administrative (including stock based compensation of $4,583,632)$11,113,382$706,523$10,406,8591,473.0 %

General, administrative, and other increased by $627,726,$10,406,859, or 97%1,473.0%, for the sixnine months ended JuneSeptember 30, 2023, compared to the sixnine months ended JuneSeptember 30, 2022. The increase in general, administrative and other is relatedrelates to various expenses,expenses, including but not limited to increases in the stock based compensation of $4,583,632, payroll expense of $2,197,564, legal consulting fees of $729,076 in connection with the Merger Agreement, Life Expectancy report fees of $515,903, medical record consulting fees of $412,279, bank fee of $231,570, Directors and Officers insurance of $185,377, financing charges related expense (excluding payroll expenses wages)to debt issuances of $245,842, an increase in$133,211, and Errors and Omissions insurance of $55,250, an increase in medical record consulting expense$116,343 due to expansion of $132,688 and an increase of $31,000 in software expenses. Additionally, $341,064 in general, administrative andactive management services. The remaining difference is attributable to other expenses were recorded in LMA Income Series, LP and LMA Income Series II GP LLvarious consolidated entities pertaining to policy servicing and administrator expenses,, and accounting legal, and bank fees.fees in connection with the Business Combination.

Depreciation and amortization expense

Depreciation and amortization expense consists primarily of depreciation on property and equipment purchased and leasehold improvements made.and amortization of intangible assets. The property at Abacus Life, Inc.the Company currently consists of furniture, fixtures and leasehold improvements for the office and are not directly used to support the servicing or trading of life settlement policies. The intangible assets at the Company consist of customer relationships, internally developed and used technology, and non-compete agreements.

Three Months Ended June 30,$ Change% Change
20232022
Depreciation$1,098$1,098$— %
68

Table of Contents
Three Months Ended September 30,$ Change% Change
20232022
Depreciation and amortization$1,694,853$1,071$1,693,782158,149.6 %

DepreciationThe increase of $1,693,782, or 158,149.6%, in depreciation and amortization expense is consistent forrelated to $1,682,083 amortization of intangible assets related to the three months ended Junecustomer relationships, internally developed and used technology, trade name, non-compete agreements and licensing, and current depreciation of $12,770. The increase of $11,699 in depreciation expense is related to the purchase of additional computers by the Company in the third quarter of 2023. There was no amortization recorded in the third quarter of September 30, 2023 and June 30, 2022 as no purchases of property and equipment were made in 2023.2022.

Six Months Ended June 30,$ Change% Change
20232022
Depreciation$2,141$2,141$— %
Nine Months Ended September 30,$ Change% Change
20232022
Depreciation and amortization$1,696,994$3,211$1,693,78352,749.4 %

DepreciationThe increase of $1,693,783, or 52,749.4%, in depreciation and amortization expense is consistent forrelated to $1,682,083 amortization of intangible assets related to the six monthscustomer relationships, internally developed and used technology, trade name, non-compete agreements and licensing, and depreciation of $14,911. The increase of $11,700 in depreciation expense related to purchase of additional computers by the Company in the third quarter of 2023. There was no amortization expense recorded during the nine month ended JuneSeptember 30, 2023 and June 30, 2022 as no purchases of property and equipment were made in 2023.2022.

Unrealized Loss (Gain) on Investments
59

Table of Contents
Three Months Ended September 30,$ Change% Change
20232022
Unrealized gain on investments$306,800$246,846$59,95424.3 %

Three Months Ended June 30,$ Change% Change
20232022
Unrealized loss (gain) on investments$(672,936)$1,039,022$(1,711,958)(165)%

Unreali
Unrealized losszed gain on investmentsinvestments increased by $1,711,958$59,954 or 24.3% for the three months ended JuneSeptember 30, 2023, compared to the three months ended JuneSeptember 30, 2022. The primary cause of this increase is driven by changes in fair value of purchased put and call options. During the three months ended JuneSeptember 30, 2023, the unrealized lossgain was $467,701, $186,470, $15,289,$195,521, $105,038 and $3,475$2,766 for LMATT Series 2024, Inc., LMATT Growth Series, Inc., and LMATT Growth and Income Series Inc.Inc, respectively, which represents a change in fair value of those options and Longevity Market Assets, LLC, respectively.is classified as an unrealized loss on investments within the results of operations.

Six Months Ended June 30,$ Change% Change
20232022
Unrealized loss (gain) on investments$(798,156)$1,054,975$(1,853,131)(176)%
Nine Months Ended September 30,$ Change% Change
20232022
Unrealized loss (gain) on investments$(491,356)$1,301,821$(1,793,177)(137.7)%

Unrealized loss (gain) on investments increasedinvestments decreased by $1,853,131$1,793,177 or 137.7% for the sixnine months ended JuneSeptember 30, 2023, compared to the sixnine months ended JuneSeptember 30, 2022. During the first and third quarters of 2022, Abacus Life, Inc.,the Company, through three subsidiaries, LMATT Series 2024, Inc., LMATT Growth Series, Inc., LMATT Growth and Income Series, Inc., and purchased S&P 500 call options and sold S&P 500 put options through a broker as an economic hedge related to the market-indexed instruments described below. The primary causecause of this decrease pertains to $540,818, $230,231, $23,632,$345,297, $125,194 and $3,475 respectively,$20,865, respectively, which represents a change in fair value of those options and isis classified as an unrealized loss on investments within the results of operations.


69

Table of Contents
(Gain) Loss on Change in Fair Value of Debt

Three Months Ended June 30,
20232022$ Change% Change
Loss on change in fair value of debt$1,445,229$333,879$1,111,350333 %
Three Months Ended September 30,
20232022$ Change% Change
(Gain) loss on change in fair value of debt$(2,088,797)$(1,235,032)$(853,765)69.1 %

Loss
Change in gain on change in fair value of debt increased by $1,111,350$853,765, or 69.1% for thethe three months ended JuneSeptember 30, 2023 compared to the three months ended JuneSeptember 30, 2022. The increase is primarily attributable to changes in the risk-free fair value of LMATT Series 2024, Inc., LMATT Growth Series, Inc., LMATT Growth and Income Series, Inc. relateddebt.

Six Months Ended June 30,$ Change% Change
20232022
Loss on change in fair value of debt$2,398,662$375,513$2,023,149539 %
Nine Months Ended September 30,$ Change% Change
20232022
(Gain) loss on change in fair value of debt$309,865$(859,519)$1,169,384(136.1)%

LossChange in gain on change in fair value of debt increaseddecreased by $2,023,149$1,169,384, or 136.1% for the sixnine months ended JuneSeptember 30, 2023, compared to the sixnine months ended JuneSeptember 30, 2022. The increasedecrease is primarily attributable to changes in the risk-free fair value of LMATT Series 2024, Inc., LMATT Growth Series, Inc., LMATT Growth and Income Series, Inc. related debt.

On March 31, 2022, LMATT Series 2024, Inc., a 70% owned subsidiary which the Company consolidates for financial reporting, issued $10,166,900 in market-indexed private placement notes.The notes,note, titled the Longevity Market Assets Target-Term Series (LMATTS) 2024, areis a market-indexed instrumentsinstrument designed to provide upside performance exposure of the S&P 500 Index, while limiting downward exposure. Upon maturity of the notesnote in 2024, the principal, plus the return based upon the S&P 500 Index must be paid. The notes havesnote has a
60

Table of Contents
feature to protect debt holders from market downturns, up to 40%. Any subsequent losses below the 40% threshold will reduce the notesnote on a one-to-one basis. As of JuneSeptember 30, 2023, $9,866,900 $9,866,900 of the principal amount remained outstanding.The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third party. As of JuneSeptember 30, 2023, the fair value of the LMATT Series 2024, Inc. notes was $9,621,141.were $9,311,800. The notes are secured by the assets of the issuing entities, which includes cash, S&P 500 options, and life settlement policies totaling $11,195,701$10,358,535 as of JuneSeptember 30, 2023. The notenote’ agreements do not restrict the trading of life settlement contracts prior to maturity of the note, as total assets of the issuing companies are considered as collateral. There are also no restrictive covenants associated with the notes with which the entities must comply.

70

Table of Contents
On September 16, 2022, LMATTS Growth Series 2.2024, Inc., a 100% owned subsidiary which the Company consolidates for financial reporting issued $2,333,391 in market-indexed private placement notes. The notes,note, titled the Longevity Market Assets Target-Term Growth Series 2.2024, Inc. (“LMATTSTM Series 2.2024, Inc.”) areis a market-indexed instrumentsinstrument designed to provide upside performance exposure of the S&P 500 Index, while limiting downward exposure. Upon maturity of the notesnote in 2024, the principal, plus the return based upon the S&P 500 Index must be paid. The notes havenote has a feature to provide upside performance participation that is capped at 120% of the performance of the S&P 500. A separate layer of the notesnote has a feature to protect debt holders from market downturns by up to 20% if the index price experiences a loss during the investment period. After the underlying index has decreased in value by more than 20%, the investmentsinvestment will experience all subsequent losses on a one-to-one basis. As of JuneSeptember 30, 2023, the entire principal amount remained outstanding. The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third party. As of JuneSeptember 30, 2023, the fair value of the LMATT Series 2.2024, Inc. notes waswere $3,446,5273,027,681. The notes are secured by the assets of the issuing entity, LMATT Series 2.2024, Inc., which includes cash, S&P 500 options, and life settlement policies totaling $3,331,8722,983,754 as of JuneSeptember 30, 2023. The notes agreementnote agreements do not restrict the trading of life settlement contracts prior to maturity of the notes,note, as total assets of the issuing company are considered as collateral. There are also no restrictive covenants associated with the notesnote with which the entity must comply.

Additionally, on September 16, 2022, LMATTLMATTS Growth and Income Series 1.2026, Inc., a 100% owned subsidiary which the Company consolidates for financial reporting issued $400,000 in market-indexed private placement notes. The notes,note, titled the Longevity Market Assets Target-Term Growth and Income Series 1.2026, Inc (“LMATTSTM Growth and Income Series 1.2026, Inc.”) areis a market-indexed instrumentsinstrument designed to provide upside performance exposure of the S&P 500 Index, while limiting downward exposure. Upon maturity of the notesnote in 2026, the principal, plus the return based upon the S&P 500 Index must be paid. The notes havenote has a feature to provide upside performance participation that is capped at 140% of the performance of the S&P 500. A separate layer of the notesnote has a feature to protect debt holders from market downturns by up to 10% if the index price experiences a loss during the investment period. After the underlying index has decreased in value by more than 10%, the investmentsinvestment will experience all subsequent losses on a one-to-one basis. These notesThis note also includeincludes a 4% dividend feature that will be paid annually. As of JuneSeptember 30, 2023, the entire principal amount remained outstanding. The notes are held at fair value, which represents the exit price, or anticipated price to transfer the liability to a third party. As of JuneSeptember 30, 2023, the fair value of the LMATT Growth and Income Series 1.2026, Inc., notes was $were 459,533$427,284. The notes are secured by the assets of the issuing entity, LMATTLMATTS Growth and Income Series 1.2026, Inc., which includes cash, S&P 500 options, and life settlement policies totaling $517,218$369,253 as of JuneSeptember 30, 2023. The notes agreement doesnote agreements do not restrict the trading of life settlement contracts prior to maturity of the note, as total assets of the issuing company are considered as collateral. There are also no restrictive covenants associated with the notesnote with which the entity must comply. See additional fair value considerations within Note 12 of the Fair Value footnote.Company’s interim financial statements.

Other Income (Expense)

Other income (expense) consists of working capital support that Abacus Life, Inc.the Company provides to two life settlement Providers through a contractual agreement (the “Strategic Services and Expenses Support
61

Tablethe SSES further discussed in Note 11 of Contents
Agreement” or “SSES”). Abacus Life, Inc.the Company’s interim financial statement. The Company entered into the SSES with the Providers and simultaneously acquired an option to purchase the outstanding equity ownership of the Providers, upon the achievement by the Providers of certain financial targets. For the years ended December 31, 2022 and December 31, 2021, the Providers were considered to be VIEs, but were not consolidated in our interim condensed consolidated financial statements as we do not hold a controlling financial interest in the Providers.

Three Months Ended June 30,$ Change% Change
20232022

Other income (expense)$121,601$(127,455)$249,056(195.4)%
Interest (expense) (584,075)- (584,075)— %
Interest income---— %
71

Table of Contents
Three Months Ended September 30,
20232022$ Change% Change
Other income (expense)$20,086$42,289$(22,203)(52.5)%
Interest (expense)(2,679,237)(2,679,237)100 %
Interest income63,826 63,826 100 %
Loss on change in fair value of warrant liability(943,400)(943,400)100 %

Other income (expense) decreased by $249,056,$22,203, or 52.5%, for the three months ended JuneSeptember 30, 2023, compared to the three months ended September 30, 2022. The decrease in other income is driven by a reduction in expense support provided to the Providers.

Interest expense was $2,679,237 for the three months ended September 30, 2023, compared to $0 the three months ended September 30, 2022. Interest expense increase is driven by the Owl Rock Credit Facility, the SPV Purchase and Sale Note, and the Sponsor PIK Note. Refer to Note 13 of the Company’s interim financial statements for additional information. The remaining increase is attributable to interest expense related to LMATT Growth & Income Series, Inc. and the dividend required to be paid out by the LMA Income Series, LP and LMA Income Series II, LP to its limited partner investors.

Interest income was $63,826, for the three months ended September 30, 2023, compared to $0 for the three months ended September 30, 2022. The increase in interest income is due to money market sweeps that LMA and its subsidiaries participated in during the third quarter of 2023.

Loss on change in fair value of warrant liability was $943,400 for the three months ended September 30, 2023, compared to $0 for the three months ended September 30, 2022. The loss is primarily attributable to the increase in the price for the public warrants from June 30, 2023 to September 30, 2023, which is a determining factor for measuring the fair value of the private warrants.

Nine Months Ended September 30,
20232022$ Change

% Change
Other income (expense)$(1,565)$(199,958)$198,393(99.2)%
Interest (expense)(3,620,695)(3,620,695)100 %
Interest income71,283 71,283 100 %
Loss on change in fair value of warrant liability(943,400)(943,400)100 %

Other expense decreased by $198,393, or 99.2%, for the nine months ended September 30, 2023, compared to the nine months ended September 30, 2022. The increasedecrease in other incomeexpense is driven by reduction of excess return expense of $117,616 and fund management fee of $67,180 at LMA Income Series, LP for the three months ended June 30, 2023. As noted above, LMA Income Series, LP did not exist during the three months ended June 30, 2022.expense. The remaining difference is attributable to dividend income of $4,063 at LMA Income Series GP and other income at Regional Investment Services for the threenine months ended JuneSeptember 30, 2023.

Interest (expense) increased by $584,075, forexpense was $3,620,695 for the threenine months ended JuneSeptember 30, 2023, compared to $0 for the nine months ended September 30, 2022. Interest expense increase is related to the Owl Rock Credit Facility, the SPV Purchase and Sale Note, and the Sponsor PIK Note, and the launch of two Income funds, LMA Income Series, LP and LMA Income Series II, LP for the nine months ended September 2023.

Interest income was $71,283, for the nine months ended September 30, 2023, compared to $0 the threenine months ended JuneSeptember 30, 2022. The increase of $63,825 in interest expense is driven by the dividend of 6.5% required to be paid out by the LMA Income Series to its limited partner investors. The remaining increase is attributable to interest expense at LMATT Growth & Income Series Inc.


Six Months Ended June 30,$ Change% Change
20232022

Other income (expense)$(21,651)$(242,247)$220,596(91.1)%
Interest (expense) (941,458)-(941,458)100 %
Interest income 7,457- 7,457100%

Other income (expense) decreased by $220,596, for the six months ended June 30, 2023, compared to the six months ended June 30, 2022. The increase in other income is driven by reductiondue to money market sweeps that LMA and its subsidiaries participated in the third quarter of excess return expense of $212,526. $29,721 was paid to the Providers during the six months ended June 30, 2023, compared to $242,247 paid during the six months ended June 30, 2022.2023. The remaining difference is attributable to dividend income of $8,125 at LMA Income Series GP and other income at Regional Investment Services for the six months ended June 30, 2023.

Interest (expense) increased by $941,458, for the six months ended June 30, 2023, compared to the six months ended June 30, 2022. The increase in interest expense is driven primarily by $713,149 and $220,309 accrued interest payments relating to LMA Income Series LP LLC and LMA Income Series II LP, respectively, along with $8,000 in interest expense for LMATT Growth & Income Series, Inc. for the six months ended June 30, 2022.

Interest income increased by $7,457, for the six months ended June 30, 2023, compared to the six months ended June 30, 2022. The increase in interest income is driven by interest on proceeds from policies that matured in the first three months of 2023.

Provision for income taxes

6272

Table of Contents
AsLoss on change in fair value of warrant liability was $943,400, for the three months ended September 30, 2023, compared to $0 for the three months ended September 30, 2022. The loss is primarily attributable to the increase in the price for the public warrants from June 30, 2023 to September 30, 2023, which is a determining factor for measuring the fair value of the private warrants.

Income Tax Expense

Prior to the Business Combination, the Company elected to file as an S corporation for federal and Florida state income tax purposes,purposes. As such, the Company incurred no federal or Florida state income taxes, except for income taxes recorded related to LMATT Series 2024, Inc. (“LMATT”), a Delaware C corporation and wholly owned subsidiary of LMX Series, LLC, (“LMX”), which Abacus Life, Inc. consolidates. Accordingly,are consolidated by the Company. Accordingly, the income tax expense has historically been attributable to income tax expense for LMATT Series 2024, Inc. However, the Business Combination resulted in changes to the tax status of certain entities which impacted the provision for income taxes by $1,383,692.

Three Months Ended June 30,$ Change% Change
20232022
Provision for income taxes$(1,184,571)$(120,132)$(1,064,439)886 %
Three Months Ended September 30,$ Change% Change
20232022
Income tax expense$1,710,315$352,081$1,358,234385.8 %

ProvisionI for income taxesncome tax expense increased by $1,064,439,$1,358,234, or 886%385.8% for the three months ended JuneSeptember 30, 2023, compared to the three months ended JuneSeptember 30, 2022. Our effective income tax rate for the three months ended JuneSeptember 30, 2023 and three months JuneSeptember 30, 2022, was 15%61.9% and 12%3.3%, respectively.The Company's effectiveeffective tax rate as of JuneSeptember 30, 2022 differed from the statutory rate of 21%21.0% due to state taxes and the release of the valuation allowance. The higher provision for income taxestax expense for the three months ended JuneSeptember 30, 2023 is mainly related to Longevity Market Assets LLC taxable income of $7,081,252 resulting in $1,203,190 of provision for income taxes from the change in tax status upon the Business Combination.unfavorable adjustment related to restricted stock award deductions limited by IRC 162(m).

Six Months Ended June 30,$ Change% Change
20232022
Provision for income taxes$(528,104)$(296,806)$(231,298)78 %
Nine Months Ended September 30,$ Change% Change
20232022
Income tax expense$2,238,419$648,887$1,589,532245.0 %

ProvisionI for income taxesncome tax expense increased by $231,298,$1,589,532, or 78%245.0% for the sixnine months ended JuneSeptember 30, 2023 compared to the sixnine months ended JuneSeptember 30, 2022. Our effective income tax rate for the sixnine months ended JuneSeptember 30, 2023 and sixnine months ended JuneSeptember 30, 2022, was 3.6%12.7% and 2.8%18%, respectively. The Company's effective tax rate as of JuneSeptember 30, 2022 differed from the statutory rate of 21%21.0% due to the impact of state income taxes and valuation allowance released, as there was sufficient evidence of the Company’s ability to generate future taxable income at JuneSeptember 30, 2022. The existence of non-taxable flow-through entities within the Company as well as a change in tax status of certain entities upon the Business Combination caused the effective tax rate to be significantly lower than the statutory rate. The higher provision for income taxesrate for the sixnine months ended JuneSeptember 30, 2023. The income tax expense for the nine months ended September 30, 2023 is mainly related to the unfavorable adjustment related to Longevity Market Assets LLC (LMA) taxable income of $13,876,206 resulting in $1,203,190 of provision for income taxes, offsetrestricted stock award deductions limited by LMATT Series 2024, Inc. net taxable loss of $2,118,344 resulting in $536,894 of income tax benefit and LMATT Growth & Income Series, Inc. net taxable loss of $303,328 resulting in $76,878 of income tax benefit and LMATT Growth Series, Inc. net taxable loss of $954,095 resulting in $241,815 of income tax benefit.IRC 162(m).

Results of Operations—Segment Results

Abacus Life, Inc.The Company organizes its business into twothree reportable segments (i) portfolio servicing, and (ii) active management, and (iii) originations, which generate revenue in different manners. During 2021, we primarily focused on the Portfolio Servicing business. At the end of June 2021, we underwent a change in our business to focus on active management services in addition to portfolio servicing. Finally, the Company originates life insurance policies as a result of the Business Combination.


73

Table of Contents
This segment structure reflects the financial information and reports used by Abacus Life, Inc.'sthe Company's management, specifically its chief operating decision maker (CODM), to make decisions regarding Abacus Life, Inc.’sthe Company’s business, including resource allocations and performance assessments as well as the current operating focus in accordance with ASC 280, Segment Reporting. Abacus Life, Inc.'sThe Company's CODM is the Chief Executive Officer of Abacus Life, Inc.the Company.

63

Table of Contents
The portfolio servicing segment generates revenues by providing policy services to customers on a contract basis. The active management segment generates revenues by buying, selling and trading policies and maintaining policies through to death benefit. Abacus Life, Inc.'sThe origination segment generates revenue by originating life insurance policy settlement contracts as a licensed life settlement provider on behalf of third-party institutional investors interested in investing in the life settlement asset class. The Company's reportable segments are not aggregated.

The following tables provides supplemental information of revenue and profitability by operating segment:

Portfolio Servicing

Three Months Ended June 30,$ Change% ChangeThree Months Ended September 30,$ Change% Change
2023202220232022
Total revenueTotal revenue$354,366 $419,422(65,056)(16)%Total revenue$224,569$382,246$(157,677)(41.3)%
Gross profit (143,885)280,303(424,188)(151)%
Gross profit (Loss)Gross profit (Loss)(626,045)(106,817)(519,228)486.1%

Total revenue for the portfolio servicing segment decreased by $65,056,$157,677, or 16%41.3%, for the three months ended JuneSeptember 30, 2023 compared to the three months ended JuneSeptember 30, 2022. The decrease in portfolio servicing revenue is primarily attributable to a decrease in the non-recurring consulting projects in Portfolio servicing revenue. Gross profit from our portfolio servicing segment decreased by $424,188$519,228 or 151%486.1%, for the three months ended JuneSeptember 30, 2023, compared to the three months ended JuneSeptember 30, 2022. The decrease in gross margin is primarily due to increases in total cost of revenue of $359,132, $361,552 or 258% and74.0% and the reduction of revenue by $65,056,$157,677, or 16%41.3%.
Six Months Ended June 30,$ Change% Change
20232022
Total revenue $590,057 $990,327 $(400,270)(40)%
Gross profit (166,128)668,752 (834,880)(125)%

Nine Months Ended September 30,$ Change% Change
20232022
Total revenue$814,626 $1,372,573 (557,947)(40.6)%
Gross profit (Loss)(792,173)561,935(1,354,108)(241.0)%

Total revenue for the portfolio servicing segment decreased by $400,270$557,947 or 40%40.6%, for the sixnine months ended JuneSeptember 30, 2023 compared to the sixnine months ended JuneSeptember 30, 2022. The decrease in portfolio servicing revenue is primarily attributable to a decrease in the non-recurring consulting projects in Portfolio servicing revenue. Gross profit from our portfolio servicing segment decreased by $834,880,$1,354,108, or 125%241.0%, for the sixnine months ended JuneSeptember 30, 2023 compared to the sixnine months ended JuneSeptember 30, 2022.The2022. The decrease in gross margin is primarily due to increases in total cost of revenue of $434,610,$796,161, or 135%98.2% and the reduction of revenue by $400,270,$557,947, or 40%40.6%.

Active Management

Three Months Ended June 30,$ Change% ChangeThree Months Ended September 30,$ Change% Change
2023202220232022
Total revenueTotal revenue $ 11,024,399 $7,979,4793,044,92038.2%Total revenue$18,926,144$11,125,5037,800,64170.1%
Gross profitGross profit 10,482,070 7,452,4793,029,59140.7%Gross profit13,856,637 9,859,6723,996,96540.5%

74

Table of Contents
Total revenue for the active management segment increased by $3,044,920$7,800,641, or 38%70.1% for the three months ended JuneSeptember 30, 2023, compared to the three months ended JuneSeptember 30, 2022. Gross profit from our active management segment increased $3,029,591,by $3,996,965, or 41%40.5% for the three months ended JuneSeptember 30, 2023, compared to the three months ended JuneSeptember 30, 2022.2022. The increase in active management revenue and gross profit was primarily attributable to the increase in revenue of $3,044,920 and decrease $7,800,641 or 70.1%, offset by the increase in cost of revenue from 7% of revenue to 5% of revenue.$102,750, or 8.1%.
64

Table of Contents
Six Months Ended June 30,$ Change% ChangeNine Months Ended September 30,$ Change% Change
2023202220232022
Total revenueTotal revenue$20,994,917 $17,285,9713,708,94621.5%Total revenue$39,921,061 $28,411,47511,509,58640.5%
Gross profitGross profit20,288,152 15,521,4714,766,68130.7%Gross profit34,144,789 25,381,1448,763,64534.5%

Total revenue for the active management segment increased by $3,708,946,$11,509,586, or 22%40.5% for the sixnine months ended JuneSeptember 30, 2023, compared to the sixnine months ended JuneSeptember 30, 2022. Gross profit from our active management segment increased $4,766,681,$8,763,645, or 31%34.5% for the sixnine months ended JuneSeptember 30, 2023, compared to the sixnine months ended JuneSeptember 30, 2022. The increase in Active management revenue and gross profit was primarily attributable to _ the increase in revenue of $3,708,946$11,509,586, or 40.5%, and decrease in cost of revenue from 10%11.0% of revenue in 2022 to 3%5.0% of revenue.revenue in 2023. The decrease in cost of revenue of approximately $1,073,064$954,984, or 31.5% was related to the decrease in consulting bonus expenses.discretionary commissions for individuals directly related to active management trading revenue.

Originations

Three Months Ended September 30,$ Change% Change
20232022
Total revenue$10,214,489$$10,214,489100.0%
Gross profit4,525,3814,525,381 100%

Total revenue for the originations segment increased by $10,214,489 for the three months ended September 30, 2023 compared to the three months ended September 30, 2022. Among the total originations revenue, the majority of the balance is related to the eliminated intercompany activity of $8,244,272 that is related to policies that Abacus originated for LMA. No originations revenue was recorded prior the Business Combination in June 2023.

Nine Months Ended September 30,$ Change% Change
20232022
Total revenue$10,214,489$$10,214,489100.0%
Gross profit4,525,3814,525,381 100%

Total revenue for the originations segment increased by $10,214,489 for the nine months ended September 30, 2023 compared to the nine months ended September 30, 2022. Among the total originations revenue, the majority of the balance is related to the eliminated intercompany activity of $8,244,272 that is related to policies that Abacus originated for LMA. No originations revenue was recorded prior the Business Combination in June 2023.


75

Table of Contents
Key Business Metrics and Non-GAAP Financial Measures

The consolidated financial statements of Abacus Life, Inc. have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission and are prepared in accordance with U.S. GAAP. We monitor key business metrics and non-GAAP financial measures that assist us in evaluating our business, measuring our performance, identifying trends and making strategic decisions. We have presented the following non-GAAP measures, their most directly comparable GAAP measure, and key business metrics:

Adjusted EBITDA

Non-GAAP Measure    
Non-GAAP MeasureComparable GAAP Measure
Adjusted Net Income, Adjusted EPSNet Income attributable to Abacus Life, Inc. and EPS
Adjusted EBITDANet Income

Adjusted Net Income, Adjusted EPS, Adjusted EBITDA and Adjusted EBITDA Margin, are not measures of financial performance under GAAP and should not be considered substitutes for GAAP measures, net income (loss) (for Adjusted EBITDA and Adjusted EBITDA Margin), net income (loss) attributable to Abacus Life, Inc. (for Adjusted Net Income) or earnings (loss) per share (for Adjusted EPS), which are considered to be the most directly comparable GAAP measures. These non-GAAP financial measures have limitations as analytical tools, and when assessing Company’s operating performance, these non-GAAP financial measures should not be considered in isolation or as substitutes for net income (loss), net income (loss) attributable to Abacus Life, Inc., earnings (loss) per share or other consolidated statements of operations and comprehensive income data prepared in accordance with GAAP.

Adjusted Net Income is presented for the purpose of calculating Adjusted EPS. The Company defines Adjusted Net Income as net income (loss) attributable to Abacus Life, Inc. adjusted for non-controlling interest income, amortization, change in fair value of warrants and non-cash stock-based compensation and the related tax effect of those adjustments. Management believes that Adjusted Net Income is an appropriate measure of operating performance because it eliminates the impact of expenses that do not relate to business performance.

Adjusted EPS measures our per share earnings and is calculated as Adjusted Net Income divided by adjusted weighted-average shares outstanding. We believe Adjusted EPS is useful to investors because it enables them to better evaluate per share operating performance across reporting periods and management believes that Adjusted EPS is an appropriate measure of operating performance because it eliminates the impact of expenses that do not relate to business performance.

Adjusted Net Income and Adjusted EPS

The following table presents a reconciliation of Adjusted Net Income to the most comparable GAAP financial measure, net income (loss) attributable to Abacus Life, Inc. and Adjusted EPS to the most comparable GAAP financial measure, earnings per share, on a historical basis for the periods indicated below:

76

Table of Contents
77

Table of Contents
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Net income attributable to Abacus Life, Inc.$903,361 $9,992,004 $15,739,009 $21,507,702 
Net income attributable to non-controlling interests147,611 363,452 (339,692)770,093 
Amortization expense1,682,083 — 1,682,083 — 
Stock based compensation4,583,632 — 4,583,632 — 
Loss on change in fair value of warrant liability943,400 — 943,400 — 
Tax impact [1]
908,271 — 908,271 — 
Adjusted Net Income$9,168,357 $10,355,456 $23,516,703 $22,277,795 
Weighted-average shares of Class A common stock outstanding63,349,823 50,369,350 54,632,826 50,369,350 
Adjusted EPS$0.14 $0.21 $0.43 $0.44 
[1] Tax impact represents the permanent difference in tax expense related to the restricted stock awards granted to the CEO due to IRC 162(m) limitations.

Adjusted Net income for the three months ended September 30, 2023 was $9,168,357 compared to adjusted net income of $10,355,456 for the three months ended September 30, 2022. The decrease of $1,187,099, or 11.5%, in adjusted Net Income is primarily due to the decrease of $9,088,643, or 91.0%, in net income. Adjusted EPS for the three months ended September 30, 2023 was $0.14 compared to $0.21 for the three months ended September 30, 2022.

Adjusted Net Income for the nine months ended September 30, 2023 was $23,516,703 compared to $22,277,795 for the nine months ended September 30, 2022. The decrease of $1,238,908, or 5.6%, in adjusted Net Income is primarily due to a decrease of $6,878,478, or 30.9%, in net income. Adjusted EPS for the ninemonths ended September 30, 2023 was $0.43 compared to $0.44 for the nine months ended September 30, 2022.

Adjusted EBITDA Net Incomeand Adjusted EBITDA Margin

Adjusted EBITDA is net income adjusted for depreciation expense, amortization, interest expense, income tax and other non-cash and non-recurring items that in our judgement significantly impact the period-over-period assessment of performance and operating results that do not directly relate to business performance within Abacus Life, Inc.'s control. These unusual items may include proceeds from the PPP loan, payments made as part of Abacus Life, Inc.'sthe Company's expense support commitment, (gain) loss on the change in fair value of debt, loss on change in fair value of warrant liability, S&P 500 put and call options that were entered into as an economic hedge related to the debt (described as the unrealized loss on investments), non-cash stock based compensation, and other non-recurring items. Management plans to terminate the agreement for the expense support commitment within the next twelve months. As such, management has deemed this to be a non-recurring item. Adjusted EBITDA should not be determined as substitution for net income (loss), cash flows provided (used in) operating, investing, and financing activities, operating income (loss), or other metrics prepared in accordance with U.S. GAAP.


78

Table of Contents
Management believes the use of Adjusted EBITDA assists investors in understanding the ongoing operating performance by presenting comparable financial results between periods. We believe that by removing the impact of depreciation and amortization and excluding certain non-cash charges, amounts spent on interest and taxes and certain other non-recurring charges that are highly variable from year to year, Adjusted EBITDA provides our investors with performance measures that reflect the impact to operations from trends in changes in revenue, policy values and operating expenses, providing a perspective not immediately apparent from net income and operating income. The adjustments we make to derive the non-GAAP measure of Adjusted EBITDA exclude items which may cause short-term fluctuations in net income and operating income and which we do not consider to be the fundamental attributes or primary drivers of our business.

The following table presents a reconciliation of Adjusted EBITDA and Adjusted EBITDA margin to the most comparable GAAP financial measure, net income (loss), on a historical basis for the periods indicated below:
65

Table of Contents

Three Months Ended June 30, 
Six Months Ended June 30, 
2023202220232022
Net income$6,723,549$5,086,199$14,348,345$11,922,339
Depreciation expense 1,0981,098 2,1412,141
 Interest Income 584,075 934,001
Income tax 1,184,571120,132 528,104296,806
Other income (expense) (121,601)127,455 21,651242,247
Loss on change in fair value of debt 1,445,229333,879 2,398,662375,513
Unrealized gain (loss) on investments (672,936)1,039,022 (798,156) 1,054,975
Adjusted EBITDA$9,143,985$6,707,785$17,434,748$13,894,021
Adjusted EBITDA Margin80.4 %79.9 %80.8 %76.0 %
Net Income Margin59.1 %60.6 %66.5 %65.2 %
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Net Income$1,050,972 $10,355,456 $15,399,317 $22,277,795 
Depreciation and amortization expense1,694,853 1,071 1,696,994 3,211 
Income Tax1,710,315 352,081 2,238,419 648,887 
Interest (Expense)2,679,237 — 3,620,695 — 
Other Income (Expenses)(20,086)(42,289)1,565 199,958 
Interest Income(63,826)— (71,283)— 
Loss on change in fair value of warrant liability943,400 — 943,400 — 
Stock based compensation4,583,632 — 4,583,632 — 
Expense support agreement— 283,047 — 283,047 
Unrealized loss (gain) on investments306,800 246,846 (491,356)1,301,821 
(Gain) loss on change in fair value of debt(2,088,797)(1,235,032)309,865 (859,519)
Adjusted EBITDA$10,796,499 $9,961,180 $28,231,248 $23,855,200 
Adjusted EBITDA Margin51.1%86.6%66.1%80.1%
Net Income Margin5.0%90.0%36.1%74.8%

Adjusted EBITDA for the three months ended Juneended September 30, 2023 was $9,143,985$10,796,499 compared to $6,707,785$9,961,180 for the three months ended JuneSeptember 30, 2022. The increase of $2,436,200,$835,319, or 36%8.4% in adjusted EBITDA is primarily due to stock-based compensation of $4,583,632, $2,679,237 in interest expense, $943,400 loss on change in fair value of warrant liability, an increase in depreciation and amortization expense of $1,693,782, or 158149.6%, and the increase of $1,637,350,$59,954, or 32%24.3%, in unrealized gain on investments. There is an offset by a decrease of $9,304,484, or 89.9%, in net and comprehensive income and a decrease in fair value of debt of $853,765, or 69.1%.

Adjusted EBITDA for the nine months ended September 30, 2023 was $28,231,248 compared to $23,855,200 for the nine months ended September 30, 2022. The increase of $1,111,350,$4,376,046, or 333%18.3%, in adjusted EBITDA is primarily due to stock-based compensation of $4,583,632, $3,620,695 in interest expense, $943,400 loss on change in fair value of warrant liability, an increase in depreciation and amortization expense of $1,693,783, or 52749.4%, and an increase of $1,169,384, or 136.1%, in gain on change in fair value of debt. There is an offset by a decrease of $6,878,478, or 30.9%, in net and comprehensive income and an increase in unrealized loss on investments of $672,936.$1,793,177, or 137.7%.
79


Table of Contents
Adjusted EBITDA for the six months ended June 30, 2023 was $17,434,748 compared to $13,894,021 for the six months ended June 30, 2022. The increase of $3,540,727, or 25% in adjusted EBITDA is primarily due to the expansion of the active management services which resulted in increased revenues of $3,708,946, or 21% and the increase of $2,023,149, or 539% in gain on change in fair value of debt.

We monitor the following key business metrics: (i) number of policies serviced, (ii) value of policies serviced, and (iii) total invested dollars. Servicing revenue involves the provision of services to one affiliate by common ownership and third parties which own life insurance policies. The number of policies and the value of policies serviced represents the volume and dollar value of policies over which the above services are performed. Total invested dollars represent the acquisition cost plus premiums paid by the policy. We use the aforementioned metrics to assess business operations and provide concrete benchmarks that provide a clear snapshot of growth between the periods under consideration. Please refer to the following Key Business Metrics below:

Six Months Ended June 30,$ Change% ChangeNine Months Ended September 30,$ Change% Change
2023202220232022
Key business metricKey business metricKey business metric
Number of policies servicedNumber of policies serviced81944137885.7%Number of policies serviced904437467106.9%
Value of policies serviced ($)Value of policies serviced ($)1,823,437,795 650,461,869 1,172,975,926 180.3%Value of policies serviced ($)943,913,658 630,312,740 313,600,918 49.8%
Total invested dollars ($)Total invested dollars ($)678,400,432 167,374,107511,026,325 305.3%Total invested dollars ($)233,180,176 163,731,77769,448,399 42.4%

Liquidity and Capital Resources
Non-GAAP MeasureComparable GAAP Measure
Proforma Adjusted Net Income, Proforma Adjusted EPSNet Income attributable to Abacus Life, Inc. and Net Income for Abacus Settlements, LLC and EPS for Abacus Life, Inc.
Proforma Adjusted EBITDANet Income for Abacus Life, Inc. and Net Income for Abacus Settlements, LLC

Proforma adjusted Net Income and Proforma Adjusted EPS

Proforma Adjusted Net Income, Proforma Adjusted EPS, Proforma Adjusted EBITDAand Proforma Adjusted EBITDA Margin, are not measures of financial performance under GAAP and should not be considered substitutes for GAAP measures, net income (loss) for Abacus Life Inc. has financed operations since our inception primarily through customer payments, debt issuances,and Abacus Settlements, LLC (for Proforma Adjusted EBITDA and Proforma Adjusted EBITDA Margin), net income (loss) attributable to Abacus Life, Inc. and net proceeds from equity financingsincome for Abacus Settlements, LLC (for Proforma Adjusted Net Income) or earnings (loss) per share (for Proforma Adjusted EPS), which are considered to be the most directly comparable GAAP measures. These non-GAAP financial measures have limitations as analytical tools, and when assessing Company’s operating performance, thesenon-GAAP financial measures should not be considered in isolation or as substitutes for net income (loss) for Abacus Life, Inc. and Abacus Settlements, LLC, net income (loss) attributable to Abacus Life, Inc. and Abacus Settlements, LLC, earnings (loss) per share or other consolidated statements of operations and comprehensive income data prepared in accordance with GAAP.

Proforma Adjusted Net Income is presented for the formpurpose of capital contributions from our limited liability company members. Our principal usescalculating Proforma Adjusted EPS. The Company defines Proforma Adjusted Net Income as net income (loss) attributable to Abacus Life, Inc. plus historical net income for Abacus Settlements, LLC prior to the Business Combination adjusted for non-controlling interest, amortization, stock based compensation, change in fair value of cashwarrants, and cash equivalents in recentthe related tax effect of those adjustments. Management believes that Proforma Adjusted Net Income is an appropriate measure of operating performance because it represents the combined results for the two legacy operating companies, Abacus Settlements, LLC and Longevity Market Assets, LLC year-over-year as if the business combination had occurred at the beginning of the years shown and eliminates the impact of expenses that do not relate to business performance.

The following table presents a reconciliation of Proforma Adjusted Net Income to the most comparable GAAP financial measure, net income (loss) attributable to Abacus Life, Inc. and net income for Abacus Life, Inc. and Proforma Adjusted EPS to the most comparable GAAP financial measure, earnings per share, on a historical basis for the periods haveindicated below:

6680

Table of Contents
been funding our operations as
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Net income attributable to Abacus Life, Inc.903,361 9,992,003 15,739,009 21,507,702 
Net income for Abacus Settlements, LLC— (122,998)(974,901)149,790 
Net income attributable to Abacus Life, Inc.903,361 9,869,005 [1]14,764,108 [2]21,657,492 [3]
Net income attributable to non-controlling interests147,611363,452(339,692)770,093
Amortization expense1,682,083 — 1,682,083 — 
Stock compensation expense4,583,632 — 4,583,632 — 
Loss on change in fair value of warrant liability943,400 — 943,400 — 
Tax impact [4]
908,271 — 908,271 — 
Proforma Adjusted Net Income9,168,358 10,232,457 22,541,802 22,427,585 
Weighted-average shares of Class A common stock outstanding62,961,688 50,369,350 54,612,922 50,369,350 
Proforma Adjusted EPS0.150.200.410.45
[1] Includes historical net income attributable to Abacus, Life, Inc. mustfor the three months ended September 30, 2022 of $9,992,003and a net loss of ($122,998) for Abacus Settlements, LLC.
[2] Includes year-to-date net income attributable to Abacus Life, Inc. as of September 30, 2023 of $15,739,009 plus net loss for the six month period ended on June 30, 2023 for Abacus Settlements, LLC of ($974,901).
[3] Includes historical net income attributable to Abacus Life, Inc. for the nine months ended September 30, 2022 of $21,507,702 and $149,790 for Abacus Settlements, LLC.
[4] Tax impact represents the permanent difference in tax expense related to the restricted stock awards granted to the CEO due to IRC 162(m) limitations.

Proforma Adjusted Net income for the three months ended September 30, 2023 was $9,168,358 compared to proforma adjusted net income of $10,232,457 for the three months ended September 30, 2022. The decrease of $1,064,099, or (10.4)%, in proforma adjusted Net Income is primarily due to the decrease of $8,965,644, or (90.8)%, in proforma net income attributable to Abacus Life Inc., which is partially offset by the adjustments amounting to $8,264,997. When adjusting for the impact of those items, the main driver is the increase in interest expense related to the credit facilities that were entered into at the end of the second quarter. Proforma Adjusted EPS for the three months ended September 30, 2023 was $0.15 compared to $0.20 for the three months ended September 30, 2022.

Proforma Adjusted Net Income for the nine months ended September 30, 2023 was $22,541,802 compared to $22,427,585 for the nine months ended September 30, 2022. The increase of $114,217, or 0.5%, in Proforma adjusted Net Income is primarily due to the increase in proforma revenue attributable to Abacus Life Inc. Proforma Adjusted EPS for the nine months ended September 30, 2023 was $0.41 compared to $0.45 for the nine months ended September 30, 2022.

81

Table of Contents
Proforma Adjusted EBITDA

Proforma Adjusted EBITDA is net income for Abacus Life, Inc. plus historical net income for Abacus Settlements, LLC prior to the Business Combination and adjusted for depreciation expense, amortization expense, interest expense, income tax and other non-cash and non-recurring items that in our judgement significantly impact the period-over-period assessment of performance and operating results that do not directly relate to business performance within Abacus Life, Inc.'s control. These unusual items may include payments made as part of the Company's expense support commitment, (gain) loss on change in fair value of debt, loss on change in fair value of warrant liability, S&P 500 put and call options that were entered into as an economic hedge related to the debt (described as the unrealized loss on investments), non-cash stock based compensation, and other non-recurring items. Management plans to terminate the agreement for the expense support commitment within the next twelve months. As such, management has deemed this to be a non-recurring item. Proforma Adjusted EBITDA should not be determined as substitution for net income (loss), cash flows provided (used in) operating, investing, and financing activities, operating income (loss), or other metrics prepared in accordance with U.S. GAAP.

Management believes the use of Proforma Adjusted EBITDA assists investors in understanding the ongoing operating performance by presenting comparable financial results between periods and represents the combined results for the two legacy operating companies, Abacus Settlements, LLC and Longevity Market Assets, LLC year-over-year as if the business combination had occurred at the beginning of the years shown. We believe that by removing the impact of depreciation and amortization and excluding certain non-cash charges, amounts spent on interest and taxes and certain other non-recurring charges that are highly variable from year to year, Proforma Adjusted EBITDA provides our investors with performance measures that reflect the impact to operations from trends in changes in revenue, policy values and operating expenses, providing a perspective not immediately apparent from net income and operating income. The adjustments we make to derive the non-GAAP measure of Proforma Adjusted EBITDA exclude items which may cause short-term fluctuations in net income and operating income and which we do not consider to be the fundamental attributes or primary drivers of our business.

The following table presents a reconciliation of Proforma Adjusted EBITDA and Proforma Adjusted EBITDA margin to the most comparable GAAP financial measure, net income (loss) for Abacus Life Inc. and net income (loss) for Abacus Settlements, LLC, on a historical basis for the periods indicated below:


82

Table of Contents
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Net Income for Abacus Life Inc.$1,050,972 $10,355,455 $15,399,317 $22,277,795 
Net Income for Abacus Settlements, LLC— (122,998)(974,901)149,790 
Proforma Net Income1,050,972 10,232,457 [1]14,424,416 [2]22,427,585 [3]
Depreciation12,770 4,219 20,508 12,360 
Amortization1,682,083 — 1,682,083 — 
Interest expense2,679,237 2,449 3,632,420 1,449 
Interest income(63,826)— (73,200)— 
Income Tax1,710,315 (948,600)2,240,708 (650,794)
Stock compensation4,583,632 — 4,583,632 — 
Other (Income) / Expenses(20,086)(42,289)1,565 199,958 
Loss on change in fair value of warrant liability943,400 — 943,400 — 
Expense support agreement— 283,047 — 283,047 
(Gain) loss on change in fair value of debt(2,088,797)(1,235,032)309,865 (859,519)
Unrealized loss / (gain) on investments306,800 246,846 (491,356)1,301,821 
Proforma Adjusted EBITDA$10,796,500 $8,543,097 $27,274,041 $22,715,907 
Revenue21,120,930 17,538,734 55,890,580 48,830,191 
Proforma Adjusted EBITDA Margin51.12 %48.71 %48.80 %46.52 %
Proforma Net Income Margin4.98 %58.34 %25.81 %45.93 %
[1] Includes historical net income for the three months ended September 30, 2022 of $10,355,455 for Abacus Life, Inc. and a loss of ($122,998) for Abacus Settlements, LLC.
[2] Includes year-to-date net income as of September 30, 2023 of $15,399,317 plus net loss for the six month period ended on June 30, 2023 for Abacus Settlements, LLC of ($974,901).
[3] Includes historical net income for the nine months ended September 30, 2022 of $22,277,795 for Abacus Life, Inc. and $149,790 for Abacus Settlements, LLC.

Proforma Adjusted EBITDA for the three months ended September 30, 2023 was $10,796,500 compared to $8,543,097 for the three months ended September 30, 2022. The increase of $2,253,403, or 26.4% in proforma adjusted EBITDA is primarily due to an increase in proforma revenue.While expenses also increased, many of these increases in expenses are being reflected in the non-recurring and non-cash adjustments shown herein as a result of the Business Combination.

Proforma Adjusted EBITDA for the nine months ended September 30, 2023 was $27,274,041 compared to $22,715,907for the nine months ended September 30, 2022. The increase of $4,558,134 or 20.1%, in proforma adjusted EBITDA is primarily due to the increase in proforma revenue. While expenses also increased, many of these increases in expenses are being reflected in the non-recurring and non-cash adjustments shown herein as a result of the Business Combination.

83

Table of Contents
Proforma Segment revenue

Proforma Segment Revenue is not a measure of financial performance under GAAP and should not be considered substitutes for GAAP measures, segment revenue for Abacus Life Inc. and Abacus Settlements, LLC, which are considered to be the most directly comparable GAAP measures. This non-GAAP financial measure has limitations as analytical tools, and when assessing Company’s operating performance, thisnon-GAAP financial measures should not be considered in isolation or as substitutes for segment revenue for Abacus Life Inc. and Abacus Settlements, LLC, or other consolidated statements of operations and comprehensive income data prepared in accordance with GAAP.

The Company defines Proforma Segment Revenue as segment revenue for Abacus Life, Inc. plus historical revenue for Abacus Settlements, LLC prior to the Business Combination adjusted for inter-segment activity for policies that Abacus Settlements, LLC has originated on behalf of Longevity Market Assets, LLC. Management believes that Proforma Segment Revenue is an appropriate measure of operating performance because it represents the combined results for the two legacy operating companies, Abacus Settlements, LLC and Longevity Market Assets, LLC year-over-year as if the business combination had occurred at the beginning of the years shown and eliminates inter-segment revenue.
Three Months Ended September 30,Nine Months Ended September 30,
2023202220232022
Portfolio Servicing$224,569 $382,245 $814,626 $1,372,573 
Proforma Active Management18,926,144 12,080,008 46,715,702 29,836,674 
Proforma Originations10,214,489 6,031,481 23,399,165 19,046,144 
Total Proforma Revenue (including intersegment)29,365,202 18,493,734 70,929,493 50,255,391 
     Intersegment elimination(8,244,272)(955,000)(15,038,913)(1,425,200)
Total Proforma Revenue21,120,930 17,538,734 55,890,580 48,830,191 

Proforma Segment Revenue for the three months ended September 30, 2023 was $21,120,930 compared to $17,538,734for the three months ended September 30, 2022. The increase of $3,582,196, or 20.4%, in Proforma Segment revenue is primarily due to an increase in Active Management revenue and Originations revenue, prior to the inter-segment elimination.

Proforma Segment Revenue for the nine months ended September 30, 2023 was $55,890,580 compared to $48,830,191 for the nine months ended September 30, 2022. The increase of $7,060,389 or 14.5% in Proforma Segment revenue is primarily due to an increase in Active Management revenue and Originations revenue, prior to the inter-segment elimination.

84

Table of Contents
Liquidity and Capital Resources

The Company finances its operations primarily through cash generated from operations and net proceeds from debt or equity financing. The Company actively managemanages its working capital and the associated cash requirements when servicing policies while also effectively utilizing cash and other sources of liquidity to purchase additional policies.policies. As of JuneSeptember 30, 2023, our principal sourcessource of liquidity was cash totaling $20,611,122.$36,649,190. During the sixnine months ended JuneSeptember 30, 2023, Abacus Life, Inc.the Company had a net income attributable to Abacus Life, Inc. of $14,348,345$15,739,009 and during the sixnine months ended JuneSeptember 30, 2022, Abacus Life, Inc.the Company had a net income attributable to Abacus Life, Inc. of $11,515,698.$21,507,702. During the sixnine months ended JuneSeptember 30, 2023, and 2022, Abacus Life, Inc.the Company had a netused $51,176,074and $6,395,331 in cash used infor operations, of $38,364,171 and $4,751,170, respectively.

AsThe Company is obligated to provide financial support to the Providers as described above, Abacus Life, Inc. has entered into an SSES within Note 2 and Note 11 of the Providers.Company’s financial statements. Since inception of the SSES on January 1, 2021 through December 31, 2021, Abacus Life, Inc.the Company had incurred $120,000 related to initial funding of operations, and $0 related to expenses. As of JuneFor the three month and nine month ended September 30, 2023, Abacus Life, Inc. did notthe Company incurred expense of $0 and rel$29,721, respectively,ated expenses to fund the Providers’ deficits. Additionally,In 2022, the Providers reimbursed Abacus Life, Inc.the Company for the initial funding of $120,000 but have not reimbursed other expenses paid by Abacus Life, Inc. on behalf of the Providers in 2022.$120,000. For the three months and sixnine months ended JuneSeptember 30, 2023, the Providers were considered to be VIEs, but were not consolidated in our consolidated financial statements due to a lack of the power criterion or the losses/benefits criterion.

Our future capital requirements will depend on many factors, including our revenue growth rate and the expansion of our active management and portfolio activities. Abacus Life, Inc. may, in the future, enter into arrangements to acquire or invest in complementary businesses, products and technologies. Abacus Life, Inc. may be required to seek additional equity or debt financing.

Cash Flows from our operations

The following table summarizes our cash flows for the periods presented:

Six Months Ended June 30,
20232022
Net cash used in operating activities$(38,364,171)$(4,751,170)
Net cash used in investing activities(7,060,627)(250,000)
Net cash provided by financing activities35,983,097 7,744,154

Nine Months Ended September 30,
20232022
Net cash used in operating activities$(51,176,074)$(6,395,331)
Net cash provided/(used) in investing activities2,569,437 (1,932,664)
Net cash provided by financing activities55,203,004 12,069,661 
Operating Activities

During the sixnine months ended JuneSeptember 30, 2023, our operating activities used $38,364,171$51,176,074 of net cash as compared to $4,751,170$6,395,331 of net cash used from operating activities during the sixnine months ended JuneSeptember 30, 2022. The increase in net cash used from operating activities during the sixnine months ended JuneSeptember 30, 2023 compared to the sixnine months ended JuneSeptember 30, 2022, was primarily due to purchases of $39,556,677 $55,516,357 net cash used to purchase life settlement policies accounted for at fair value and $11,374,605$5,601,493 net cash used to purchase life settlement policies accounted for at cost during the sixnine months ended JuneSeptember 30, 2023, partially offset by $3,163,451 in higher operational expense accruals and $4,583,632 of non-cash stock-based compensation, compared to purchases of $7,211,509$7,105,000 life settlement polices accounted for at fair value and $7,204,753$61,876,742 life settlement polices accounted for at cost, partially offset by $45,456,779 in higher operational expense accruals and receipts from active management services, during the sixnine months ended in JuneSeptember 30, 2022.

85

Table of Contents
Investing Activities

During the sixnine months ended Juneended September 30, 2023, investing activities used $7,060,627provided $2,569,437 of net cash as compared to $250,000$1,932,664 net cash used during the sixnine months ended JuneSeptember 30, 2022. $7,060,627$2,569,437 of net cash usedprovided in investinginvesting activities during the sixnine months ended JuneSeptember 30, 2023, was related to paymentsreceipts of $6,760,627 due$3,016,158 from affiliates, $350,000 used to purchase other investments, and $300,000 of net cash was$96,721 used for theto purchase of other investments. $250,000equipment. $1,932,664 of net cash used in investing activities during the sixnine months ended JuneSeptember 30, 2022, $1,682,664 was relatedused to therepay affiliates and $250,000 was used to purchase of other investments.

67

Table of Contents
Financing Activities

During the sixnine months ended JuneSeptember 30, 2023, financing activities generated $35,983,097$55,203,004 of net cash as compared to $7,744,154 of $12,069,661 of net cash generated during the sixnine months ended JuneSeptember 30, 2022. The increase of $28,238,943 $43,133,343 in net cash generated in financing activities during the sixnine months ended JuneSeptember 30, 2023 compared to JuneSeptember 30, 2022, was mainly related to the proceeds of $25,000,000 received from the SPV Purchase and Sale Note as well as $35,206,351$87,478,232 from the issuance of debt certificates, offset by $23,533,072$23,533,073 of capital distributions to members and $10,841,551 in transaction costs during JuneSeptember 30, 2023.

Contractual Obligations and Commitments

Our significant contractual obligations as of JuneSeptember 30, 2023, include three notes, LMATTSTM 2024, LMATTSTM 2.2024, and LMATTSTM 1.2026. The $10,166,900 LMATTSTM 2024 notes are a market-indexed instrument designed to provide upside performance exposure of the S&P 500 Index, while limiting downward exposure. Upon maturity of the notes in 2024, the principal, plus the return based upon the S&P 500 Index must be paid. The notes have a feature to protect debt holders from market downturns, up to 40%. Any subsequent losses below the 40% threshold will reduce the notes. The notes do not pay interest to the holders.holders. As of JuneSeptember 30, 2023, $9,866,900 $9,866,900 of the principal amount remained outstanding.

The $2,333,391 LMATTSTM 2.2024 notes are market-indexed instruments designed to provide upside performance exposure of the S&P 500 Index, while limiting downward exposure. Upon maturity of the notes in 2024, the principal, plus the return based upon the S&P 500 Index must be paid. The notes have a feature to protect debt holders from market downturns, up to 20%. Any subsequent losses below the 20% threshold will reduce the notes. The notes do not pay interest to the holders.holders. As of JuneSeptember 30, 2023, the entire$2,333,391 principal amount remained outstanding.

The $400,000 LMATTSTM 1.2026 notes are market-indexed instruments designed to provide upside performance exposure of the S&P 500 Index, while limiting downward exposure. Upon maturity of the notes in 2026, the principal, plus the return based upon the S&P 500 Index must be paid. The notes have a feature to protect debt holders from market downturns, up to 10%. Any subsequent losses below the 10% threshold will reduce the notes. The notes pay annual interest of 4% on invested capital to the holders. As of JuneSeptember 30, 2023, the entire$400,000 principal amount remained outstanding.


86

Table of Contents
Additionally, LMA Income Series, GP, LLC, wholly owned and controlled by that LMA Series, LLC, formed a limited partnership, LMA Income Series, LP and issued partnership interests to limited partners in a private placement offering. The initial term of the offering is three years with the ability to extend for two additional one-year periods at the discretion of the general partner, LMA Income Series, GP, LLC. The limited partners will receive an annual dividend of 6.5%paid quarterly and 25% of returns in excess of a 6.5% internal rate of return capped at a 15% net internal rate of return. The General Partner will receive 75% of returns in excess of a 6.5% internal rate of return to limited partners then 100% in excess of a 15% net internal rate of return. It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series, LP and thus has fully consolidated the limited partnership in its consolidated financial statements for the year ended December 31, 2022, and interim condensed consolidated financial statements for the three and sixnine months ended JuneSeptember 30, 2023.

During the three months ended March 31, 2023, LMA Income Series II, GP, LLC, wholly owned and controlled by that LMA Series, LLC, formed a limited partnership, LMA Income Series II, LP and issued partnership interests to limited partners in a private placement offering. The initial term of the offering is three years with the ability to extend for two additional one-year periods at the discretion of the general partner, LMA Income Series II, GP, LLC. The limited partners will receive annual dividends equal to the Preferred Return Amounts as follows: Capital commitment less than $500,000, 7.5%; between $500,000 and $1,000,000, 7.75%7.8%; over $1,000,000, 8%. Thereafter, 100% of the excess to be paid to the General Partner. It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series, LP and thus has
68

Table of Contents
fully consolidated the limited partnership in its consolidated financial statements for the three and sixnine months ended JuneSeptember 30, 2023.

The private placement offerings proceeds for both LMA Income Series, LP and LMA Income Series II, LP will be used to acquireacquire an actively managed large and diversified portfolio of financial assets. Abacus Life, Inc. elected to account for the secured borrowings at fair value under the collateralized financing entity guidance within ASC 810-10-30. As of JuneSeptember 30, 2023, the fair value of the LMA Income Series, LP secured borrowing was $22,124,676.$22,242,291. As of JuneSeptember 30, 2023, the fair value of the LMA Income Series II, LP secured borrowing was $20,041,851.$24,535,851.

Additionally, Abacus Life, Inc. has operating lease obligations, which are included as liabilities on our balance sheet, for our office space. As of JuneSeptember 30, 2023, operating lease obligations were $244,425$173,799 with $227,561$173,799 due in less than one year and $16,864 $0 due within one to three years, which are comprised of the minimum commitments for our office space.

Critical Accounting Policies and Estimates

Abacus Life, Inc. hasThe Company prepared ourits consolidated financial statements in accordance with GAAP. Our preparation of these financial statements requires us to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities and related disclosures at the date of the financial statements, as well as revenue and expense recorded during the reporting periods. Abacus Life, Inc.The Company evaluates our estimates and judgments on an ongoing basis. Abacus Life, Inc.The Company bases ourits estimates on historical experience and or other relevant assumptions that Abacus Life, Inc.the Company believes to be reasonable under the circumstances. Actual results may differ materially from management’s estimates.

While our significant accounting policies are described in more detail in Note 2 to our consolidated financial statements included in this Quarterly Report on Form 10-Q, Abacus Life, Inc.the Company believes the following accounting policies to be critical to the judgments and estimates used in the preparation of our financial statements.

87

Table of Contents
Longevity Market Assets Target-Term Series (LMATTSTM) Note

On March 31, 2022, LMATT Series 2024, Inc., which Abacus Life, Inc. consolidates for financial reporting, issued approximately $10,166,900 in market-indexed private placement notes. The notes, LMATTSTM 2024, are market-indexed instruments designed to provide upside performance exposure of the S&P 500 Index, while limiting downward exposure. Upon maturity of the notes in 2024, the principal, plus the return based upon the S&P 500 Index must be paid. The notes have a feature to protect debt holders from market downturns, up to 40%. Any subsequent losses below the 40% threshold will reduce the notes. The notes do not pay interest to the holders.holders. As of JuneSeptember 30, 2023, $9,866,900$9,866,900 of the principal amount remained outstanding.

On September 16, 2022, LMATT Growth Series, Inc., which Abacus Life, Inc. consolidates for financial reporting, issued approximately $2,333,391 in market-indexed private placement notes. The notes, LMATTSTM 2.2024, are market-indexed instruments designed to provide upside performance exposure of the S&P 500 Index, while limiting downward exposure. Upon maturity of the notes in 2024, the principal, plus the return based upon the S&P 500 Index must be paid. The notes have a feature to protect debt holders from market downturns, up to 20%. Any subsequent losses below the 20% threshold will reduce the notes. The notes do not pay interest to the holders.holders. As of JuneSeptember 30, 2023, the entire $2,333,391 principal amount remained outstanding.

On September 16, 2022, LMATT Growth and Income Series, Inc., which Abacus Life, Inc. consolidates for financial reporting, issued approximately $400,000 in market-indexed private placement notes. The notes, LMATTSTM 1.2026, are market-indexed instruments designed to provide upside performance exposure of
69

Table of Contents
the S&P 500 Index, while limiting downward exposure. Upon maturity of the notes in 2024, the principal, plus the return based upon the S&P 500 Index must be paid. The notes have a feature to protect debt holders from market downturns, up to 10%. Any subsequent losses below the 10% threshold will reduce the notes. The notes pay an annual 4% interest rate on invested capital to the holders. As of JuneSeptember 30, 2023, the entire$400,000 principal amount remained outstanding.

Abacus Life, Inc. has elected the fair value option in accounting for the instruments. Fair value is determined using Level 3 inputs. The valuation methodology is based on the Black-Scholes-Merton option-pricing formula and a discounted cash flow analysis. Inputs to the Black-Scholes-Merton model include (i) the S&P 500 Index price, (ii) S&P 500 Index volatility, (iii) a risk-free rate based on data published by the US Treasury, and (iv) a term assumption based on the contractual term of the LMATTTM note. The discounted cash flow analysis includes a discount rate that is based on the implied discount rate assumption developed by calibrating a valuation model to the purchase price on the initial investment date. The implied discount rate is evaluated for reasonableness by benchmarking it to yields on actively traded comparable securities.

For the three months ended JuneSeptember 30, 2023, Abacus Life, Inc. has recognized a lossgain of $620,085$1,293,945 and a loss of $765,591$ 753,978 for the LMATTSTM 2024, Inc. notes and LMATTSTM Growth Series, Inc. notes respectively on the change in fair value fair value of the debt resulting from risk-free valuation scenarios, which is included within (gain) loss on change in fair value of debt within the interim Condensed Consolidated Statement of Operations. For the sixnine months ended JuneSeptember 30, 2023, Abacus Life, Inc. has recognized a loss of $1,305,293$11,349 and a loss of $1,033,816$279,838 for the LMATTSTM 2024, Inc. notes and LMATTSTM Growth Series, Inc. notes, respectively on the change in fair value fair value of the debt resulting from risk-free valuation scenarios, which is included withinwithin (gain) loss on change in fair value of debt within the interim Condensed Consolidated Statement of Operations.

88

Table of Contents
Longevity Market Assets Income Series, LP

On November 30, 2022, LMA Income Series, GP, LLC, wholly owned and controlled by that LMA Series, LLC, which Abacus Life, Inc. consolidates, formed a limited partnership, LMA Income Series, LP and issued partnership interests to limited partners in a private placement offering. It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series, LP and thus has fully consolidated the limited partnership in its consolidated financial statements for the year ended December 31, 2022. The limited partners will receive an annual dividend of 6.5% paid quarterly and 25% of returns in excess of a 6.5% internal rate of return capped at 9% which would require a 15% net internal rate of return. The General Partner will receive 75% of returns in excess of a 6.5% internal rate of return to limited partners then 100% in excess of a 15% net internal rate of return. The general partner committed $250,000, with the limited partners contributing $17,428,349. Additional limited partner contributions of $4,461,095 were raised in the first quarter of 2023 bringing the total deposit amount to $22,139,444.

The private placement offerings proceeds were used to acquire an actively managed large and diversified portfolio of financial assets. Abacus Life, Inc., through its consolidated subsidiaries, serves as the portfolio manager for the financial asset portfolio, which includes investment sourcing and monitoring. In this role, Abacus Life, Inc. has the unilateral ability to acquire and dispose of any of the above investments. Abacus Life, Inc. elected to account for the secured borrowing at fair value under the collateralized financing entity guidance within ASC 810-10-30. As of JuneSeptember 30, 2023, the fair value of the secured borrowing, not including the $250,000$250,000 committed from the general partner, was $22,124,676$22,242,292 and there was no gain or loss recognized.

Longevity Market Assets Income Series II, LP

On January 31, 2023, LMA Series, LLC, a wholly owned subsidiary of the Company, signed an Operating Agreement to be the sole member of a newly created general partnership, LMA Income Series II, GP, LLC. Subsequent to that, LMA Income Series II, GP, LLC formed a limited partnership, LMA Income Series II, LP
70

Table of Contents
and issued partnership interests to limited partners in a private placement offering. It was determined that LMA Series, LLC is the primary beneficiary of LMA Income Series II, LP and thus has fully consolidated the limited partnership in its consolidated financial statements for the three months ended June 30, 2023. The limited partners will receive annual dividends equal to the preferred return amounts as follows: Capital commitment less than $500,000, 7.5%; between $500,000 and $1,000,000, 7.75%7.8%; over $1,000,000, 8%. Thereafter, 100% of the excess to be paid to the General Partner.

The private placement offerings proceeds were used to acquire an actively managed large and diversified portfolio of financial assets. Abacus Life, Inc., through its consolidated subsidiaries, serves as the portfolio manager for the financial asset portfolio, which includes investment sourcing and monitoring. In this role, Abacus Life, Inc. has the unilateral ability to acquire and dispose of any of the above investments. Abacus Life, Inc. elected to account for the secured borrowing at fair value under the collateralized financing entity guidance within ASC 810-10-30.810-10-30. As of JuneSeptember 30, 2023, the fair value of the secured borrowing, not including the commitment from the general partner, was $20,041,851$24,535,851 and there was no gain or loss recognized.

Valuation of Life Insurance Policies

Abacus Life, Inc. accounts for its holdings of life insurance settlement policies at fair value in accordance with ASC 325-30, Investments in Insurance Contracts. Any resulting changes in estimates are reflected in operations in the period the change becomes apparent.

89

Table of Contents
Abacus Life, Inc. follows ASC 820, Fair Value Measurements and Disclosures, in estimating the fair value of its life insurance policies, which defines fair value as an exit price representing the amount that would be received if an asset were sold or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the guidance establishes a three-level, fair value hierarchy that prioritizes the inputs used to measure fair value. Level 1 relates to quoted prices in active markets for identical assets or liabilities. Level 2 relates to observable inputs other than quoted prices included in Level 1. Level 3 relates to unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Abacus Life, Inc.'s valuation of life settlements is considered to be Level 3, as there is currently no active market where Abacus Life, Inc. is able to observe quoted prices for identical assets. Abacus Life, Inc.'s valuation model incorporates significant inputs that are not observable.

The aggregate face value of policies held at fair value is approximately $195,205,585$303,605,030 as of JuneSeptember 30, 2023, with a corresponding fair value of approximately $56,685,617. Aggregate$83,585,374. The aggregate face value of policies accounted for using the investment method is $39,520,877$37,300,000 as of JuneSeptember 30, 2023, with a corresponding carrying value of approximately $9,889,610.$4,116,499.

Equity Investments in Privately-Held Companies

Equity investments without readily determinable fair values include our investments in privately-held companies in which Abacus Life, Inc. holds less than a 20% ownership interest and does not have the ability to exercise significant influence. Abacus Life, Inc. determines fair value using level 3 inputs under the measurement alternative. These investments are recorded at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.

In addition, Abacus Life, Inc. monitors these investments to determine if impairment charges are required based primarily on the financial condition and near-term prospects of these companies.companies. As of JuneSeptember 30, 2023, Abacus Life, Inc. did not identify any impairment indicators and determined that the carrying value
71

Table of Contents$
of $1,600,0001,650,000 is the fair value for these equity investments in privately held companies, given that there have been no observable price changes.

Available-For-Sale Securities

Abacus Life, Inc. has investments in securities that are classified as available-for-sale securities, and which are reflected on the Consolidated Balance Sheets at fair value. These securities solely consist of a convertible promissory note in a private company that was entered into an arms-length. Abacus Life, Inc. determines the fair value using unobservable inputs by considering the initial investment value, next round financing, and the likelihood of conversion or settlement based on the contractual terms in the agreement. Unrealized gains and losses on these investments are included as a separate component of accumulated other comprehensive loss, net of tax, on the Consolidated Balance Sheets. Abacus Life, Inc. classifies its available-for-sale securities as short-term or long-term based on the nature of the investment, its maturity date and its availability for use in current operations. Abacus Life, Inc. monitors its available-for-sale securities for possible other-than-temporary impairment when business events or changes in circumstances indicate that the carrying value of the investment may not be recoverable. As of JuneSeptember 30, 2023, Abacus Life, Inc. evaluated the fair value of its investment and determined that the fair value approximates the carrying value of $1,000,000,$1,000,000, and no unrealized gains and losses were recorded.

Quantitative and Qualitative Disclosures About Market Risk

Not required for smaller reporting companies.

JOBS Act Election

Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable.

Abacus Life, Inc. has irrevocably elected to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, Abacus Life, Inc., as an emerging growth company, will adopt the new or revised standard at the time public companies adopt the new or revised standard. As a result, following the consummation of the Business Combination, Abacus Life, Inc. will comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies.


7290

Table of Contents

ABACUS SETTLEMENTS, LLC MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis provide information that management believes is relevant to an assessment and understanding of Abacus’Abacus Settlements, LLC’s financial condition and results of operations. This discussion should be read in conjunction with Abacus’Abacus Settlements, LLC’s financial statements and related notes thereto that appear elsewhere in this Quarterly Report.

In addition to historical financial analysis, this discussion and analysis contains forward-looking statements based upon current expectations that involve risks, uncertainties and assumptions, as described under the heading “Cautionary Note Regarding Forward-Looking Statements.” Actual results and timing of selected events may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under “Risk Factors” or elsewhere in this quarterly statement. Unless the context otherwise requires, references in this “Abacus Settlements, LLC Management’s Discussion and Analysis of Financial Condition and Results of Operations” to “we,” “us,” “our,” and “Abacus” are intended to mean the business and operations of Abacus Settlements, LLC.LLC..

Overview

Abacus originates life insurance policy settlement contracts as a licensed life settlement provider on behalf of third-party institutional investors (“Financing Entities”) interested in investing in the life settlement asset class. Specifically, Abacus originates policies through three primary origination channels (Agents/Financial Advisors, Direct-to-Consumers, Life Settlement Brokers) and Third-Party Intermediaries,Intermediaries. Abacus screens them for eligibility by verifying that the policy is in force, obtaining consents and disclosures, and submitting cases for life expectancy estimates. This process is characterized as our origination services, which averages a fee of approximately 2% of face value (“Origination Revenue”).

Our Business Model

As a life settlement provider, Abacus serves as a purchaser of outstanding life insurance policies. When serving as a purchaser, Abacus’ primary purpose in the transaction is to connect buyers and sellers through an origination process. The origination process is core to Abacus’ business and drives its economics. Abacus averages approximately 2% of face value in origination fees on policies and has developed three high quality origination channels which include agents and Financial Advisors, direct to consumer and Life Settlements Brokers. Abacus also originates policies with Third-Party Intermediaries. Generally, diversification across multiple origination channels lowers average policy acquisition costcosts and increases estimated returns. Abacus finds sellers through its origination channels using strategic marketing practices in its core markets, with the purpose of finding policy owners who want to capitalize on their investments prior to death by extracting value from their policies through the sale of such policies to Financing Entities.

Key Factors Affecting Our Performance

Our operations and financial performance are impacted by economic factors affecting the industry, including:


91

Table of Contents
Opportunities in the Life Settlements Industry

Within the life settlements industry, there is significant policy value that lapses on an annual basis. Currently, the life settlements industry only captures a narrow portion of the potential market leaving significant runway for future growth for industry participants. With the anticipation of growth in total face value of life insurance policies, we believe we are well positioned to capitalize on the overall market growth. Abacus is currently conducting business in 49 states and the District of Columbia. The company holds viatical settlement and or life settlement provider licenses in forty-three (43) of those jurisdictions. Abacus also conducts business in seven (7) jurisdictions which do not currently have life and or viatical settlement provider licensing requirements. Abacus conducts business where is it legally allowed to across the United States. The
73

Table of Contents
only state Abacus is not currently conducting business in is Alaska and there are no current plans to procure a license.
Our ability to originate policies is essential to scale our business over time. In order to support this expected growth, we continue to invest in our technology and marketing infrastructure. In general, we expect our efforts will continue to focus on driving education and awareness of life settlements. In order to meet this growing demand, we have increased our total headcount by 18% since December, 2022, and anticipate a total of 36% growth of our total headcount from December 31, 2022 to December 31, 2024, of which 18% has already been captured.

Macroeconomic Changes

Global macroeconomic factors, including regulatory policies, unemployment, changes in retirement savings, the cost of healthcare, inflation, and tax rate changes impact demand for our origination services. These factors evolve over time and while these changes have not currently made any significant impact on performance, these trends may shift the timing and volume of transactions, or the number of customers using our origination services.

Components of Results of Operations

Results of Operations

The following tables set forth our results of operations for each of the periods indicated, and we presented and expressed the relationship of certain line items as a percentage of revenue for those periods. The period-to-period comparison of financial results is not necessarily indicative of future results.


92

Table of Contents
The following tables set forth our historical results for the periods indicated, and the changes between periods:

Three Months Ended June 30,Six Months Ended June 30,
2023202220232022
Origination revenue$1,689,088 $743,388 $3,252,738 $3,185,068 
Related-party revenue5,195,602 4,948,528 9,931,938 9,829,596
Total revenue6,884,6905,691,916 13,184,67613,014,664
Cost of revenue1,505,333 956,625 2,734,949 3,265,313
Related party cost of revenue3,392,647 2,615,307 6,558,354 5,522,312
Gross profit1,986,7102,119,984 3,891,373 4,227,039
Operating expenses
General and administrative expenses2,297,5772,208,051 4,848,5803,948,358
Depreciation expense2,5613,048 5,5975,988
Total operating expenses2,300,1382,211,099 4,854,1773,954,346
Income (loss) from operations(313,428)(91,115)(962,804)272,693
Other income (expense)
Interest income1,193599 1,9171,147
Interest (expense)(5,863)— (11,725)— 
Other income— 273 — 273 
Total other income (expense)(4,670)872 (9,808)1,420
Income (loss) before income taxes(318,098)(90,243)(972,612)274,113
74

Table of Contents
Provision for income taxes— — 2,2891,325
Net income (loss) and comprehensive income$(318,098)$(90,243)$(974,901)$272,788 

Three Months Ended
June 30
Three Months Ended
September 30
Six Months Ended
June 30
Nine Months Ended
September 30
2023202220232022
Origination revenue$1,689,088 $1,766,853 $3,252,738 $4,951,921 
Related-party revenue5,195,602 4,264,628 9,931,938 14,094,223 
Total revenue6,884,690 6,031,481 13,184,676 19,046,144 
Cost of revenue1,505,333 933,089 2,734,949 4,198,402 
Related party cost of revenue3,392,647 2,930,990 6,558,354 8,453,302 
Gross profit1,986,710 2,167,401 3,891,373 6,394,440 
Operating expenses
General and administrative expenses2,297,577 2,284,061 4,848,580 6,232,419 
Depreciation expense2,561 3,161 5,597 9,149 
Total operating expenses2,300,138 2,287,222 4,854,177 6,241,568 
Income (loss) from operations(313,428)(119,820)(962,804)152,872 
Other income (expense)
Interest income1,193 358 1,917 1,505 
Interest (expense)(5,863)(2,954)(11,725)(2,954)
Other income— — — 273 
Total other (expense)(4,670)(2,596)(9,808)(1,176)
Income (loss) before income taxes(318,098)(122,417)(972,612)151,696 
Provision for income taxes— 582 2,289 1,907 
Net income (loss) and comprehensive income$(318,098)$(122,999)$(974,901)$149,789 
Origination Revenue

Abacus recognizes revenue from origination activities by acting as a provider of life settlements and viatical settlements by representing investors that are interested in purchasing life settlements on the secondary or tertiary market. Revenue from origination services consists of fees negotiated for each purchase and sale of a policy to an investor, which also include any agent and broker commissions received and the reimbursement of transaction costs.
Three Months Ended June 30,
20232022$ Change% Change
Origination revenue$1,689,088 $743,388 $945,700 127 %
Three Months Ended June 30Three Months Ended September 30
20232022
Origination revenue$1,689,088 $1,766,853 


93

Table of Contents
Revenue increased by $945,700, or 127%, for the three months ended June 30, 2023 compared to the three months ended Juneand September 30, 2022. This increase2022 was primarily attributable to higher pricing on the sale$1,689,088 and $1,766,853, respectively, and is comprised of broker policies arising from various factors such as policy death benefits, cash surrender values, life expectancysales commission, origination fees revenue, services revenue, and policyholder age pertaining to the policies sold. These factors resulted in an increase of the commission fee paid to Abacus.transaction fees reimbursements.
Six Months Ended
June 30
Nine Months Ended
September 30
20232022
Origination revenue$3,252,738 $4,951,921 

Six Months Ended June 30,
20232022$ Change% Change
Origination revenue$3,252,738 $3,185,068 $67,670 %

Revenue increased by $67,670, or 2%, for the six months ended June 30, 2023 compared to the sixand nine months ended JuneSeptember 30, 2022. The increase2022 was $3,252,738 and $4,951,921, respectively, and is comprised of revenue in revenue is primarily attributable to an increase in agent and client direct sales during 2023, which is driven by higherbroker channel based on face values on the policies originated with consistent third party customers, origination fees, services revenue, and higher commission flows, partially offset by a decrease in broker sales. The agent, broker, and client direct sales are all in line with normal, recurring business.transaction fees reimbursements.

Related Party Revenue

Abacus has a related party relationship with Nova Trading (US), LLC (“Nova Trading”), a Delaware limited liability company and Nova Holding (US) LP, a Delaware limited partnership (“Nova Holding” and, collectively with Nova Trading, the “Nova Funds”) as the owners of Abacus jointly own 11% of the Nova Funds. PricingThe pricing for origination fees areis governed by origination contracts that have been negotiated by both parties and are considered to be arms-length and consistent with origination fees charged to third party customers. For its origination services to the Nova Funds, Abacus earns origination fees equal to the lesser of (i) 2% of the net death benefit for the policy or (ii) $20,000.
Three Months Ended June 30,
20232022$ Change% Change
Related Party Revenue$5,195,602 $4,948,529 $247,073 %
Three Months Ended
June 30
Three Months Ended
September 30
20232022
Related Party Revenue$5,195,602 $4,264,628 

Related Party Revenue for the three months ended June 30, 2023 and September 30, 2022 was $5,195,602 and $4,264,628, respectively. For the three months ended June 30, 2023 and JuneSeptember 30, 2022, Abacus hashad originated 38 and 9277 policies for the Nova funds with a total value of $56,688,680 and $15,719,830, respectively, and is comprised of origination services to LMA and transaction fees reimbursed by the related party. Further, Abacus had originated 69 policies for LMA with a total value of $114,999,768 for the three months ended June 30, 2023.
Six Months Ended
June 30
Nine Months Ended
September 30
20232022
Related Party Revenue$9,931,938 $14,094,223 

Related party revenue for the six months ended June 30, 2023 was $9,931,938 and $14,094,223, respectively. For six months ended June 30, 2023 and nine months ended September 30, 2022, Abacus had originated 72 and 265 policies for the Nova Funds with a total value of approximately $56,688,680$96,674,080 and $102,307,954 respectively. This decrease in the origination$67,019,830, respectively, and is comprised of Nova Fund policies was partially offset by increases in origination services to Longevity Market Assets, LLC (“LMA”). ForLMA and transaction fees reimbursed by the threerelated party. Further, for the six months ended June 30, 2023, andAbacus had originated 103 policies, for LMA with a total value of $192,685,578.


7594

Table of Contents
June 30, 2022, Abacus has originated 69 and 8 policies, respectively, for LMA with a total value of approximately $114,999,768 and $31,200,000, respectively.

Related party revenue decreased by $247,073, or 5%, for the three months ended June 30, 2023 compared to the three months ended June 30, 2022. The decrease in related party revenue is primarily attributable to decrease in Nova origination sales and transaction fee reimbursement of $2,176,724 and $1,196,167, partially offset by increased LMA originations services of $3,438,539.
Six Months Ended June 30,
20232022$ Change% Change
Related Party Revenue$9,931,938 $9,829,596 $102,342 %

For the six months ended June 30, 2023 and June 30, 2022, Abacus has originated 72 and 183 policies, respectively, for the Nova Funds with a total value of approximately $96,674,080 and $282,804,838, respectively. This decrease in the origination of Nova Fund policies was partially offset by increases in origination services to Longevity Market Assets, LLC (“LMA”). For the six months ended June 30, 2023 and June 30, 2022, Abacus has originated 103 and 8 policies, respectively, for LMA with a total value of approximately $192,685,578 and $31,200,000, respectively.

Related party revenue decreased by $102,342 or 1%, for the six months ended June 30, 2023 compared to the six months ended June 30, 2022. The decrease in related party revenue is primarily attributable to a decrease in Nova origination sales and transaction fee reimbursement of $4,770,057 and $1,284,679, partially offset by increased LMA originations services of $6,324,441.

Cost of Revenue, Related Party Cost of Revenue, and Gross Margin

Cost of revenue is primarily comprised of third-party commissions, which includes third-party sales and marketing commission fees, as well as transaction costs that are reimbursed as part of the origination activity and depreciation and amortization expense. Abacus receives an origination fee plus any commission to be paid from the purchaser for its part in arranging the life settlement transactions. Out of that fee income, Abacus pays commissions to the licensed representative of the seller, if one is required. Commission expense is recorded at the same time revenue is recognized and is included within cost of revenue. Depreciation expense consists of depreciation of property and equipment assets, which are computer equipment. Amortization expense consists primarily of amortization of capitalized costs incurred for the development of internal use software. The costs incurred exclusively consist of fees incurred from an external consulting firm during the development stage of the project and is amortized on the straight-line basis over an estimated useful life of three years.
Three Months Ended June 30,Three Months Ended
June 30
Three Months Ended
September 30
20232022$ Change% Change20232022
Cost of revenueCost of revenue$1,505,333 $956,625 $548,708 57 %Cost of revenue$1,505,333 $933,089 
Related party cost of revenueRelated party cost of revenue3,392,647 2,615,307777,340 30 %Related party cost of revenue3,392,647 2,930,990 
Gross ProfitGross Profit1,986,7102,119,984(133,274)(6)%Gross Profit1,986,710 2,167,402 
Gross MarginGross Margin29%37%Gross Margin29 %36 %

Cost of revenue increased by $548,708 or 57%, for the three months ended June 30, 2023 compared to the three months ended Juneand September 30, 2022. The increase in cost2023 was $1,505,333 and $933,089, respectively, and is comprised of revenue is primarily due to increases in sales-agentssales agent commission, expenses of $838,577, partially offset by a decrease in marketing origination payoutprofessional and consulting fees.

Related party cost of revenue increased by $777,340 or 30%, for the three months ended June 30, 2023 comparedand September 30, 2022 was $3,392,647 and $2,930,990, respectively, and is comprised of LMA agent commission expenses and originations of policies sold to Nova.

Gross profit for the three months ended June 30, 2022. The increase in related2023 and for the three months ended September 30, 2022 was $1,986,710 and $2,167,402, respectively. Gross margin for the three months ended June 30, 2023 and for the three months ended September 30, 2022 was 29% and 36%, respectively.
Six Months Ended
June 30
Nine Months Ended
September 30
20232022
Cost of revenue$2,734,949$4,198,402
Related party cost of revenue6,558,3548,453,302
Gross Profit3,891,3736,394,440
Gross Margin30 %34 %

Cost of revenue for the six months ended June 30, 2023 and for the nine months ended September 30, 2022 was $2,734,949 and $4,198,402 and is comprised of sales agents commission, professional and consulting fees.

Related party cost of revenue for the six months ended June 30, 2023 and for the nine months ended September 30, 2022 was $6,558,354 and $8,453,302 and is primarilycomprised of LMA agent commission expenses, originations of policies sold to the Nova Funds, and transaction fees reimbursements.

7695

Table of Contents
attributable to an increase in LMA agent commission expenses of $2,245,314 partially offset by a decrease in the originations of policies sold to Nova Fund of $1,478,661.

Gross profit decreased by $133,274 or 6%, for the three months ended June 30, 2023 compared to the three months ended June 30, 2022. Gross margin decreased to 29% for the three months ended June 30, 2023 compared to 37% for the three months ended June 30, 2022. The decrease in gross profit and gross margin is primarily due to the increased commission expense per related party policy and correspondingly the decrease in gross margin due to a greater portion of the profit margin allocated to the licensed agent or broker.

Six Months Ended June 30,
20232022$ Change% Change
Cost of revenue$2,734,949$3,265,313$(530,364)(16)%
Related party cost of revenue6,558,3545,522,3121,036,042 19 %
Gross Profit3,891,3734,227,039(335,666)(8)%
Gross Margin30%32%

Cost of revenue decreased by $530,364, or 16%, for the six months ended June 30, 2023 compared toand for the sixnine months ended JuneSeptember 30, 2022. The decrease in cost of revenue is primarily due to decreases in sales-agents commission expenses2022 was $3,891,373 and marketing origination payout.

Related party cost of revenue increased by $1,036,042, or 19%,$6,394,440, respectively. Gross margin for the six months ended June 30, 2023 compared toand for the sixnine months ended JuneSeptember 30, 2022. The increase in related party cost of revenue is primarily attributable to increase in LMA agent commission expenses of $4,634,216 partially offset by a decrease in the originations of policies sold to Nova Fund of $3,368,361.

Gross profit decreased by $335,666, or 8%2022 was 30% and 34%, for the six months ended June 30, 2023, compared to the six months ended June 30, 2022. Gross margin decreased to 30% for the six months ended June 30, 2023, compared to 32% for the six months ended June 30, 2022. The decrease in gross profit and gross margin is primarily due to the increased commission expense per related party policy and correspondingly the decrease in gross margin due to a greater part of the profit margin allocated to the licensed agent or broker.respectively.

Operating Expenses

Operating expenses isare comprised of general and administrative expenses as well as depreciation expense.

General and administrative expenses include compensation, payroll, advertising, marketing, rent, insurance, recruitment, trade shows, telephone & internet, licenses, and other professional fees.

Depreciation expense consists of depreciation of property and equipment assets, which are computer equipment, office furniture and lease improvement.
Three Months Ended June 30,Three Months Ended
June 30
Three Months Ended
September 30
20232022$ Change% Change20232022
General and administrative expensesGeneral and administrative expenses$2,297,577 $2,208,444 $89,133 4%General and administrative expenses$2,297,577 $2,284,061 
Depreciation expenseDepreciation expense2,5613,048(487)(16)%Depreciation expense2,561 3,161 

General and administrative expenses increased by $89,133, or 4%, for the three months ended June 30, 2023 compared to the three months ended June 30, 2022. The increase in general and administrative expenses are primarily due to increases in payroll expenses of $180,520 for administration support as a result of higher employee headcounts, and compensation raises, partially offset by a decrease in payroll expenses of $11,963 for the sales department. There was an increase in marketing expenses of $80,723 due to increased spending in internet advertising. There was also an increase of $57,000 in sponsorships. Rent and office
77

Table of Contents
expense also increased by $15,508 and $34,812 respectively. Salaries and payroll expense, as a percentage of total revenue, represented 23% and 25% for the three months ended June 30, 2023 and September 30, 2022 respectively.was $2,297,577 and $2,284,061, respectively, and is comprised of payroll expenses for administration support and for sales departments, marketing expenses, sponsorship costs, rent costs, office expenses, escrow fees, professional fees, and legal fees.

Depreciation expense decreased by $487, or 16%, for the three months ended June 30, 2023 compared toand for the three months ended JuneSeptember 30, 2022.2022 was $2,561 and $3,161, respectively. The decrease in depreciation expense is primarily due tofor both the declining book value of obsolescentperiods were computed on property and equipment (i.e., computer equipment, office furniture, in normal course of business operations.and leasehold improvements).
Six Months Ended June 30,Six Months Ended
June 30
Nine Months Ended
September 30
20232022$ Change% Change20232022
General and administrative expensesGeneral and administrative expenses$4,848,580 $3,948,358 $900,222 23%General and administrative expenses$4,848,580 $6,232,419 
Depreciation expenseDepreciation expense5,597 5,988 (391)(7)%Depreciation expense5,597 9,149 

General and administrative expenses increased by $900,222, or 23%, for the six months ended June 30, 2023, compared to the six months ended June 30, 2022. The increase in general and administrative expenses are primarily due to increases in payroll expenses of $138,944 for the sales department and $479,068 for administration support as a result of higher employee headcounts, and compensation raises. There was an increase in marketing expenses of $186,987 due to increased spending in internet advertising. There was also an increase of $125,500 in sponsorships. Rent and office expense also increased by $41,271 and $71,688 respectively. Salaries and payroll expense, as a percentage of total revenue, represented 24% and 19% for the six months ended June 30, 2023 and for the nine months ended September 30, 2022 respectively.was $4,848,580 and $6,232,419, respectively, and is comprised of payroll expenses for administration support, sales department, marketing expenses, sponsorships, rent and office expenses.

Depreciation expense decreased by $391, or 7%, for the six months ended June 30, 2023 compared toand for the sixnine months ended JuneSeptember 30, 2022.2022 was $5,597 and $9,149, respectively. The decrease indepreciation expense for both the expense is primarily due to the declining book value of obsolescentperiods were computed on property and equipment (i.e., computer equipment, office furniture, in normal course of business operations.and leasehold improvements).


96

Table of Contents
Other income (expense)

Other income (expense) includes interest income, consulting income, and other income. Interest income represents the interest earned on Abacus’ certificates of deposits. Consulting income represents income earned on various origination consulting services performed. Other income comprises of income from credit card cash rewards.
Three Months Ended June 30,Three Months Ended
June 30
Three Months Ended
September 30
20232022$ Change% Change20232022
Interest incomeInterest income$1,193 $599 $594 99 %Interest income$1,193 $358 
Interest (expense)Interest (expense)(5,863)— (5,863)(100)%Interest (expense)(5,863)(2,954)
Other income— 273 (273)(100)%

Interest income increased by $594, or 99%, for the three months ended June 30, 2023 compared toand for the three months ended JuneSeptember 30, 2022.2022 was $1,193 and $358, respectively. The increase in interest income is primarily due to favorable changes infor both the periods represents interest rate terms for theearned on Abacus certificate of deposit.

Interest expense increased by $5,863, or 100% for the three months ended June 30, 2023 compared to the three months ended Juneand September 30, 2022. The increase in interest expense2022 was $5,863 and 2,954, respectively, and is primarily due to thecomprised of amortization of the deferred financing fees and certificate of deposit fees.

Other income decreased by $273, or 100% for the three months ended June 30, 2023, compared to the three months ended June 30, 2022. The decrease in other income is primarily due to none collected credit card cash rewards during 2023.

Six Months Ended June 30,
20232022$ Change% Change
78

Table of Contents
Six Months Ended
June 30
Nine Months Ended
September 30
20232022
Interest incomeInterest income$1,917 $1,147 $770 67 %Interest income$1,917 $1,505 
Interest (expense)Interest (expense)(11,725)— (11,725)(100)%Interest (expense)(11,725)(2,954)
Other incomeOther income— 273 (273)(100)%Other income— 273 

Interest income increased by $770, or 67%, for the six months ended June 30, 2023 compared toand for the sixnine months ended JuneSeptember 30, 2022.2022 was $1,917 and $1,505, respectively. The increase in interest income is primarily due to favorable changes infor both the periods represents interest rate terms for theearned on Abacus certificate of deposit.

Interest expense increased by $11,725, or 100% for the six months ended June 30, 2023 compared toand for the sixnine months ended JuneSeptember 30, 2022. The increase in interest expense2022 was $11,725 and $2,954, respectively, and is primarily due to thecomprised of amortization of the deferred financing fees.

Other income decreased by $273 or 100%Income for the sixnine months ended JuneSeptember 30, 2023, compared to the six months ended June 30, 2022. The decrease in other income is primarily due to none collected credit card cash rewards during 2023.2022 was $273.

Provision for Income Taxes
Three Months Ended June 30,
20232022$ Change% Change
Provision for income taxes$— $— $— — %
Three Months Ended
June 30
Three Months Ended
September 30
20232022
Provision for income taxes$— $582 

Provision for income taxes reflected no change for the three months ended June 30, 2023 compared towas $0. Provision for income taxes for the three months ended JuneSeptember 30, 2022.2022 was $582. This amount is primarily attributable to annual report filing fees with various states.

Six Months Ended June 30,
20232022$ Change% Change
Provision for income taxes$2,289 $1,325 $964 73%
97

Table of Contents
Six Months Ended
June 30
Nine Months Ended
September 30
20232022
Provision for income taxes$2,289 $1,907 

Provision for income taxes increased by $964, or 73%, for the six months ended June 30, 2023 compared toand for the sixnine months ended JuneSeptember 30, 2022. These2022 was $2,289 and $1,907, respectively. The amounts for both the periods are primarily LLC annual report filing fees within thewith various states.

Business Segments

Operating as a centrally led life insurance policy intermediary, Abacus’ Chief Executive Officer is the Chief Operating Decision Maker (CODM) who allocates resources and assesses financial performance. As a result of this management approach, Abacus is organized as a single operating segment. The CODM reviews performance and allocates resources based on the total originations, total corresponding revenue generated for the period, gross profit, and adjusted EBITDA.

Key Business Metrics and Non-GAAP Financial Measures

Management uses non-GAAP financial measures, in conjunction with GAAP financial measures, as an integral part of managing our business and to, among other things: (i) monitor and evaluate the performance of our business operations and financial performance; (ii) facilitate internal comparisons of the historical operating performance of our business operations; (iii) review and assess the operating performance of our management team; (iv) analyze and evaluate financial and strategic planning decisions regarding future operating investments; and (v) plan for and prepare future annual operating budgets and determine appropriate levels of operating investments.

We monitor the following key business metrics and non-GAAP financial measures that assist us in evaluating our business, measuring our performance, identifying trends and making strategic decisions. As
79

Table of Contents
such, we have presented the following non-GAAP measure, their most directly comparable U.S. GAAP measure, and key business metrics:

Non-GAAP MeasureComparable U.S. GAAP Measure
Adjusted EBITDANet Income

Adjusted EBITDA is net income adjusted for depreciation expense, provision for income taxes, interest income, and non-recurring items that in our judgement significantly impact the period-over-period assessment of performance and operating results. Adjusted EBITDA should not be construed as an indicator of our operating performance, liquidity, or cash flows provided by or used in operating, investing, and financing activities, as there may be significant factors or trends that it fails to address. We caution investors that non-GAAP financial information departs from traditional accounting conventions. Therefore, its use can make it difficult to compare current results with results from other reporting periods and with the results of other companies.


98

Table of Contents
Management believes the use of Adjusted EBITDA measures assists investors in understanding the ongoing operating performance by presenting comparable financial results between periods. We believe that by removing the impact of depreciation and amortization, amounts spent on interest and taxes and certain other non-recurring income and charges that are highly variable from year to year, Adjusted EBITDA provides our investors with performance measures that reflect the impact to operations from trends in changes in revenue and operating expenses, providing a perspective not immediately apparent from net income and operating income. The adjustments we make to derive the non-GAAP measure of Adjusted EBITDA exclude items which may cause short-term fluctuations in net income and operating income and which we do not consider to be the fundamental attributes or primary drivers of our businessbusiness.

The following table illustrates the reconciliations from net income to adjusted EBITDA for the three months ended June 30, 2023, and the three months ended September 30, 2022 and for the six months ended June 30, 2023, and the nine months ended September 30, 2022:

Three Months Ended June 30,Six Months Ended June 30,Three Months Ended
June 30
Three Months Ended
September 30
Six Months Ended
June 30
Nine Months Ended
September 30
20232022202320222023202220232022
Net income (loss) and comprehensive incomeNet income (loss) and comprehensive income$(318,098)$(90,243)$(974,901)$272,788 Net income (loss) and comprehensive income$(318,098)$(122,999)$(974,901)$149,789 
Depreciation expenseDepreciation expense2,5613,0485,5975,988Depreciation expense2,561 3,161 5,597 9,149 
Provision for income taxesProvision for income taxes— — 2,2891,325Provision for income taxes— 582 2,289 1,907 
Interest incomeInterest income(1,193)(599)(1,917)(1,147)Interest income(1,193)(358)(1,917)(273)
Interest expenseInterest expense5,863— 11,725— Interest expense5,863 2,954 11,725 1,449 
Adjusted EBITDAAdjusted EBITDA$(310,867)$(87,794)$(957,207)$278,954 Adjusted EBITDA$(310,867)$(116,660)$(957,207)$162,021 

Adjusted EBITDA for the three months ended June 30, 2023 and September 30, 2022 was $(310,867) compared to $(87,794) for the three months ended June 30, 2022. This decrease was attributable to lower revenues and gross profit during second quarter of 2023 as well as increased general and administrative costs including payroll, legal and marketing expenses for three months ended June 30, 2023.$(116,660), respectively.

Adjusted EBITDA for the six months ended June 30, 2023, was $(957,207), compared to $278,594 and for the sixnine months ended JuneSeptember 30, 2022. This decrease2022 was attributable to higher costs of revenue primarily driven by higher commission expense during 2023 as well as increased general and administrative costs and interest expense for the six months ended June 30, 2023.$162,021.

We monitor the following key business metrics such as the number of policies originated year-over-year in measuring our performance. Origination revenues represent fees negotiated for each purchase and sale of a policy to an investor. The number of policy originations represents the volume of policies over which the above origination services are performed. The number of policy originations directly correlates with
80

Table of Contents
origination revenues allowing management to evaluate fees earned upon each transaction. There are no estimates, assumptions, or limitations specific to the number of policy originations.
Three Months Ended June 30,% ChangeSix Months Ended June 30,% Change
2023202220232022
Number of Policy Originations141 135 %253 259 (2)%
Three Months Ended
June 30
Three Months Ended
September 30
Six Months Ended
June 30
Nine Months Ended
September 30
2023202220232022
Number of Policy Originations141 112 253 371 


99

Table of Contents
Liquidity and Capital Resources

We have financed operations since our inception primarily through customer payments and net proceeds from equity financingsfinancing in the form of capital contributions from our members. Our principal (uses)uses of cash and cash equivalents in recent periods have been funding our operations. As of June 30, 2023 and JuneSeptember 30, 2022, our principal sources of liquidity were cash and cash equivalents and restricted cash totalingof $808,226 and $1,439,522, respectively,$919,424 and we had retained earnings of $509,953 and $2,251,914,$2,127,476, respectively. During the three months ended June 30, 2023, we had a net (loss)loss of $(318.098),$(318,098) and net cash provided by operations of $20,655. During the six months ended June 30, 2023, we had a net (loss)loss of $(974,901), and net cash (used)used by operations of $24,292.($24,292). We believe our existing cash and cash equivalents restricted cash,as well as proceeds from equity financingsfinancing will be sufficient to fund anticipated cash requirements for the next twelve months.

Our future capital requirements will depend on many factors, including our revenue growth rate, the expansion of our sales and marketing activities, the timing and extent of spending to support product development efforts. We may, in the future, enter into arrangements to acquire or invest in complementary businesses, products and technologies. We may be required to seek additional equity or debt financing. The additional debt financing would result in debt service obligations, and any future instruments governing such debt could provide for operating and financing covenants that could restrict our operations.

Cash Flows

Cash Flows for the Six Months Ended June 30, 2023 and Nine Months Ended September 30, 2022:

The following table summarizes our cash flows for the six months ended June 30, 2023 and nine months ended September 30, 2022:
Six Months Ended June 30,
20232022
Net cash (used) in operating activities(24,292)(452,367)
Net cash (used) in investing activities(182,528)(35,687)
Net cash (used) in financing activities(443,694)(671,726)
Six Months Ended
June 30
Nine Months Ended
September 30
20232022
Net cash used in operating activities$(24,292)$(875,892)
Net cash used in investing activities(182,528)(130,821)
Net cash used in financing activities(443,694)(673,165)

Operating Activities

During the six months ended June 30, 2023 and the nine month ended September 30, 2022, our operating activities (used) $(24,292)used $24,292 and $875,892 of net cash as compared to net cash (used)used in operating activities, of $(452,367) during the six months ended June 30, 2022. The decrease in net cash from operating activities during six months ended June 30, 2023, compared to six months ended June 30, 2022, was primarily due to decreases in contract liabilities. The timing of revenue recognition, customer billing, and cash collection can result in billed accounts receivable, unbilled revenue (contract assets), and deferred revenues (contract liabilities). This decrease in contract liabilities was partially offset by decreases in net income and certificate of deposit.respectively.

Investing Activities

During the six months ended June 30, 2023 and the nine months ended September 30, 2022, our investing activities (used) $(182,528) of net cash as compared to net cash (used) in investing activities of $(35,687) during the six months ended June 30, 2022. The change in cash (used) in investing activities was primarily attributable to the purchases of property, plant,used $182,528 and
81

Table of Contents
equipment for $108,394. Net cash (used) in investing activities also increased due to an increase in accounts receivable for expenses related to the Merger and payments to members / affiliates as a result of payroll true up with the LMA entity for shared employees. $130,821, respectively.

Financing Activities

During the six months ended June 30, 2023 financing activities (used) $(443,694) of net cash as compared to $(671,726) duringand the sixnine months ended June 30, 2022. Net cash (used) in financing activities during the six months ended June 30, 2023, was primarily related to the distribution to members of $442,283. Net cash (used) in financing activities for the six months ended JuneSeptember 30, 2022, was primarily related to a distribution to members of $659,869, offset by a $11,857 change in due from membersour financial activities used $443,694 and affiliates.$673,165, respectively.


100

Table of Contents
Contractual Obligations and Commitments

Our contractual obligations as of June 30, 2023, which are included as liabilities on our balance sheet, include operating lease obligations of $190,521 with $177,873 due in less than one year and $12,648 due within one to three years, which are comprised of the minimum commitments for our office space.

Critical Accounting Policies and Estimates

We have prepared our financial statements in accordance with GAAP. Our significant accounting policies are described in more detail in Note 2 to our financial statements included in this quarterly filing statement. While our preparation of these financial statements requires us to make estimates, assumptions and judgments from time to time that may affect the reported amounts of assets, liabilities and related disclosures, as of the date of these financial statements, we have not identified any estimates made in accordance with generally accepted accounting principles that involve a significant level of estimation uncertainty which have had or are reasonably likely to have a material impact on the financial condition or results of operations.

Related Party Receivables

Related party receivables include fees to be reimbursed to Abacus from life expectancy reports, assisted physician services and escrow services incurred on policies that related party financing entities purchase as part of the origination agreement with Abacus. Related party receivables are stated at their net realizable value. All of the outstanding receivables of $5,710 as of June 30, 2023 were collected in July, 2023 and 55%2023. About 36% of these fees due or $386,724 as of JuneSeptember 30, 2022, were collected in July,October 2022. Abacus provides an allowance for doubtful accounts equal to the estimated collection losses that will be incurred in collection of all receivables. The estimated losses are based upon historical collection experience coupled with a review of the current status of all existing receivables. Account balances are charged off against the allowance for doubtful accounts after all means of collection have been exhausted and the potential for recovery is remote. There is no allowance for doubtful accounts as of June 30, 2023 or JuneSeptember 30, 2022.

Intangible Assets

Intangible assets are stated at cost, less accumulated amortization, and consist of capitalized costs incurred for the development of internal use software. The costs incurred exclusively consist of fees incurred from an external consulting firm during the development stage of the project and are subject to capitalization under ASC 350-40, Internal-Use Software. The software is amortized on the straight-line basis over an estimated useful life of 3 years. Abacus reviews definite-lived intangible assets and other long-lived assets for impairment at least annually or whenever an event occurs that indicates the carrying amount of an asset may not be recoverable. No impairment was recorded for the three months endingended June 30, 2023 and September 30, 2022 or for the six months endingended June 30, 2023 and nine months ended September 30, 2022.





82

Table of Contents
Revenue Recognition

Abacus recognizes revenue from origination activities by acting as a provider of life settlements and viatical settlements representing investors that are interested in purchasing life settlements on the secondary or tertiary market. Revenue from origination services consists of fees negotiated for each purchase and sale of a policy to an investor, which also include any agent and broker commissions received and the reimbursement of transaction costs.


101

Table of Contents
Abacus’ revenue-generating arrangements are within the scope of Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Abacus originates life settlements policies with third parties that include settlement brokers, life insurance agents, and direct consumers or policyholders. Abacus then provides the administration services needed to initiate the transfer of the life settlement policies to investors in exchange for an origination fee. Such transactions are entirely performed through an escrow agent. In these arrangements, the customer is the investor, and Abacus has a single performance obligation to originate a life settlement policy for the investor. The consideration transferred upon each policy is negotiated directly with the investor by Abacus and is dependent upon the policy death benefits held by each life settlement policy. The revenue is recognized when the performance obligation under the terms of the contracts with customers are satisfied. Abacus recognizes revenue from life settlement transactions when the closing has occurred and any right of rescission under applicable state law has expired (i.e., the customer obtains control over the policy and has the right to use and obtain the benefits from the policy). While rescission periods may vary by state, most states grant the owner the right to rescind the contract before the earlier of 30 calendar days after the execution date of the contract or 15 calendar days after life settlement proceeds have been sent to the owner. Purchase and sale of the policies generally occurs simultaneously, and only the fees received, including any agent and broker commissions and transaction costs reimbursed, are recorded as gross revenue.

For agent and broker commissions received and transaction costs reimbursed, Abacus has determined that they are acting as the principal in the relationship as they maintain control of the services being performed as part of performance obligation prior to facilitating the transfer of the life settlement policy to the investor.

While the origination fees are fixed amounts based on the face value of the policy death benefit, there is variable consideration present due to the ownersowner’s rescission right. When variable consideration is present in a contract, Abacus estimates the amount of variable consideration to which it expects to be entitled at contract inception and again at each reporting period until the amount is known. Abacus applies the variable consideration constraint so that variable consideration is included in the transaction price only to the extent it is probable that a subsequent change in estimate will not result in a significant revenue reversal. While origination fees are variable due to the rescission periods, given the that the rescission periods are relatively short in nature, Abacus has concluded that such fees are fully constrained until the rescission period lapses and thus records revenue at a fixed amount based on the face value of the policy death benefit after the rescission period is over.
Item 3. Quantitative and Qualitative Disclosures About Market Risk

Not required for smaller reporting companies.

JOBS Act Election

Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable.

83102

Table of Contents
Abacus Settlement, LLC. has irrevocably elected to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, Abacus Settlement, LLC., as an emerging growth company, will adopt the new or revised standard at the time public companies adopt the new or revised standard. As a result, following the consummation of the Business Combination, Abacus Life, Inc. will comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies.
Item 4. Controls and Procedures

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. In light of the restatement of our financial statements included in this Annual Report on Form 10-K, we plan to enhance our processes to identify and appropriately apply applicable accounting requirements to better evaluate and understand the nuances of the complex accounting standards that apply to our financial statements. Our plans at this time include providing enhanced access to accounting literature, research materials and documents and increased communication among our personnel and third-party professionals with whom we consult regarding complex accounting applications. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects.
84103

Table of Contents
Part II Other Information
Item 1. Legal Proceedings

From time-to-time, the Company is involved in various civil actions as part of its normal course of business. The Company is not a party to any litigation that is material to ongoing operations as defined in Item 103 of Regulation S-K as of the period ended June 30, 2023.
Item 1A. Risk Factors
Factors that could cause our actual results to differ materially from those in this report include the risk factors described in our Annual Report on Form 10-K filed with the SEC on April 18, 2023. As of the date of this Report, other than material weakness related to financial instruments and accounting for accruals, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
None
Item 3. Defaults Upon Senior Securities
None
Item 4. Mine Safety Disclosures
None
Item 5. Other Information
None
Item 6. Exhibits
The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.
Exhibit
Number
Description
3.1
3.2
4.3
4.4
4.5
4.6
4.7
85104

Table of Contents
4.8
4.9
4.1
10.1
10.2
10.3
10.4
10.5
10.6
10.7
10.8
14.1
21.1
31.1
31.2
32.1
32.2
104*
* Filed herewith












86

Table of Contents

EXHIBIT 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Jay Jackson, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Abacus Life, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
87

Table of Contents
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: August 14, 2023
/s/ Jay Jackson
Jay Jackson
Chief Executive Officer
(Principal Executive Officer)











































88

Table of Contents
EXHIBIT 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, William McCauley, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Abacus Life, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
89

Table of Contents
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: August 14, 2023
/s/ William McCauley
William McCauley
Chief Financial Officer
(Principal Accounting and Financial Officer)



















































90

Table of Contents
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Abacus Life, Inc. (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2023, as filed with the Securities and Exchange Commission (the “Report”), I, Jay Jackson, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as added by §906 of the Sarbanes-Oxley Act of 2002, that:

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.




Dated: August 14, 2023


/s/ Jay Jackson
Jay Jackson
Chief Executive Officer
(Principal Executive Officer)


























91

Table of Contents
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Abacus Life, Inc. (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2023, as filed with the Securities and Exchange Commission (the “Report”), I, William McCauley, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as added by §906 of the Sarbanes-Oxley Act of 2002, that:

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.







Dated: August 14, 2023

/s/ William McCauley
William McCauley
Chief Financial Officer
(Principal Accounting and Financial Officer)
92105

Table of Contents
Signatures
93